<SEC-DOCUMENT>0001193125-21-108254.txt : 20210407
<SEC-HEADER>0001193125-21-108254.hdr.sgml : 20210407
<ACCEPTANCE-DATETIME>20210407081453
ACCESSION NUMBER:		0001193125-21-108254
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20210506
FILED AS OF DATE:		20210407
DATE AS OF CHANGE:		20210407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DELCATH SYSTEMS, INC.
		CENTRAL INDEX KEY:			0000872912
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				061245881
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16133
		FILM NUMBER:		21810727

	BUSINESS ADDRESS:	
		STREET 1:		1633 BROADWAY
		STREET 2:		SUITE 22C
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		(212) 489-2100

	MAIL ADDRESS:	
		STREET 1:		1633 BROADWAY
		STREET 2:		SUITE 22C
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DELCATH SYSTEMS INC
		DATE OF NAME CHANGE:	19990607
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d153004ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:17pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:17pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:17pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Rule <FONT STYLE="white-space:nowrap">14a-101)</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9746;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to &#167; <FONT STYLE="white-space:nowrap">240.14a-12</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:21pt; font-family:Times New Roman" ALIGN="center"><B>Delcath Systems, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11</FONT>
(Set forth the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g153004g70x52.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1633 Broadway, Suite 22C </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10019 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;7,
2021 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders of Delcath Systems, Inc.: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are
cordially invited to attend our annual meeting of stockholders to be held at 9:30 a.m. Eastern Time, on Thursday, May&nbsp;6, 2021 in a virtual format. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to continued public health concerns related to the <FONT STYLE="white-space:nowrap">COVID-19,</FONT> pandemic, and to support the health and
safety of all of our stockholders and other meeting participants, and taking into account current federal, state and local guidance, we have determined that the annual meeting will be held in a virtual meeting format only, via the Internet, with no
physical <FONT STYLE="white-space:nowrap">in-person</FONT> meeting. Stockholders will be able to attend, vote and submit questions (both before, and for a portion of, the meeting) from any location via the Internet at
<U>www.virtualshareholdermeeting.com/DCTH2021</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information regarding each of the matters to be voted on at the virtual annual meeting is contained in
the accompanying Notice of Annual Meeting of Stockholders and Proxy Statement. Our Board of Directors recommends that you vote &#147;for&#148; each of the proposals to be presented at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whether or not you plan to attend the virtual annual meeting, we urge you to complete, sign and date the accompanying proxy card and return it in the enclosed
postage-prepaid envelope as soon as possible. If you later decide to attend the virtual annual meeting or change your vote, you may withdraw your proxy and vote via the Internet, by telephone or at the virtual annual meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your vote is important. Whether you own a few shares or many, and whether or not you plan to attend the virtual annual meeting, it is important that your
shares be represented and voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We thank you for your continued support of Delcath Systems, Inc. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g153004g66y02.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gerard Michel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g153004g70x52.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1633 Broadway, Suite 22C </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10019 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON MAY&nbsp;6, 2021 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the Stockholders of Delcath Systems, Inc.: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice is hereby given that the 2021 Annual Meeting of Stockholders of Delcath Systems, Inc., a Delaware corporation (the &#147;Company&#148;),
will be held at 9:30 a.m. Eastern Time on Thursday, May&nbsp;6, 2021, in a virtual format only for the purpose of considering and taking action on the following proposals: </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to elect two Class&nbsp;III nominees as Class&nbsp;III directors for a term expiring at the 2024 annual meeting
of the Company&#146;s stockholders and until their successors are elected and qualified; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to approve an amendment of the Company&#146;s 2020 Omnibus Equity Incentive Plan to increase by 1,800,000
shares the number of shares available under the 2020 Omnibus Equity Incentive Plan; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to ratify the selection, by the Audit Committee of our Board of Directors, of Marcum LLP as the independent
registered public accounting firm of the Company for the fiscal year ending December&nbsp;31, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation of our
named executive officers as disclosed in the proxy statement; and </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to transact such other business as may properly come before the 2021 Annual Meeting or any adjournments
thereof. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The matters listed in this notice of annual meeting of stockholders are described in detail in the accompanying
proxy statement. The Board is not aware of any other business to come before the 2021 Annual Meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has fixed the close of
business on March&nbsp;12, 2021 as the record date for determining those stockholders who are entitled to notice of and to vote at the 2021 Annual Meeting or any adjournment of our 2021 Annual Meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In response to continued public health concerns related to the <FONT STYLE="white-space:nowrap">COVID-19,</FONT> pandemic, and to support the
health and safety of all of our stockholders and other meeting participants, and taking into account current federal, state and local guidance, we have determined that the Annual Meeting will be held in a virtual meeting format only, via the
Internet, with no physical <FONT STYLE="white-space:nowrap">in-person</FONT> meeting. Stockholders will be able to attend, vote and submit questions (both before, and for a portion of, the meeting) from any location via the Internet at
<U>www.virtualshareholdermeeting.com/DCTH2021</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A complete list of registered stockholders entitled to vote at the Annual Meeting will
be available for ten days prior to the Annual Meeting for any purposes germane to the Annual Meeting between the hours of 9:00 a.m. and 5:00 p.m., at our principal executive offices at 1633 Broadway, Suite 22C, New York, New York 10019, by
contacting the Secretary of the Company. Due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, registered stockholders must make an appointment and must comply with the Company&#146;s <FONT STYLE="white-space:nowrap">COVID-19</FONT>
protocols. The list will be available at the Annual Meeting, and through the conclusion of the Annual Meeting, on the virtual Annual Meeting website at www.virtualshareholdermeeting.com/DCTH2021. Only those persons logging into the virtual Annual
Meeting as a registered stockholder will be able to access the list. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><U>Your vote is important</U></B><B>.</B> Whether or not you plan
to attend the virtual Annual Meeting, please submit a proxy as promptly as possible by using the internet or the designated toll-free telephone number, or by signing, dating and returning by mail the proxy card in the return envelope provided. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On or about April&nbsp;7, 2021, we will commence mailing of the proxy statement and form of proxy. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">By order of the Board</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em" ALIGN="center">


<IMG SRC="g153004g12w27.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em" ALIGN="center">


<IMG SRC="g153004g66y02.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Roger G. Stoll, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gerard Michel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 7, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chair of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Executive Officer</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE
OF CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_1">INFORMATION ABOUT THE 2021 ANNUAL MEETING AND VOTING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">1</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_2">PROPOSAL 1: ELECTION OF TWO CLASS III DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">7</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_3">PROPOSAL 2: APPROVAL OF THE AMENDMENT OF DELCATH SYSTEMS, INC. 2020 OMNIBUS
 EQUITY INCENTIVE PLAN</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">10</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_4">PROPOSAL 3: RATIFICATION OF THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD
OF DIRECTORS, OF MARCUM LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2021</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">18</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_5">PROPOSAL 4: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE NAMED EXECUTIVE
 OFFICER COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">20</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_6">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">21</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_7">CORPORATE GOVERNANCE AND RELATED MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">24</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_15">TRANSACTIONS WITH RELATED PERSONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">28</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_16">DIRECTOR COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">29</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_17">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">30</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_18">EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">30</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_8">COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">33</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_9">SUMMARY COMPENSATION TABLE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">34</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_19">GRANTS OF PLAN-BASED AWARDS&#151;2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">35</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_20">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END&#151;2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">35</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_21">EMPLOYMENT ARRANGEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">36</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_22">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">38</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_10">AUDIT COMMITTEE REPORT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">39</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_11">STOCKHOLDER PROPOSALS FOR THE 2022 ANNUAL MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">40</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_12">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">41</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">41</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc153004_14">APPENDIX A: DELCATH SYSTEMS, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN, AS AMENDED
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g153004g70x52.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1633 Broadway, Suite 22C </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10019 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_1"></A>INFORMATION ABOUT THE 2021 ANNUAL MEETING AND VOTING </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The enclosed proxy is solicited by the Board of Directors of Delcath Systems, Inc. (&#147;Delcath,&#148; &#147;we,&#148; &#147;our,&#148;
&#147;us&#148; or &#147;the Company&#148;) to be voted at our 2021 Annual Meeting of Stockholders (the &#147;2021 Annual Meeting&#148;) to be held at 9:30 a.m. Eastern Time on May&nbsp;6, 2021 in a virtual meeting format only at
<U>www.virtualshareholdermeeting.com/DCTH2021</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>the Stockholder Meeting to be Held on May&nbsp;6, 2021</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.30em; margin-right:0.30em; font-size:10pt; font-family:Times New Roman" ALIGN="center">A copy of the this Proxy Statement, the Form of Proxy Cards, the Notice of Annual Meeting of
Stockholders, and the Company&#146;s 2020 Annual Report are available on the Internet at <U>www.proxyvote.com</U> as well as the 2021 Annual Meeting website referenced below.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Purpose of the 2021 Annual Meeting.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and vote on the following proposals:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(1)&#8194;&#8201;&#8202;to elect the two Class&nbsp;III nominees named in this proxy statement as Class&nbsp;III
directors to hold office until the 2024 annual meeting of the Company&#146;s stockholders and until their successors are elected and qualified;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(2)&#8194;&#8201;&#8202;to approve an amendment of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(3)&#8194;&#8201;&#8202;to ratify the selection,
by the Audit Committee of our Board of Directors, of Marcum LLP as the independent registered public accounting firm of the Company for the fiscal year ending December&nbsp;31, 2021;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(4)&#8194;&#8201;&#8202;to approve, on a <FONT
STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation of our named executive officers as disclosed in this proxy statement; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(5)&#8194;&#8201;&#8202;to transact such other business as may properly come before the 2021 Annual Meeting or any
adjournment or postponement thereof.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Stockholders entitled to vote.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only stockholders of record at the close of business on March&nbsp;12, 2021 are entitled to notice of and to vote at the 2021 Annual
Meeting. At the close of business on March&nbsp;12, 2021, there were 6,249,807 shares of our common stock, $0.01 par value per share (the &#147;Common Stock&#148;), 17,506 shares of our Series E Convertible Preferred Stock, $0.01 par value per
share, and 2,975 shares of our Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock issued, outstanding and entitled to vote.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Beneficial Ownership Limitation: The voting of the Series E Convertible Preferred Stock and the Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible
Preferred Stock (referred to in this paragraph as the &#147;Convertible Preferred&#148;) is limited by the certificates of designation for such</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Convertible Preferred, which provide that the Company shall not affect any conversion of the Convertible Preferred, and a holder of Convertible Preferred will not have the right to convert any portion of the Convertible
Preferred, to the extent that, after giving effect to the conversion, the holder (together with its affiliates and any persons acting as a group together with the holder or any of the holder&#146;s affiliates) (such persons, &#147;Attribution
Parties&#148;), would beneficially own in excess of the Beneficial Ownership Limitation. For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such holder and its affiliates and Attribution Parties shall
include the number of shares of Common Stock issuable upon conversion of the Convertible Preferred with respect to which such determination is being made, but will exclude the number of shares of Common Stock which are issuable upon
(i)&nbsp;conversion of the remaining, unconverted Stated Value of Convertible Preferred beneficially owned by such holder or any of its affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion of the unexercised or unconverted portion
of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained in the certificate of designations (including, without limitation, the Convertible Preferred and related warrants),
beneficially owned by such holder or any of its affiliates or Attribution Parties. To the extent that the Beneficial Ownership Limitation applies, the determination of whether the Convertible Preferred is convertible (in relation to other securities
owned by such holder together with any affiliates and Attribution Parties) and of how many shares of Convertible Preferred are convertible is in the sole discretion of such holder, and the submission of a notice of conversion to the Company will be
deemed to be such holder&#146;s determination of whether the shares of Convertible Preferred may be converted (in relation to other securities owned by such holder together with any affiliates and Attribution Parties) and how many shares of the
Convertible Preferred are convertible, in each case subject to the Beneficial Ownership Limitation. The &#147;Beneficial Ownership Limitation&#148; is 4.99% (or, upon written election by a holder which is delivered to the Company prior to the
issuance of any shares of Convertible Preferred to such holder, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Convertible
Preferred held by the applicable holder. A holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation applicable to its Convertible Preferred provided that the Beneficial Ownership Limitation in no event exceeds
9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of Convertible Preferred held by the holder. Any such increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> day after such notice is delivered to the Company and will only apply to such holder and no other holder.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Number of votes.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Holders of Common Stock have one vote for each share of Common Stock held and holders of the Series E Convertible Preferred Stock and the Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock are entitled
to vote with the holders of shares of Common Stock, and not as a separate class, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, subject to the Beneficial Ownership Limitation applicable to the Series E Convertible Preferred Stock
and the Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock as set forth in the Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock and Certificate of Designation of
Preferences, Rights and Limitations of Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock, incorporated by reference as Exhibits 4.1 and 4.2 to the Company&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2020.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The shares of Series E Convertible Preferred Stock are convertible
into an aggregate of 1,750,600 shares of Common Stock and the shares of Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock are convertible into an aggregate of 297,500 shares of Common Stock, amounting to an aggregate of
2,048,100 shares of Common Stock, prior to taking into account the Beneficial Ownership Limitations. The aggregate number of shares entitled to vote, including all Common Stock, Series E Convertible Preferred Stock and Series <FONT
STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock on an as converted basis, after taking into account Beneficial Ownership Limitations, is 6,827,307 shares.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Attending the virtual meeting</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders of record as of March&nbsp;12, 2021 will be able to participate in the 2021 Annual Meeting by visiting our 2021 Annual
Meeting website at <U>www.virtualshareholdermeeting.com/DCTH2021</U>. To participate in the 2021 Annual Meeting, you will need the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number included on your proxy card or on the instructions
that accompanied your proxy materials.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2021 Annual Meeting will begin promptly
at 9:30 a.m. Eastern time on Thursday, May&nbsp;6, 2021.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Online <FONT
STYLE="white-space:nowrap">check-in</FONT> will begin at 9:15 a.m. Eastern time, and you should allow approximately 15 minutes for the online <FONT STYLE="white-space:nowrap">check-in</FONT> procedures.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>How to Vote.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whether or not you plan to virtually attend the 2021 Annual Meeting and regardless of the number of shares of the Company&#146;s Common
Stock or Preferred Stock that you own, please cast your vote, at your earliest convenience, as instructed in the proxy card and/or voting instruction form. Your vote is very important. Your vote before the 2021 Annual Meeting will ensure
representation of your shares at the 2021 Annual Meeting even if you are unable to virtually attend. You may submit your vote by the Internet, telephone, mail or during virtual attendance at the 2021 Annual Meeting. Voting over the Internet or by
telephone is fast and convenient, and your vote is immediately confirmed and tabulated. By using the Internet or telephone, you help us reduce postage, printing and proxy tabulation costs. We encourage all holders of record to vote in accordance
with the instructions on the proxy card and/or voting instruction form prior to the 2021 Annual Meeting even if they plan on virtually attending the meeting. Submitting a vote before the 2021 Annual Meeting will not preclude you from voting your
shares at the meeting should you decide to virtually attend.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">You may vote using the
following methods:</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="70%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;


<IMG SRC="g153004g41v01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Visit the website listed on your proxy card/voting instruction form to vote via<BR>the Internet.</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">&nbsp;&nbsp;


<IMG SRC="g153004g41v02.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle">Sign, date and return your proxy card/voting instruction form to vote by mail.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">During the 2021 Annual Meeting, visit our 2021 Annual Meeting website at<BR><U>www.virtualshareholdermeeting.com/DCTH2021</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;


<IMG SRC="g153004g41v03.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Call the telephone number on your proxy card/voting instruction form to vote by telephone.</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Quorum.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The presence of the holders of a majority of the shares of the Company&#146;s Common Stock and preferred stock (on an as converted to Common Stock basis) issued and outstanding and entitled to vote at the 2021 Annual Meeting,
logging in to virtually attend the 2021 Annual Meeting using the control number or represented by proxy, will constitute a quorum for purposes of voting at the 2021 Annual Meeting. Abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> are counted as present and entitled to vote for purposes of determining a quorum.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Broker <FONT STYLE="white-space:nowrap">non-votes.</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you do not provide your bank, broker or other nominee with instructions on how to vote your shares held in &#147;street name,&#148;
your bank, broker or other nominee will have discretionary authority to vote your shares with respect to &#147;routine&#148; proposals, but not with respect to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> proposals.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Routine proposal. Proposal 3
(ratification of the appointment of our independent registered public accounting firm) is a routine proposal and may be voted upon by your bank, broker or other nominee if you do not submit voting instructions to your bank, broker or other
nominee.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&#149;&#8195;&#8202;Non-routine</FONT> proposals. Proposals 1 (the election of two
Class&nbsp;III nominees), 2 (the approval of an amendment of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan) and 4 (the approval, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis of the executive compensation of
the Company&#146;s named executive officers as described in the proxy statement) are <FONT STYLE="white-space:nowrap">non-routine</FONT> proposals and may not be voted upon by your bank, broker or other nominee in the absence of specific
instructions from you as to how you would like your shares to be voted. <B>If you hold your shares in &#147;street name,&#148; we strongly encourage you to provide instructions regarding the voting of your shares as your bank, broker or other
nominee cannot vote your shares with respect to these proposals without voting instructions from you. </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vote required; treatment of abstentions and broker <FONT STYLE="white-space:nowrap">non-votes.</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal 1 (Election of Two Class</I><I></I><I>&nbsp;III Directors)</I>: Under Delaware law, directors are elected by the affirmative
vote of a plurality of the shares of stock present in person or represented by proxy and entitled to vote at the Annual Meeting. This means that with respect to the election of two Class&nbsp;III directors to hold office until the 2024 annual
meeting of stockholders, the nominees receiving the greatest number of affirmative votes cast are elected as directors.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may either vote &#147;<B>FOR</B>&#148; or &#147;<B>WITHHOLD</B>&#148; authority to vote for each nominee for the Board. Shares present at the meeting or
represented by proxy and entitled to vote where the stockholder properly withholds authority to vote for such nominee in accordance with the proxy instructions will not be counted toward such nominee&#146;s achievement of plurality. Broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will not be included as &#147;votes cast&#148; with respect to Proposal 1 and will not have an effect on the outcome of such proposal.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares present or represented and not so marked as to withhold authority to vote for a
particular nominee will be voted in favor of a particular nominee and will be counted toward such nominee&#146;s achievement of a plurality.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Proposals 2 (Amendment to Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan), 3 (Ratification of Appointment of Marcum LLP) and 4 <FONT
STYLE="white-space:nowrap">(Non-Binding</FONT> Advisory Vote on Executive Compensation): </I>The affirmative vote of a majority of the shares of stock present in person or represented by proxy at the 2021 Annual Meeting and entitled to vote is
required for the approval of Proposal 2 (the approval of an amendment of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan), Proposal 3 (the ratification of the appointment of our independent registered public accounting firm) and
Proposal 4 (the approval, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis of the executive compensation of the Company&#146;s named executive officers as described in the proxy statement). With respect to Proposals 2, 3 and
4, you may vote &#147;<B>FOR</B>,&#148; &#147;<B>AGAINST</B>&#148; or &#147;<B>ABSTAIN</B>.&#148;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A vote to &#147;<B>ABSTAIN</B>&#148; will have the effect of a vote
&#147;<B>AGAINST</B>&#148; Proposals 2, 3 and 4. With respect to Proposal 3 (the ratification of the appointment of our independent registered public accounting firm), because this proposal is considered a &#147;routine&#148; matter under applicable
stock exchange rules, we do not expect to receive any broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on this proposal. Proposals 2 and 4 are considered <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters; therefore,
your bank, broker or other nominee does not have discretion to vote your shares with respect to these Proposals without voting instructions from you and, in the absence of such voting instructions, your shares will not affect the outcome of the
Proposals.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">With respect to Proposals 2, 3 and 4, if you just sign and submit your
proxy card without marking your voting instructions, your shares will be voted &#147;<B>FOR</B>&#148; such proposal by the proxies.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Voting recommendation of the Board of Directors; voting of proxies.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Our Board recommends a vote &#147;<B>FOR&#148;</B> all of&nbsp;the Proposals. Your shares will be voted in accordance with the instructions contained in your signed proxy card. <B></B><B>If you return a signed proxy card without
giving specific voting instructions with respect to each Proposal, proxies will be voted in favor of the Board&#146;s recommendations with respect to the Proposals as set forth in this Proxy Statement. </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>How to revoke your proxy.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your proxy is revocable. The procedure you must follow to revoke your proxy depends on how you hold your shares.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a registered holder of our Common Stock or Preferred Stock, you may revoke a
previously submitted proxy by submitting another valid proxy (whether by telephone, the Internet or mail) or by providing a signed letter of revocation to the Corporate Secretary of the Company before the closing of the polls at the virtual annual
meeting on May&nbsp;6, 2021. Only the latest-dated validly executed proxy will count. You also may revoke any previously submitted proxy and vote your shares online during the virtual annual meeting; however, simply attending the 2021 Annual Meeting
in virtual format without taking one of the above actions will not revoke your proxy.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">If you hold shares in street name, in general, you may revoke a previously submitted voting instruction by submitting to your broker/custodian another valid
voting instruction (whether by telephone, the Internet or mail) or a signed letter of revocation. Please contact your bank, broker or other nominee for detailed instructions on how to revoke your voting instruction and the applicable deadlines.
Please note that your attendance at the virtual annual meeting in and of itself will not be sufficient to revoke your proxy.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Expenses and solicitation.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">We will bear the cost for the solicitation of proxies, including printing and mailing costs. In addition to the solicitation of proxies by mail, proxies may also be solicited personally by directors, officers and employees of
Delcath, without additional compensation to these individuals. Delcath will request that banks, brokers and other firms holding shares in their names that are beneficially owned by others to forward proxy materials to and obtain proxies from such
beneficial owners, and will reimburse such banks, brokers and other firms for their reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Other matters.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">We are not aware of any matters to be presented at the 2021 Annual Meeting other than those described in this Proxy Statement. If any matters not described in this Proxy Statement are properly presented at the 2021 Annual
Meeting, the proxy holders will use their own judgment to determine how to vote your shares. If the 2021 Annual Meeting is adjourned or postponed, the proxy holders can vote your shares at the new meeting as well unless you have subsequently revoked
your proxy.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vote results.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The preliminary results of the voting on the proposals will be reported at the 2021 Annual Meeting. The final certified results of the voting will be reported in a Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> within four business days after the 2021 Annual Meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Who should I call if I have additional questions?</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">If you hold your shares directly, please call Delcath&#146;s transfer agent, American Stock Transfer and Trust Company, LLC
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at&nbsp;1-800-937-5449.&nbsp;If</FONT></FONT></FONT> your shares are held in street name, please call the telephone number provided on your proxy card
or contact your bank, broker or other nominee holding your shares directly.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_2"></A>PROPOSAL 1: ELECTION OF TWO CLASS III DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws, each as currently amended and in effect, state that our Board of Directors (the
&#147;Board&#148;) will consist of a number of directors that will be fixed exclusively by the Board from time to time in accordance with the bylaws of the Company. Our Board has fixed the number of directors comprising the Board of Directors at six
members. Each director holds office until his or her successor is duly elected and qualified or until his or her death, incapacity, resignation or removal. Any vacancy in the Board, including a vacancy that results from an increase in the number of
directors, may be filled only by the vote of a majority of the remaining directors then in office. Our certificate of incorporation also provides that our Board is divided into three classes of directors, with the classes as nearly equal in number
as possible. Subject to any earlier resignation or removal in accordance with the terms of our certificate of incorporation and bylaws, our current Class&nbsp;III directors, if elected, will serve until the 2024 Annual Meeting of Stockholders; our
current Class&nbsp;I directors will serve until the 2022 Annual Meeting of Stockholders; and our current Class&nbsp;II directors will serve until the 2023 Annual Meeting of Stockholders. Any additional directorships resulting from an increase in the
number of directors will be apportioned by our Board among the three classes as equally as possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has nominated Roger G.
Stoll, Ph.D. and Steven Salamon for election as Class&nbsp;III directors at the 2021 Annual Meeting, to serve until the 2024 Annual Meeting of Stockholders. Both of the nominees are presently directors, and both have indicated a willingness to
continue to serve as director, if elected. If a nominee becomes unable or unwilling to serve, proxies may be voted for substitute nominees selected by our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominees for Election as Class&nbsp;III Directors </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Position&nbsp;with&nbsp;Delcath</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director&nbsp;Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roger G. Stoll, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Salamon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Mr.&nbsp;Salamon was appointed as a director on May&nbsp;6, 2020 to fill a vacancy on our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Biographical information, including principal occupation and business experience during the last five years, for our director nominees is set
forth below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Roger G. Stoll, Ph.D. </I></B>was appointed as a director of the Company in December 2008. He became Executive Chairman in September
2014 and has served as Chairman of the Board&nbsp;since October 2015. From 2002 to 2008 he served as Chairman and Chief Executive Officer of Cortex Pharmaceuticals, Inc. (now RespireRx Pharmaceuticals Inc.) (&#147;Cortex&#148;).&nbsp;In August 2008
he was appointed Executive Chairman of the board of directors of Cortex and served in such role until his retirement in 2012. From 2001 to 2002 he was a consultant to several east coast venture capital firms and startup ventures.&nbsp;From 1998 to
2001, he&nbsp;was Executive Vice President of Fresenius Medical Care-North America, in charge of the dialysis products division and the diagnostic business units, which included hemodialysis machines, dialysis filters, dialysate solutions, and
attendant devices used in the dialysis procedure.&nbsp;From 1991 to 1998, Dr.&nbsp;Stoll was Chief Executive of Ohmeda, a global leader in anesthetic agents, critical care drugs and related operating room devices with sales of $1&nbsp;billion
annually. From 1994 until the sale of Ohmeda in 1998, he was also a member of the board of directors of The BOC Group, plc in London, UK (now part of Linde). From 1986 to 1991, Dr.&nbsp;Stoll held several positions of increasing responsibility at
Bayer, AG, including, Chief Administrative Officer, President of Bayer&#146;s Consumer Healthcare business unit, and Executive Vice-President and General Manager for its worldwide Diagnostic Business Group, which included the acquisition of Cooper
Technicon and the global integration of the Bayer and Technicon business units and resulted in a global diagnostic business in excess of $1&nbsp;billion in sales annually.&nbsp;Prior to that he worked for American Hospital Supply Corporation, where
he rose from Director of Clinical Pharmacology to President of the American Critical Care Drug division. Mr.&nbsp;Stoll began his pharmaceutical career at the Upjohn Company working in drug metabolism and pharmacokinetic studies in a clinical
development unit in 1972.&nbsp;Dr.&nbsp;Stoll obtained his BS in Pharmacy degree at Ferris State University, his PhD in Biopharmaceutics and Drug </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Metabolism at the University of Connecticut and was a post-doctoral fellow for two years at the University of Michigan.&nbsp;He served on the Board of Directors of Questcor
Pharmaceuticals&nbsp;from 1999 to 2005 and on the boards of Agensys, Inc. from 2003 until its sale to Astellas in late 2007 and Chelsea Therapeutics from 2008 until it was acquired in 2014 by Lundbeck A/S.&nbsp;From 1991 to 2002, Dr.&nbsp;Stoll also
served on the board of directors of St. Jude Medical (1991 to 2001) and the industry boards HIMA and PMA (now PhRMA). Dr.&nbsp;Stoll also serves on the University of Connecticut School of Pharmacy Advisory Board.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that Dr.&nbsp;Stoll&#146;s extensive management experience in the pharmaceutical and medical devices and equipment industries qualifies him to
serve on our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Steven Salamon</I></B> was appointed as a director of the Company in May 2020. Mr.&nbsp;Salamon is a <FONT
STYLE="white-space:nowrap">co-founder</FONT> of and has served as Portfolio Manager at Rosalind Advisors, Inc., a life sciences-focused investment manager (&#147;Rosalind Advisors&#148;), since 2006. Mr.&nbsp;Salamon holds a MBA from the Ivey
Business School and an Engineering Physics degree from the University of Toronto. Prior to <FONT STYLE="white-space:nowrap">co-founding</FONT> Rosalind Advisors, Mr.&nbsp;Salamon worked as an equity analyst at HSBC Securities and RBC Capital Markets
(formerly RBC Dominion Securities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that Mr.&nbsp;Salamon&#146;s qualifications to sit on our Board include, among other
things, his financial and investment industry experience, his understanding of our business and our industry and his strategic insight. In addition, Mr.&nbsp;Salamon provides a valuable stockholder perspective to the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; THE ELECTION OF THE TWO CLASS III DIRECTOR NOMINEES. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors Continuing in Office </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Position&nbsp;with&nbsp;Delcath</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director&nbsp;Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gilad Aharon, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Director</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elizabeth Czerepak</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Director</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Director</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Sylvester</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Director</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biographical information, including principal occupation and business experience during the last five years, for our directors
whose terms continue is set forth below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;I Directors (Term Expires at 2022 Annual Meeting) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gilad Aharon, Ph.D.</I></B> was appointed as a director of the Company in May 2020. Dr.&nbsp;Aharon is a
<FONT STYLE="white-space:nowrap">co-founder</FONT> of and has served as a Portfolio Manager at Rosalind Advisors, since 2006. Dr.&nbsp;Aharon holds a Ph.D. in Biophysics and Molecular Biology from the University of Toronto. Prior to <FONT
STYLE="white-space:nowrap">co-founding</FONT> Rosalind Advisors, Dr.&nbsp;Aharon worked as an equity analyst at Infinium Securities Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that
Dr.&nbsp;Aharon&#146;s qualifications to sit on our Board include, among other things, his financial and investment industry experience, his understanding of our business and our industry and his educational background. In addition, Dr.&nbsp;Aharon
provides a valuable stockholder perspective to the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gerard Michel</I></B> was appointed as a director of the Company and its Chief Executive
Officer in October 2020. Mr.&nbsp;Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. Prior to joining the Company as its Chief Executive Officer on October&nbsp;1, 2020,
he was Chief Financial Officer of Vericel Corp., a biopharmaceutical company, since June 2014 where he was a key member of the management team which integrated a transformative acquisition and revised the company&#146;s business model from a
research focused company to a fully integrated, profitable commercial business. Mr.&nbsp;Michel also served as Chief Financial Officer and Vice President, Corporate Development of Biodel, Inc. from November 2007 to May 2014, and Chief Financial
Officer and Vice President of Corporate Development of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
NPS Pharmaceuticals Inc. from August 2002 to November 2007. Prior to that, Mr.&nbsp;Michel was a Principal at Booz Allen and held a variety of commercial roles at both Lederle Labs and Wyeth
Labs. Mr.&nbsp;Michel holds a M.S. in Microbiology from the University of Rochester School of Medicine, an M.B.A. from the Simon School of Business, and a B.S. in both Biology and Geology from the University of Rochester. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that Mr.&nbsp;Michel&#146;s leadership experience as a senior executive of a publicly traded biopharmaceutical company qualifies him to serve on
our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information concerning Gerard Michel, one of our directors and our Chief Executive Officer, is provided under
&#147;&#151;Information About Our Executive Officers&#148; and elsewhere in this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;II Directors (Term Expires at 2023
Annual Meeting) </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Elizabeth Czerepak</I></B> was appointed as a director of the Company in February 2020. Ms.&nbsp;Czerepak serves as Chief
Financial Officer at BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies, since September 2020. Prior to that, from May 2018 to January 2020, she served as Chief
Financial Officer and Chief Business Officer of Genevant Sciences, Inc., a technology focused nucleic acid delivery company. Earlier experience includes CFO roles at other biotechnology companies including Altimmune, Inc NASDAQ:ALT), Isarna
Therapeutics, and Cancer Genetics (NASDAQ:CGIX), where she led Altimmune&#146;s IPO through reverse merger, and Cancer Genetics&#146; IPO and subsequent uplisting to NASDAQ. She has extensive experience in biotech venture capital investment as a
Managing Director at JP Morgan/Bear Stearns, where she led investments in 13 biotechs, providing primary support in completing large private financings, and exits through IPO and acquisition. Elizabeth began her career serving in senior and
executive level positions for 18 years at BASF Pharma, <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche, and Merck&nbsp;&amp; Co. Her pharma executive level experience includes M&amp;A, licensing, business development and finance.
Ms.&nbsp;Czerepak also serves on the board of directors and is chair of the Audit Committee of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) since June 2019. She also serves as a director of Scilex Holdings Company, a pharmaceutical company since
September 2019. Earlier, from 2001 to 2010, Ms.&nbsp;Czerepak served as a director for many, mostly private, companies in which she was an investor. She received a B.A. magna cum laude in Spanish and Mathematics Education from Marshall University
and an MBA from Rutgers University. In 2019, Elizabeth earned a Corporate Director Certificate from Harvard Business School. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that
Ms.&nbsp;Czerepak&#146;s extensive experience in the pharmaceutical and biotech industries, including as a senior finance executive of publicly traded biopharmaceutical companies, qualifies her to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>John R Sylvester</I></B> was appointed as a director of the Company in July 2019. He is currently serving as CEO of Curium Pharma&#146;s SPECT and
International businesses. Prior to that he served as Chief Commercial Officer of BTG plc, which he joined in 2011 and had roles leading both their Interventional Oncology and Interventional Vascular businesses as well as a period as Chief
Development Officer accountable for Strategy, M&amp;A and Market access. This culminated in an exit to Boston Scientific for $4.2&nbsp;billion. Prior to BTG, John was Managing Director of Biocompatibles plc, building their Interventional Oncology
business which led to a successful exit to BTG for &pound;166.0&nbsp;million. John joined Biocompatibles following a period as the Vice President of Marketing for Baxter Healthcare&#146;s $750.0&nbsp;million European Medication Delivery business
based in Brussels, then Zurich, accountable for six strategic business units incorporating drugs, devices and drug device combinations. Before this, John held a number of senior commercial roles in the industrial sector. Immediately prior to Baxter
Healthcare, John was the General Manager of a Minerals company with $4.0&nbsp;billion of assets on three continents, $500.0&nbsp;million of sales and 1,500 employees. John graduated with joint honors in Biochemistry and Applied Molecular Biology
from the University of Manchester. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that Mr.&nbsp;Sylvester&#146;s extensive international experience with business strategy
and commercialization in the healthcare space qualifies him to serve on our Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_3"></A>PROPOSAL 2: APPROVAL OF THE AMENDMENT OF DELCATH SYSTEMS, INC.
2020 OMNIBUS EQUITY INCENTIVE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are asking our stockholders to approve an amendment to the Company&#146;s 2020 Omnibus Equity
Incentive Plan, which we refer to in this Proposal as the &#147;2020 Plan,&#148; to increase the number of shares of the Company&#146;s Common Stock available for issuance under the 2020 Plan by 1,800,000. The 2020 Plan was initially adopted by the
Company&#146;s Board of Directors on September&nbsp;30, 2020, subject to stockholder approval, which was obtained at the Company&#146;s 2020 annual meeting of stockholders held on November&nbsp;23, 2020. Our Board unanimously approved the proposed
amendment (which we refer to in this Proposal as the &#147;Amendment&#148;) of the 2020 Plan on March&nbsp;30, 2021, subject to stockholder approval. If approved by the stockholders, the Amendment will become effective as of the date of the 2021
Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have recently announced positive <FONT STYLE="white-space:nowrap">top-line</FONT> preliminary results from our Phase 3
FOCUS trial of HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) in patients with liver dominant metastatic ocular melanoma (mOM), and the Company expects to resubmit its New Drug Application, or NDA, in the first quarter
of 2022. There remains a need to supplement the Company&#146;s 36 employees by recruiting new executives, including a General Counsel, Chief Financial Officer as well as senior medical and commercial officers and to make additional hires (to
supplement our current 36 employees) in order to prepare for U.S. commercialization of HEPZATO KIT, to expand our clinical development activities to include a broader set of solid tumors, to build out our manufacturing and sales capabilities and for
other operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not view the 95,000 shares remaining currently available for grant under the 2020 Plan as sufficient to allow us
to execute on our near-term plans, and the proposed increase in the share reserve under the 2020 Plan is expected to provide sufficient shares available for approximately the next two years as we scale the business. We are not able to provide a
public forecast as to the level of total shares outstanding and utilization of equity awards as a result of the unpredictability of the underlying assumptions and estimates. In particular, our actual usage of stock plan shares for employee awards
under the 2020 Plan will be impacted by changes in the number and level of our employees, the type of equity awards we grant, our potential growth and activities, the financial impact of grants and financing activities, as well as other factors,
such as industry performance and general business, economic, regulatory, market and financial conditions. These general factors and ones specific to our business are difficult to predict, many are beyond our control and some or all could combine to
change the expected life of the stock plan request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the increase in authorized shares is to secure adequate shares to fund
expected awards under the Company&#146;s long-term incentive program, which is intended to promote the interests of Delcath through grants of awards to employees, directors and consultants in order to: (i)&nbsp;attract and retain employees,
directors and consultants; (ii)&nbsp;provide an additional incentive to each award holder to work to increase the value of Delcath&#146;s stock; and (iii)&nbsp;provide each award holder with a stake in the future of Delcath that strengthens the
mutuality of interests between such award holder and Delcath&#146;s stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If approved by our stockholders, the Amendment will
increase by 1,800,000 shares of Common Stock the current authorization of 675,000 shares of Common Stock for equity compensation awards, for a total share reserve under the 2020 Plan of 2,475,000 shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining the amount of the increase contemplated by the Amendment, the Board has taken into consideration the analysis conducted by our
compensation consultant F. W. Cook, which looked to manage annual share spend, total overhang levels and competitive market grant practices in an appropriate manner. The analysis considered that we have a large number of outstanding <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> warrants and convertible preferred shares, which results in a capital structure that has approximately 12,500,000 common shares and common share equivalents
outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed reservation of an additional 1,800,000 shares under the 2020 Plan is most
appropriately considered as a percentage of the totality of common share equivalents with the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> warrants and convertible preferred shares included. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Another factor considered is our anticipated &#147;burn rate&#148; for issuances of new awards under the 2020 Plan over the next two years,
which is defined generally as (a)&nbsp;shares subject to options and other awards granted in the year, divided by (b)&nbsp;weighted-average common shares and common share equivalents outstanding for the applicable year (common share equivalents
include <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> warrants and convertible preferred shares). Taking into account our hiring plans over that period, we believe that our burn rate will be
approximately six percent (6%) if awards are granted as stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2021, only 95,000 shares of Common Stock
remained available for grant of future equity awards under the 2020 Plan. We believe that the additional 1,800,000 reserved shares will be sufficient to provide an adequate number of awards to the new employees that the Company intends to hire in
order to build out its team as discussed above, as well as to provide additional incentive awards to the Company&#146;s current employees, consistent with the market for their services, over that period of time. This increase will improve the
Company&#146;s ability to grant equity awards that are competitive with the levels of equity compensation provided by the companies with which it competes to attract and retain talented executives and other key employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board recommends that the stockholders approve the Amendment. If the requisite stockholder approval of the Amendment is not obtained, the
Amendment will not take effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the 2020 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary of the material terms of the 2020 Plan, which takes into account the proposed Amendment, is qualified in its entirety by
reference to the full text of the 2020 Plan (as amended if this Proposal Two is approved), marked to show the changes implemented by the Amendment, attached as<U>&nbsp;Appendix A</U>&nbsp;to this Proxy Statement. The 2020 Plan is not <FONT
STYLE="white-space:nowrap">a&nbsp;tax-qualified&nbsp;deferred</FONT> compensation plan under Section&nbsp;401(a) of the Code and is not intended to be an employee benefit plan within the meaning of the Employee Retirement Income Security Act of
1974. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Administration.</I></B>&nbsp;Our Board has the authority to interpret the terms and conditions of the 2020 Plan, to determine
eligibility for and terms of awards for participants and to make all other determinations necessary or advisable for the administration of the 2020 Plan. The Board may delegate its authority to any committee of the Board (the Board or such committee
is referred to below as the &#147;Administrator&#148;). To the extent consistent with applicable law, the Administrator may further delegate the ability to grant awards to our Chief Executive Officer or other of our officers. In addition,
subcommittees may be established to the extent necessary to comply with <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3&nbsp;under</FONT> the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Eligible Award Recipients.</I></B><FONT STYLE="white-space:nowrap">&nbsp;Our&nbsp;non-employee&nbsp;directors,</FONT> employees and
consultants, and any individual to whom we or our affiliates have extended a formal offer of employment, are eligible to receive awards under the 2020 Plan. There is no limit on the number or class of employees, directors, or consultants that are
eligible to receive awards. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Awards.</I></B>&nbsp;Awards under the 2020 Plan may be made in the form of incentive stock <FONT
STYLE="white-space:nowrap">options,&nbsp;non-qualified&nbsp;options,</FONT> stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards, other stock-based awards or cash awards. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Shares Subject to the 2020 Plan.</I></B>&nbsp;Subject to adjustment as set forth below, the total number of shares of Common Stock
reserved and available for grant and issuance pursuant to awards under the 2020 Plan is equal to 2,475,000 (assuming that the stockholders approve the Amendment), the full amount of which may be issued pursuant to incentive stock options. For
purposes of counting shares against the share reserve, awards denominated in shares of Common Stock and other awards that may be exercised for, settled in or convertible into shares of Common Stock will be counted against the 2020 Plan reserve on
the date of grant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
of the award based on the maximum number of shares that may be issued pursuant to the award, as determined by the Administrator. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Award Limits</I></B>. With respect to any one participant (other than
<FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director),</FONT> during any calendar year, (i)&nbsp;the maximum number of shares of Common Stock underlying options and stock appreciation rights that may be granted under the 2020 Plan is
500,000 shares; (B)&nbsp;the maximum number of shares of Common Stock subject to restricted stock awards, awards of restricted stock units and other stock-based awards that may be granted under the 2020 Plan is 500,000 shares; and (C)&nbsp;the
maximum amount of a cash award that may be paid is $3,000,000. No director, in any <FONT STYLE="white-space:nowrap">approximate&nbsp;12-month&nbsp;period</FONT> beginning on the date of a regular annual meeting and ending on the date of the next
regular annual meeting may be granted awards, that, together with any cash fees received from the Company during such period, exceed an aggregate value of $750,000 (with value of each equity award based on its grant date fair value). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Terms and Conditions of Awards </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Options and Stock Appreciation Rights</I></B>. An &#147;incentive stock option&#148; is an option that
meets the requirements of Section&nbsp;422 of the Code, and <FONT STYLE="white-space:nowrap">a&nbsp;&#147;non-qualified&nbsp;stock</FONT> option&#148; is an option that does not meet those requirements. A &#147;stock appreciation right&#148; (or
SAR) is the right of a participant to a payment, in cash, shares of Common Stock, or a combination of cash and shares equal to the amount by which the market value of a share of Common Stock exceeds the base price of the stock appreciation right. An
option or SAR granted under the 2020 Plan will be exercisable only to the extent that it is vested on the date of exercise. No option or SAR may be exercisable more than ten years from the grant date. The Administrator may include in the option
agreement the period during which an option may be exercised following termination of employment or service. SARs may be granted to participants in tandem with options or separately. Tandem SARs will generally have substantially similar terms and
conditions as the options with which they are granted. The exercise price or base price per share under each option or SAR granted under the 2020 Plan may not be less than 100% of the fair market value of the Company&#146;s Common Stock on the grant
date of such award. For this purpose, and for so long as the Company&#146;s Common Stock is listed on the Nasdaq Stock Market, fair market value of the Common Stock will be the closing price of the Company&#146;s Common Stock on the grant date. The
2020 Plan prohibits repricing of options and SARs without stockholder approval. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Restricted Stock and Restricted Stock Units</I></B>. Restricted stock is an award of Common Stock on which
certain restrictions are imposed over specified periods that subject the shares to a substantial risk of forfeiture. A restricted stock unit is a unit, equivalent in value to a share of Common Stock, credited by means of a bookkeeping entry in our
books to a participant&#146;s account, which is settled in stock or cash upon or after vesting. Subject to the provisions of the 2020 Plan, the Administrator will determine the terms and conditions of each award of restricted stock or restricted
stock units, including the restricted/vesting period for all or a portion of the award, and the restrictions applicable to the award. Restricted stock and restricted stock units granted under the 2020 Plan will vest based on a period of service
specified by our Administrator or the occurrence of events specified by our Administrator. Unless otherwise provided in an award agreement, dividends declared with respect restricted stock will be held back and paid only to the extent the related
restricted stock vests. Further, dividend equivalent rights may be granted with respect to restricted stock units, entitling the participant to receive, subject to the vesting conditions applicable the restricted stock unit, an amount equal to cash
or stock dividends or other distributions paid by the Company in respect of one share of Common Stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Performance Awards</I></B>. Performance awards may be granted as an option, stock appreciation right,
restricted stock award, restricted stock unit award, other stock-based award or cash award. Performance awards will be based on the attainment of performance goals that are established by the Administrator for the relevant performance period prior
to the grant of the award. The Administrator will determine and set forth in the award agreement such terms as (i)&nbsp;the nature, length and starting date of any performance period; (ii)&nbsp;the applicable performance goals that shall be used to
determine the time and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
extent to which the award has been earned; and (iii)&nbsp;the effect of a termination of participant&#146;s service on a performance award. At the end of the applicable performance period, the
Administrator will determine the extent to which a performance award has been earned, including the extent to which performance goals have been attained and the degree of achievement between minimum and maximum levels. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Other Stock-Based Awards and Cash Awards</I></B>. The Administrator may grant other stock-based awards or
cash awards not otherwise described by the terms of the 2020 Plan. Other stock-based awards are payable in, valued in whole or in part by reference to, or otherwise based on or related to shares of the Company&#146;s Common Stock, including, but not
limited to, shares of Common Stock awarded as a bonus or other compensation which are issued without restrictions on transfer and free from forfeiture conditions. A cash award is an award denominated in cash that is subject to such performance goals
and service requirements as specified by the Administrator in the applicable award agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Termination of Employment</I></B>. Except as otherwise determined by the Administrator, in the event a
participant&#146;s employment terminates for any reason other than &#147;cause&#148; (as defined in the 2020 Plan), all of such participant&#146;s unvested options and SARs will be forfeited and all vested options and SARs will remain exercisable
until the 90th day following the date of termination (or the expiration of the award&#146;s maximum term, whichever is earlier); however, in the event of termination by reason of death or &#147;disability&#148; (as defined in the 2020 Plan, vested
options and SARs will remain exercisable for 12 months (or the expiration of the award&#146;s maximum term, whichever is earlier). Except as otherwise determined by the Administrator, in the event of a participant&#146;s termination for cause, all
unvested and vested options then outstanding will immediately be forfeited and canceled. Further, for all other types of awards under the 2020 Plan, the Administrator may specify in any award agreement that a participant&#146;s award will be
forfeited upon termination for cause. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Other Forfeiture Provisions; Clawback</I></B>. All awards granted under the 2020 Plan will be subject to
recoupment in accordance with the Company&#146;s clawback policy or applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an award agreement or compensation clawback policy as the Board
determines necessary or appropriate, including a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting cause. Further, unless otherwise provided in an
award agreement, if at any time within 1 year after an award is exercised, vests, becomes payable, either (i)&nbsp;the participant is terminated for cause, or (ii)&nbsp;the committee determines that while in service the participant had engaged in an
act which would have warranted termination for cause, or following termination of service the participant violated continuing obligation or duty to the Company, the Administrator may require the participant to pay back to the Company any gain
realized by the participant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Change in Capitalization or Other Corporate Event</I></B>. The number or amount of shares of stock, other
property or cash covered by outstanding awards, the number and type of shares of stock that have been authorized for issuance under the 2020 Plan, the exercise or base price (as applicable) of each outstanding award, and the other terms and
conditions of outstanding awards, will be subject to adjustment by the Administrator in the event of any stock dividend, extraordinary dividend, stock split or share combination or any recapitalization, merger, consolidation, exchange of <FONT
STYLE="white-space:nowrap">shares,&nbsp;spin-off,&nbsp;liquidation</FONT> or dissolution of the Company or other similar transaction affecting the Company&#146;s Common Stock. Any such adjustment would not be considered repricing for purposes of the
prohibition on repricing described above. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Effect of a Change in Control</I></B>. The Administrator has the ability to prescribe the effect of a
future change in control in the award agreement or otherwise, including, for example, settlement of awards based on the consideration provided for in the agreement pursuant to which the change in control awards. Unless otherwise determined by the
Committee, no accelerated vesting of awards will occur if awards are assumed and/or replaced in the change in control with substitute awards unless the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
participant&#146;s employment is involuntarily terminated without &#147;cause&#148; within 12 months following the date of the change in control. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Deferrals of Payment</I></B><B>.</B>&nbsp;Under the 2020 Plan, the Administrator may determine that payment
pursuant to an award shall be deferred and may establish programs and procedures for deferral elections to be made by participants, provided that such deferrals will be made in accordance with Section&nbsp;409A of the Code. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></I></B>. The 2020 Plan restricts the ability of
an award holder from transferring awards granted under the 2020 Plan other than by will, the laws of descent and distribution or, with the prior approval of the Administrator. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Amendment and Termination</I></B>. The Board may, in its discretion, amend or terminate the 2020 Plan at
any time; provided that the Board may not take any action that materially impairs the rights of any participant with respect to an outstanding award without the consent of the participant. Stockholder approval is required (i)&nbsp;to materially
increase the number of shares subject to the 2020 Plan (other than pursuant to an equitable adjustment in connection with changes relating to the Company&#146;s Common Stock as permitted under the 2020 Plan); (ii) to materially expand the class of
individuals eligible to receive awards under the 2020 Plan; (iii)&nbsp;materially reduce the price at which Common Stock may be issued or purchased under the 2020 Plan; (iv)&nbsp;materially extend the term of the 2020 Plan; (v)&nbsp;materially
expand the types of awards available for issuance under the 2020 Plan, or (vii)&nbsp;as otherwise required by applicable law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Term of the 2020 Plan</I></B>. The term of the 2020 Plan extends for a period of ten years from
September&nbsp;30, 2020 and, accordingly, will remain in effect unless sooner terminated through September&nbsp;30, 2030. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Federal
Income Tax Consequences </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief summary of the intended United States federal income tax consequences applicable to
awards granted under the 2020 Plan. The discussion below is based upon United States federal income tax laws in effect as of the date of this Proxy Statement. This summary is not intended to be exhaustive and does not address all matters that may be
relevant to a particular participant based on his or her specific circumstances, or the tax consequences of any awards granted to participants who reside outside of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Nonqualified Stock Options</I></B>. Nonqualified stock options will not be taxable to a participant at grant but generally will result
in taxation at exercise, at which time the participant will recognize ordinary income in an amount equal to the difference between the option&#146;s exercise price and the fair market value of a share of our Common Stock on the exercise date. The
Company will be entitled to deduct a corresponding amount as a business expense in the year the participant recognizes this income, subject to Section&nbsp;162(m) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options</I></B>. A participant will generally not recognize ordinary income on receipt or exercise of an incentive stock
option (an &#147;ISO&#148;) so long as he or she has been an employee of the Company or its subsidiaries from the date the ISO was granted until three months before the date of exercise; however, the amount by which the fair market value of the
shares of our Common Stock on the exercise date exceeds the exercise price is an adjustment in computing the participant&#146;s alternative minimum tax in the year of exercise. If the participant holds the shares of our Common Stock received on
exercise of the ISO until at least one year after the date of exercise (and for at least two years from the date of grant of the ISO), any difference between the amount realized upon the disposition of the shares and the amount paid for the shares
will be treated as long-term capital gain (or loss, if applicable) to the participant. If the participant exercises an ISO and satisfies these holding period requirements, the Company may not deduct any amount in connection with the ISO. If the
participant exercises an ISO but engages in a &#147;disqualifying disposition&#148; by selling the shares acquired on exercise before the expiration of the one <FONT STYLE="white-space:nowrap">and&nbsp;two-year&nbsp;holding</FONT> periods described
above, the participant generally will recognize ordinary income (for regular income tax purposes only) in the year of the disqualifying disposition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equal to the excess, if any, of the fair market value of the shares on the date of exercise over the exercise price; and any excess of the amount realized on the disposition over the fair market
value on the date of exercise will be taxed as long- or short-term capital gain (as applicable). If, however, the fair market value of the shares on the date of the disqualifying disposition is less than on the date of exercise, the participant will
recognize ordinary income equal only to the difference between the amount realized on the disqualifying disposition and the exercise price. In either event of a disqualifying disposition, the Company will generally be entitled to deduct an amount
equal to the amount constituting ordinary income to the participant in the year of the disqualifying disposition, subject to Section&nbsp;162(m) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stock Appreciation Rights</I></B>. There are no immediate tax consequences to a participant when a stock appreciation right is granted.
When a participant exercises a stock appreciation right, the participant will recognize ordinary income equal to the amount of cash and the fair market value of any shares received. The Company will generally be entitled to deduct the same amount as
a business expense in the same year, subject to Section&nbsp;162(m) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock</I></B>.&nbsp;The recognition of
income from an award of restricted stock for federal income tax purposes depends on the restrictions imposed on the shares. Generally, taxation will be deferred until the first taxable year the shares are no longer subject to substantial risk of
forfeiture. At the time the restrictions lapse, the participant will recognize ordinary income equal to the then fair market value of the stock. The participant may, however, make an election, within 30 days following the date the shares are issued,
to include the value of the shares in gross income in the year of the award despite such restrictions; in such case, any subsequent appreciation of the shares will be treated as a capital gain. Generally, the Company will be entitled to deduct the
fair market value of the shares transferred to the participant as a business expense in the year, and in the same amount, that the participant includes the compensation in income, subject to Section&nbsp;162(m) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Units</I></B>. Generally, a participant will not recognize ordinary income until Common Stock, cash, or other property
becomes payable under a restricted stock unit, even if the award vests in an earlier year. The Company will generally be entitled to deduct the amount the participant includes in income as a business expense in the year of payment, subject to
Section&nbsp;162(m) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Performance Awards</I></B>. Generally, a participant will not incur any income tax liability upon
the initial grant of performance awards. At the end of the performance or measurement period, however, the participant will generally realize ordinary income on any amounts received in cash or shares of our Common Stock, and any subsequent
appreciation in shares will be treated as a capital gain (unless the award is in the form of an option or stock appreciation right in which case the tax consequences described above for such awards will generally apply). The Company will generally
be entitled to deduct the amount the participant includes in income as a business expense in the year of payment, subject to Section&nbsp;162(m) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Other Stock-Based Awards and Cash Awards</I></B>. Any cash payments or the fair market value of any shares of our Common Stock or other
property a participant receives in connection with other stock-based awards or cash awards are includable in income in the year received or made available to the participant without substantial limitations or restrictions. The Company will generally
be entitled to deduct the amount the participant includes in income as a business expense in the year of payment, subject to Section&nbsp;162(m) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A of the Code</I></B>. Certain types of awards under the 2020 Plan, such as restricted stock
units (and any related dividend equivalent rights), may constitute, or provide for, a deferral of compensation under Section&nbsp;409A of the Code. Unless certain requirements set forth in Section&nbsp;409A of the Code are complied with, holders of
such awards may be taxed earlier than would otherwise be the case (e.g., at the time of vesting instead of the time of payment) and may be subject to an additional 20% penalty tax (and, potentially, certain interest penalties). To the extent
applicable, the 2020 Plan has been, and we intend that awards under the 2020 Plan will be, structured and interpreted in a manner intended to either comply with or be exempt from Section&nbsp;409A of the Code and the Department of Treasury
regulations and other interpretive guidance that may be issued under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;409A of the Code. To the extent determined necessary or appropriate by the Administrator, the 2020 Plan and applicable award agreements may be amended to further comply with
Section&nbsp;409A of the Code or to exempt the applicable awards from Section&nbsp;409A of the Code. However, the 2020 Plan does not provide for an indemnity by the Company of any participant for any taxes incurred by reason of Section&nbsp;409A of
the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Historical Grant Information. </I></B>Options to purchase 550,000 shares, at a purchase price of $11.67 per share, were
conditionally granted under the 2020 Plan to certain employees <FONT STYLE="white-space:nowrap">and&nbsp;non-employee&nbsp;directors</FONT> on October&nbsp;1, 2020, subject to approval of the 2020 Plan by the stockholders of the Company, which
approval was obtained on November&nbsp;23, 2020. Such options vest monthly over three years, and vest in full upon a change in control of the Company. On December&nbsp;7, 2020, an option to purchase 30,000 shares, at a purchase price of $15.32 per
share, was granted to a new employee. Such options vest over three years: <FONT STYLE="white-space:nowrap">one-third</FONT> on the first anniversary of grant, and thereafter monthly over the remaining two years, and vest in full upon a change in
control of the Company. All future awards granted under the 2020 Plan will be made at the discretion of the Compensation Committee and, accordingly, are not yet determinable. In addition, benefits under the 2020 Plan will depend on a number of
factors, including the fair market value of our shares on future dates and the exercise decisions made by the participants. Consequently, it is not possible to determine the benefits that might be received by participants under the 2020 Plan. The
table below shows the amount of options received under the 2020 Plan to date (or to be received under the 2020 Plan, if determinable) by the persons and groups of persons identified in the table. The table does not include any information on future
awards under the 2020 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2020 Plan </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Dollar&nbsp;Value&nbsp;($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Options&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel, Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, Chief Operating Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,981,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula, Interim Principal Accounting Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Group<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,208,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive&nbsp;Director</FONT> Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,472,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive&nbsp;Officer</FONT> Employee Group<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,995,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The grant date dollar value of the options was preliminarily estimated using the Black-Scholes option pricing
model using the following assumptions: (a)&nbsp;stock price of $11.67 per share for the October 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> grants and $15.32 per share for the December
7<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> grant; (b)&nbsp;expected term of 5.77 years; (c)&nbsp;volatility of 181%; (d)&nbsp;dividend rate of 0.00%; and (e)&nbsp;a risk-free rate of 0.27%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The executive group is comprised of Gerard Michel, John Purpura and Christine Padula. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">The&nbsp;non-executive&nbsp;officer</FONT> employee group includes all
employees, including all current officers who are not executive officers, as a group. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration with the Securities and Exchange
Commission </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We filed a Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> with the Securities and Exchange
Commission (the &#147;Commission&#148;) for the purpose of registering shares of Common Stock under the 2020 Plan pursuant to the Securities Act of 1933 (the &#147;Securities Act&#148;) and intend to file an amended Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> with the Commission as soon as practicable to register additional shares of Common Stock under the 2020 Plan, subject to the approval of the Amendment by our stockholders at the 2021 Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE AMENDMENT TO THE 2020 PLAN.
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EQUITY COMPENSATION PLAN INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information as of December&nbsp;31, 2020 with respect to compensation plans (including individual compensation
arrangements) under which shares of Common Stock are authorized for issuance. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;securities<BR>to be issued
upon<BR>exercise&nbsp;of<BR>outstanding&nbsp;options,<BR>warrants&nbsp;and&nbsp;rights<BR>(a)</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise price of<BR>outstanding<BR>options, warrants<BR>and&nbsp;rights<BR>(b)<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of securities<BR>remaining available<BR>for future issuance<BR>under equity<BR>compensation plans<BR>(excluding
securities<BR>reflected&nbsp;in&nbsp;column&nbsp;(a))<BR>(c)</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders<SUP
STYLE="font-size:85%; vertical-align:top">&nbsp;(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">498,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,078,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes stock options for an aggregate of 499 shares of Common Stock issued under the 2019 Plan. As of
November&nbsp;2, 2020, no additional grants may be made under the 2019 Plan. In addition, pursuant to an employment agreement dated as of August&nbsp;31, 2020 between the Company and Gerard Michel, the Company&#146;s Chief Executive Officer, on
October&nbsp;1, 2020, the Company granted to Mr.&nbsp;Michel a nonqualified and <FONT STYLE="white-space:nowrap">non-plan</FONT> stock option &#147;inducement award&#148; to purchase 498,000 shares of the Company&#146;s common stock in reliance on
Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement. Additional information about this stock option award can be found elsewhere in this Proxy Statement under the heading &#147;Gerard Michel Employment Agreement.&#148;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_4"></A>PROPOSAL 3: RATIFICATION OF THE SELECTION, BY THE AUDIT
COMMITTEE OF OUR BOARD OF DIRECTORS, OF MARCUM LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER&nbsp;31, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has appointed Marcum LLP (&#147;Marcum&#148;) as Delcath&#146;s independent registered public accounting firm for the
fiscal year ending December&nbsp;31, 2021. Marcum also served as Delcath&#146;s independent registered public accounting firm for the fiscal year ended December&nbsp;31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although ratification by our stockholders is not required by law or by our <FONT STYLE="white-space:nowrap">by-laws,</FONT> the Audit
Committee believes that submission of its selection to our stockholders is a matter of good corporate governance. Even if the appointment is ratified, the Audit Committee, in its discretion, may select a different independent registered public
accounting firm at any time if the Audit Committee believes that such a change would be in Delcath&#146;s best interests and in the best interests of our stockholders. If our stockholders do not ratify the selection of Marcum, the Audit Committee
will take that fact into consideration, together with such other factors as it deems relevant, in determining its next selection of an independent registered public accounting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Representatives of Marcum are expected to be present at the 2021 Annual Meeting, and will have the opportunity to make a statement if he or
she (or they) so desires and to respond to appropriate questions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fees Paid to Independent Registered Public Accounting Firms. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate fees billed to the Company by Marcum for professional services rendered as our independent registered public accounting firm
during the fiscal years ended December&nbsp;31, 2020 and 2019, respectively, were: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">410,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">286,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">410,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">286,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Fees</I></B><I>.</I><I></I>&nbsp;These are fees for services rendered in connection with the audit of the annual
financial statements included in our Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> the review of the financial statements included in our Quarterly Reports on Forms <FONT STYLE="white-space:nowrap">10-Q;</FONT> and for
services that are normally provided by an independent auditor in connection with statutory and regulatory filings or engagements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit-Related
Fees.</I></B><B></B>&nbsp;Marcum did not perform any assurance and related services that were reasonably related to the performance of the audit or review of our financial statements for the years ended December&nbsp;31, 2020 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Fees.</I></B>&nbsp;Marcum did not perform any tax compliance services for us during the years ended December&nbsp;31, 2020 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>All Other Fees.</I></B>&nbsp;Marcum did not receive any other fees from us for the years ended December&nbsp;31, 2020 and 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies: Audit and <FONT STYLE="white-space:nowrap">Non-Audit</FONT> Services. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee <FONT STYLE="white-space:nowrap">pre-approves</FONT> all audit services and the terms of such services and permissible <FONT
STYLE="white-space:nowrap">non-audit</FONT> services provided by Delcath&#146;s independent registered public accounting firm, prior to its engagement for the provision of such services. The Chair of the Audit Committee has been delegated the
authority by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
committee to <FONT STYLE="white-space:nowrap">pre-approve</FONT> interim services by Delcath&#146;s independent registered public accounting firm; provided that the Chair reports all such <FONT
STYLE="white-space:nowrap">pre-approvals</FONT> to the entire Audit Committee at the next Audit Committee meeting. There were no <FONT STYLE="white-space:nowrap">non-audit</FONT> services provided to Delcath by our independent registered public
accounting firm for 2020 and 2019 that required review by the Audit Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE
&#147;FOR&#148; THE RATIFICATION OF THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF MARCUM LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER&nbsp;31, 2021. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_5"></A>PROPOSAL 4: APPROVAL, ON A
<FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> ADVISORY BASIS, OF THE NAMED EXECUTIVE OFFICER COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Section&nbsp;14A of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;), we are providing our stockholders
with the opportunity to vote on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory resolution to approve the compensation of our named executive officers, as disclosed in this Proxy Statement pursuant to Item&nbsp;402 of Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> including the compensation tables and narrative discussion. This proposal, commonly known as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> proposal,
gives our stockholders the opportunity to express their views on our named executive officers&#146; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive
officers and our compensation philosophy, policies and practices described in this Proxy Statement. Accordingly, we ask our stockholders to vote &#147;<B>FOR</B>&#148; the following resolution at the meeting: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the compensation of Delcath&#146;s named executive officers, as disclosed in this Proxy Statement pursuant to
Item&nbsp;402 of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> including the compensation tables and narrative discussion, is hereby APPROVED.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total compensation of our named executive officers consists primarily of base salary, annual incentive cash bonuses and long-term equity
incentive awards in the form of stock options and restricted stock awards, as well as other benefits that are available to all Delcath employees. Base salary and annual incentive cash bonuses are viewed as short-term compensation to reward our named
executive officers for meeting individual and company performance objectives, while stock options and restricted stock awards are viewed as rewards for improving corporate performance over the long term and increasing stockholder value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation philosophy and programs for our named executive officers are described in detail under the heading &#147;Executive
Compensation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The resolution that is the subject of this proposal is advisory in nature and, therefore, is not binding on Delcath,
the Compensation and Stock Option Committee or our Board. However, the views expressed by our stockholders, whether through this vote or otherwise, are important to us and our Board and the Compensation and Stock Option Committee intends to take the
results of the vote on this proposal into account when considering future decisions regarding the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; THE APPROVAL, ON A
<FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> ADVISORY BASIS, OF THE NAMED EXECUTIVE OFFICER COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_6"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the beneficial ownership of our Common Stock and Series E Convertible Preferred
Stock and Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock as of the record date, March&nbsp;12, 2021, held by: (i)&nbsp;each director and director nominee; (ii)&nbsp;each of the named executive officers; (iii)&nbsp;all
of our directors and executive officers as a group; and (iv)&nbsp;each additional person or group who is known by us to own beneficially more than 5% of our Common Stock, Series E Convertible Preferred Stock or Series
<FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock. Except as indicated in the footnotes below, the address of the persons or groups named below is c/o Delcath Systems, Inc., 1633 Broadway, Suite 22C, New York, New York 10019.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center"><B>Shares Beneficially Owned<SUP STYLE="font-size:85%; vertical-align:top"> (1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Beneficial Owner:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series E<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Series&nbsp;E-1</FONT><BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of<BR>Total&nbsp;Voting<BR>Power</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Named Executive Officers and Directors:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel<B><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, M.S.<B><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.11</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.02</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula<SUP STYLE="font-size:85%; vertical-align:top">(</SUP><B><SUP
STYLE="font-size:85%; vertical-align:top">4)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roger G. Stoll, Ph.D.<B><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gilad Aharon, Ph.D.<B><SUP STYLE="font-size:85%; vertical-align:top">(6)(12) </SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">679,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.08</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.08</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elizabeth Czerepak<B><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Salamon<B><SUP STYLE="font-size:85%; vertical-align:top">(8)(12)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">681,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.11</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.11</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Sylvester<B><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer Simpson,<I> former chief executive officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>All directors and executive officers as a
group<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>:<SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">928,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.43</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.01</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>5% Stockholders</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosalind Master Fund L.P.<B><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></B><BR></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosalind Opportunities Fund I L.P.<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">77 Bloor St W, 3rd FL<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Toronto, Ontario M5S 1M2<BR></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">673,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.99</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.99</TD>
<TD NOWRAP VALIGN="bottom">%<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deerfield Partners, L.P.<B><SUP STYLE="font-size:85%; vertical-align:top"> (13)</SUP></B><BR></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">780 Third Ave., 37<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York 10017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.32</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guoqing Ma<B><SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP></B><BR></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">P.O. Box 11067<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">McLean, Virginia 22102</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">377,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.04</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.53</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Silver Arc Capital Management, LLC<B></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B>and<B><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B>Devesh Gandhi<SUP
STYLE="font-size:85%; vertical-align:top">(</SUP><B><SUP STYLE="font-size:85%; vertical-align:top">15)</SUP></B><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">20 Park Plaza, 4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts 02116</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.63</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than 1% </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as indicated in these footnotes: (i)&nbsp;each person named in this table has sole voting and investment
power with respect to all shares of Common Stock, Series E Convertible Preferred Stock and Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock beneficially owned by such person; (ii)&nbsp;the number of shares beneficially
owned by each person as of March&nbsp;12, 2021, includes any vested and unvested shares of restricted stock, and shares of Common Stock that may be acquired through the exercise of options and warrants that such person or group has the right to
acquire within 60 days of March&nbsp;12, 2021, and after giving effect to any applicable limitations on beneficial ownership described in the footnotes below, or the Beneficial Ownership Limitation, and (iii)&nbsp;the beneficial ownership
percentages shown above are based on a total of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
6,249,807 shares of Common Stock outstanding as of March&nbsp;12, 2021 and 6,827,307 eligible voting shares outstanding, the latter is comprised of (a) 6,249,807 shares of Common Stock, (b)
1,750,600 shares of Common Stock assuming conversion of 17,506 shares of Series E Convertible Preferred Stock, and (c) 297,500 shares of Common Stock assuming conversion of 2,975 shares of Series <FONT STYLE="white-space:nowrap">E-1</FONT>
Convertible Preferred Stock outstanding as of March&nbsp;12, 2021, respectively. Shares of Series E Convertible Preferred Stock and Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock vote together with the Common Stock on
an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, subject to any applicable Beneficial Ownership Limitation, on all matters submitted to holders of Common Stock for approval. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 7,500 shares of Common Stock held by Mr.&nbsp;Michel and 96,833 shares of Common Stock which
Mr.&nbsp;Michel has the right to acquire upon exercise of outstanding options pursuant to his inducement grant dated October&nbsp;1, 2020, which have vested and are exercisable within 60 days of March&nbsp;12, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 27,826 shares of Common Stock held by Mr.&nbsp;Purpura, 2,822 shares of Common Stock which
Mr.&nbsp;Purpura has the right to acquire upon exercise of outstanding warrants and 39,246 shares of Common Stock which Mr.&nbsp;Purpura has the right to acquire upon exercise of outstanding options exercisable within 60 days of March&nbsp;12, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 4,444 shares of Common Stock which Ms.&nbsp;Padula has the right to acquire upon exercise of
outstanding options exercisable within 60 days of March&nbsp;12, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 9,300 shares of Common Stock held by Dr.&nbsp;Stoll, 4,038 shares of Common Stock which Dr.&nbsp;Stoll
has the right to acquire upon exercise of outstanding warrants and 9,031 shares of Common Stock which Dr.&nbsp;Stoll has the right to acquire upon exercise of outstanding options exercisable within 60 days of March&nbsp;12, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 2,000 shares of Common Stock held by Dr.&nbsp;Aharon and 4,444 shares of Common Stock, which
Dr.&nbsp;Aharon has the right to acquire upon exercise of outstanding options exercisable within 60 days of March&nbsp;12, 2021. These amounts also include shares owned by Rosalind (defined below), which are described in footnote 12.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 4,444 shares of Common Stock, which Ms.&nbsp;Czerepak has the right to acquire upon exercise of
outstanding options exercisable within 60 days of March&nbsp;12, 2021 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 4,500 shares of Common Stock held by Mr.&nbsp;Salamon and 4,444 shares of Common Stock, which
Mr.&nbsp;Salamon has the right to acquire upon exercise of outstanding options exercisable within 60 days of March&nbsp;12, 2021. These amounts also include shares owned by Rosalind (defined below), which are described in footnote 12.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 6,667 shares of Common Stock, which Mr.&nbsp;Sylvester has the right to acquire upon exercise of
outstanding options exercisable within 60 days of March&nbsp;12, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on information provided by the Company&#146;s transfer agent and the Company&#146;s records.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes shares of Common Stock held directly and shares of Common Stock issuable upon the exercise of
options/warrants that are exercisable within 60 days of March&nbsp;12, 2020. This number includes shares owned by Rosalind (defined below), which are described in footnote 12. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based partially on the Company&#146;s records and in part on information provided on a Statement on Schedule
13D/A jointly filed with the SEC on May&nbsp;14, 2020, by and on behalf of Rosalind Advisors, Inc., Rosalind Opportunities Fund I L.P., Rosalind Master Fund L.P., Steven Salamon and Dr.&nbsp;Gilad Aharon (collectively, &#147;Rosalind&#148;),
Rosalind Advisors, Inc., Mr.&nbsp;Salamon and Dr.&nbsp;Aharon have shared voting power and dispositive power of 185,000 shares of Common Stock, 1,967,500 shares of Common Stock issuable upon conversion of 19,675 shares of preferred stock, 1,510
shares of Common Stock issuable upon the conversion of certain convertible notes and 1,468,956 shares of Common Stock issuable upon exercise of warrants. Rosalind Opportunities Fund I L.P. has shared voting power and dispositive power of 185,000
shares of Common Stock, 1,266,000 shares of Common Stock issuable upon conversion of 12,660 shares of preferred stock and 1,164,484 shares of Common Stock issuable upon exercise of warrants. Rosalind Master Fund L.P. has shared voting power and
dispositive power of 701,500 shares of Common Stock issuable upon conversion of 10,015 preferred stock and 304,472 shares of Common Stock issuable upon exercise of warrants. Rosalind&#146;s shares of preferred stock are subject to a 9.99% blocker
and warrants to purchase 615,000 shares of Common Stock are subject to a 9.99% blocker and warrants to purchase 853,958 shares of Common Stock are subject to a 4.99% blocker. Mr.&nbsp;Salamon and Dr.&nbsp;Aharon are members of the Board of
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Directors of the Company pursuant to a Board Appointment Agreement. Mr.&nbsp;Salamon and Dr.&nbsp;Aharon disclaim beneficial ownership with respect to these securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on information provided on a Statement on Schedule 13G filed with the SEC on December&nbsp;17,
2020, James E. Flynn, Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Partners, L.P. have shared voting power and dispositive power of 500,000 shares of Common Stock owned by Deerfield Partners, L.P., of which Deerfield Mgmt,
L.P. is the general partner and Deerfield Management Company, L.P. is the investment advisor. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on information provided on a Statement on Schedule 13G filed with the SEC on November&nbsp;13,
2020, Mr.&nbsp;Ma has sole voting power and dispositive power of all of the shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on information provided on a Statement on Schedule 13G filed with the SEC on March&nbsp;10, 2021,
SilverArc Capital Management, LLC (&#147;SilverArc&#148;) and Devesh Gandhi (&#147;Gandhi&#148;), the sole member of SilverArc, have shared voting power and dispositive power of 351,616 shares of Common Stock. SilverArc, an investment adviser
registered under Section&nbsp;203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 351,616 shares, as a result of acting as investment adviser to various clients. Gandhi is the Sole Member of SilverArc and as such is
deemed to be the beneficial owner of 351,616 shares. Clients of SilverArc have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities. SilverArc Capital Alpha Fund I,
L.P., a Delaware limited partnership for which SilverArc acts as an investment adviser, may be deemed to beneficially own 32,765 of these 351,616 shares. SilverArc Capital Alpha Fund II, L.P., a Delaware limited partnership for which SilverArc acts
as an investment adviser, may be deemed to beneficially own 296,088 of these 351,616 shares. 2b LLC, a Delaware limited liability company for which SilverArc acts as investment adviser, may be deemed to beneficially own 22,763 of these 351,616
shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_7"></A>CORPORATE GOVERNANCE AND RELATED MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have
six directors serving on the Board of Directors. The Board of Directors oversees the business affairs of the Company and monitors the performance of management. In accordance with our corporate governance principles, our Board does not involve
itself in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations of the Company. The directors keep themselves informed through discussions with the Chairman of the Board, Dr.&nbsp;Stoll,
Mr.&nbsp;Michel, in his capacity as Director and Chief Executive Officer, or CEO, and other key executives, and by reading the reports and other materials that management sends them and by participating in Board and committee meetings. Our directors
hold office until their successors have been elected and qualified unless the director resigns or is removed or by reason of death or other cause is unable to serve in the capacity of director. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Independence. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board determined
each of its <FONT STYLE="white-space:nowrap">non-employee</FONT> directors that served as a director during the 2020 fiscal year, including Dr.&nbsp;Marco Taglietti and William Rueckert who resigned in 2020, satisfied the criteria for independence
in compliance with NASDAQ listing standards. Of our six director nominees, five of our six directors are &#147;independent&#148; directors within the meaning of the NASDAQ listing rules (Dr.&nbsp;Aharon, Ms.&nbsp;Czerepak, Mr.&nbsp;Salamon,
Dr.&nbsp;Stoll and Mr.&nbsp;Sylvester). In making such determination, the Board considered the relationships that each such <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with the Company and all other facts and circumstances that
the Board deemed relevant in determining their independence. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Attendance. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors met 17 times in 2020 (including regularly scheduled and special meetings). During 2020, each director attended at least
75% of the aggregate of: (i)&nbsp;the total number of meetings of the Board (held during the period for which he or she served as a director) and (ii)&nbsp;the total number of meetings held by all committees of the Board of Directors on which he or
she served (held during the period for which he or she served on such committees). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has no specific policy regarding director
attendance at its annual meetings of stockholders. Four of the six directors attended the Company&#146;s 2020 annual meeting of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board
Leadership Structure. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Stoll serves as Chairman of the Board and has been a member of the Board of Directors since 2008. It is
our policy to separate the Chairman and Chief Executive Officer, or CEO, roles. We believe this structure is appropriate for the Company because it allows our CEO to concentrate on our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations, while providing for effective oversight by the Chairman, who is involved in strategic and key matters, such as business strategy, major
transactions and the broader business of the Company. For a company like ours that is focused on the development, approval and commercialization of a specialized product in an extremely technical, highly regulated and intensely competitive industry,
we believe our CEO is in the best position to lead our management team and to respond to the current pressures and needs of a company in the stage of growth and development of Delcath, with assistance from our Chairman who also focuses the
Board&#146;s attention on the broader issues of corporate business strategy and corporate governance. We believe that splitting the roles between Chairman, on the one hand, and CEO, on the other hand, minimizes any potential conflicts that may
result from combining the roles of CEO and Chairman, and maximizes the effectiveness of our management and governance processes to the benefit of our stockholders. Our CEO and Chairman regularly consult with each other as part of this structure.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Role in Risk Oversight. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board as a whole is responsible for risk oversight, with reviews in certain areas being conducted by the relevant Board committees. Each of
the Board&#146;s committees oversees the management of risks associated with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
their respective areas of responsibility. In performing this oversight function, the committees are assisted by management which provides visibility about the identification, assessment and
monitoring of potential risks and management&#146;s strategy to mitigate such risks. Key members of management responsible for a particular area report directly to the Board committee charged with oversight of the associated function and, if the
circumstances require, the whole Board. The Board committees review various risk exposures with the full Board and otherwise keep the full Board abreast of the committees&#146; risk oversight activities throughout the year, as necessary or
appropriate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Assessment of Compensation Programs. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation and Stock Option Committee annually evaluates whether our compensation programs encourage excessive risk-taking by employees
at the expense of long-term value of the Company. Based upon its assessment, including a review of the overall annual award limitations and individual annual limitations in our stock incentive plans and the Compensation and Stock Option
Committee&#146;s role in the consideration and approval of certain awards, the Compensation and Stock Option Committee does not believe that our compensation programs encourage excessive or inappropriate risk-taking, motivate imprudent risk-taking
or create risks that are reasonably likely to have a material adverse effect on the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has three standing committees: an Audit Committee, a Compensation and Stock Option Committee and a Nominating and Corporate
Governance Committee. No individual director is the chair of more than one committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit Committee. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee provides assistance to the Board in fulfilling its oversight responsibilities with respect to our financial statements, our
system of internal accounting and financial controls and the independent audit of our financial statements. Functions of the Audit Committee include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the selection, evaluation and, where appropriate, replacement of our outside auditors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an annual review and evaluation of the qualifications, performance and independence of our outside auditors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the approval of all auditing services and permitted <FONT STYLE="white-space:nowrap">non-audit</FONT> services
provided by our outside auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the review of the adequacy and effectiveness of our accounting and internal controls over financial reporting;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the review and discussion with management and with our outside auditors of the Company&#146;s financial
statements to be filed with the SEC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the Audit Committee are Ms.&nbsp;Czerepak (Chair), Mr.&nbsp;Salamon and
Dr.&nbsp;Stoll. The Board has determined that each of Ms.&nbsp;Czerepak, Mr.&nbsp;Salamon and Dr.&nbsp;Stoll qualifies as an &#147;audit committee financial expert&#148; as defined by SEC rules. During 2020, the Audit Committee met four times. Each
member of the Audit Committee is &#147;independent&#148; within the meaning of the NASDAQ listing rules and otherwise meets the financial statement proficiency requirements of the NASDAQ listing rules. The Audit Committee has a written charter,
which is available on our website; go to www.delcath.com, click on &#147;Investors,&#148; then &#147;Corporate Governance.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation and
Stock Option Committee. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation and Stock Option Committee, or the Compensation Committee, assists the Board of Directors in
the discharge of the Board&#146;s responsibilities with respect to the compensation of our directors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
executive officers, and other key employees and consultants. The Compensation Committee establishes our overall compensation philosophy and is authorized to approve the compensation payable to
our executive officers, including our named executive officers, and other key employees, including all perquisites, equity incentive awards, cash bonuses, and severance packages. The Compensation Committee also administers certain of the
Company&#146;s employee benefit plans, including its equity incentive plans, and is responsible for assessing the independence of compensation consultants and legal advisors. The Compensation Committee exercises sole power to retain compensation
consultants and advisors and to determine the scope of the associated engagements. During the fiscal year 2020, our Compensation Committee engaged Pearl Meyer in an effort to better align our compensation program with best practices. The current
members of the Compensation and Stock Option Committee are Dr.&nbsp;Stoll (Chair), Ms.&nbsp;Czerepak and Dr.&nbsp;Aharon, each of whom is &#147;independent&#148; within the meaning of the NASDAQ listing rules. During 2020, the Compensation and Stock
Option Committee met six times. The Compensation and Stock Option Committee has a written charter, which is available on our website; go to www.delcath.com, click on &#147;Investors,&#148; then &#147;Corporate Governance.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominating and Corporate Governance Committee. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee, or the Nominating Committee, is responsible for identifying individuals qualified to become
Board members, and recommends to the Board the director nominees to be proposed by the Board for election by the stockholders (as well as any director nominees to be appointed by the Board to fill interim vacancies). The Nominating Committee also
recommends the directors to be selected for membership on each Board committee. The Nominating Committee is also responsible for developing and recommending to the Board appropriate corporate governance guidelines and policies, and for leading the
Board in its annual review of the Board&#146;s performance. The current members of the Nominating Committee are Mr.&nbsp;Salamon (Chair), Dr.&nbsp;Stoll and Mr.&nbsp;Sylvester, each of whom is &#147;independent,&#148; within the meaning of the
NASDAQ listing rules. During 2020, the Nominating Committee met one time. The Nominating Committee has a written charter, which is available on our website; go to www.delcath.com, click on &#147;Investors,&#148; then &#147;Corporate
Governance.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating Committee with, when it deems it necessary, the assistance of a third-party search firm, identifies
candidates for director nominees. In considering candidates for the Board, the Nominating Committee considers each candidate&#146;s credentials as a whole, including, but not necessarily limited to, outstanding achievement in a candidate&#146;s
personal career, broad and relevant experience, integrity, sound and independent judgment, experience and knowledge of the business environment and markets in which we operate, business acumen, and willingness and ability to devote adequate time to
Board duties. The Nominating Committee considers the competencies required of its members in the context of the Board as a whole, including the personal characteristics, experience and background of directors and nominees to facilitate Board
deliberations that reflect a broad range of perspectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;8, 2020, we entered into a Board Appointment Agreement with
Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P. (collectively, the &#147;Rosalind Funds&#148;) pursuant to which the Board increased the number of directors constituting the Board to eight members and elected Mr.&nbsp;Salamon and
Dr.&nbsp;Aharon as independent directors of the Company to fill vacancies created by the increase in the number of directors. Mr.&nbsp;Salamon was elected to serve as a Class&nbsp;III director with a term scheduled to expire at the 2021 Annual
Meeting and Dr.&nbsp;Aharon was elected to serve as a Class&nbsp;I director with a term scheduled to expire at the Company&#146;s 2022 annual meeting of stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendations by Stockholders of Director Nominees. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating Committee will consider any recommendation by a stockholder of a candidate for nomination as a director. If a stockholder wants
to recommend a director candidate for consideration by the Nominating Committee, the stockholder should submit the name of the proposed nominee, together with the reasons why the stockholder believes the election of the candidate would be beneficial
to the Company and our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders and the information about the nominee that would be required in a proxy statement requesting proxies to vote in favor of the candidate. The stockholder&#146;s submission must be
accompanied by the written consent of the proposed nominee to being nominated by the Board and the candidate&#146;s agreement to serve if nominated and elected. Any such submission should be directed to the Nominating Committee at our principal
office, 1633 Broadway, Suite 22C, New York, New York 10019. If a stockholder intends to nominate a person for election to the Board of Directors at an annual meeting, the stockholder must provide us with written notice of his or her intention no
later than the deadline for receiving a stockholder proposal for inclusion in our proxy statement for such meeting and must otherwise comply with our amended and restated certificate of incorporation. Copies of any recommendation received in
accordance with these procedures will be distributed to each member of the Nominating Committee. One or more members of the Nominating Committee may contact the proposed candidate to request additional information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications with the Board of Directors. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any stockholder wishing to communicate with the Board or with any specified director should address his or her communication to the Board of
Directors or to the particular director(s) in care of the Corporate Secretary, Delcath Systems, Inc., 1633 Broadway, Suite 22C, New York, New York 10019. All such written communication, other than items determined by our legal counsel to be
inappropriate for submission to the intended recipient(s), will be submitted to the Board or to the particular director(s). Any stockholder communication not so delivered, will be made available upon request to any director. Examples of stockholder
communications that would be considered inappropriate for submission include, without limitation, customer complaints, business solicitations, product promotions, job inquiries, junk mail and mass mailings, as well as material that is unduly
hostile, threatening, illegal or similarly unsuitable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Ethics. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain a Code of Business Conduct and Ethics (the &#147;Code&#148;) that applies to all employees, including our principal executive
officer, principal financial officer, principal accounting officer, controller and persons performing similar functions, and including our independent directors, who are not our employees, with regard to their company-related activities. The Code
incorporates guidelines designed to deter wrongdoing and to promote honest and ethical conduct and compliance with applicable laws, rules and regulations. The Code also incorporates our expectations of our employees that enable us to provide
accurate and timely disclosure in our filings with the SEC and other public communications. In addition, the Code incorporates guidelines pertaining to topics such as complying with applicable laws, rules, and regulations; insider trading; reporting
Code violations; and maintaining accountability for adherence to the Code. The full text of our Code is published on our website. Please go to www.delcath.com, click on &#147;Investors,&#148; then &#147;Corporate Governance.&#148; We intend to
disclose future amendments to certain provisions of our Code, or waivers of such provisions granted to our principal executive officer, principal financial officer or principal accounting officer and persons performing similar functions, on our
website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Hedging and Pledging Policy</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our Insider Trading Policy, we prohibit our employees, our executive officers, members of the Board, and certain consultants and
contractors from engaging in any hedging or monetization transactions relating to our securities, including through the use of financial instruments such as prepaid variable forwards contracts, equity swaps, collars and exchange funds. We also
prohibit our employees, our executive officers, members of the Board, and certain consultants and contractors from holding our securities in a margin account or otherwise pledging our securities as collateral for a loan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_15"></A>TRANSACTIONS WITH RELATED PERSONS</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes that related person transactions present a heightened risk of conflicts of interest. As a general matter, it is the
preference of the Company to avoid related person transactions. The term &#147;related person transaction&#148; refers to a transaction required to be disclosed pursuant to Item 404 of Regulation S-K, under the Securities Act of 1933, as amended.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for the participation of certain senior management, directors and greater than 5% shareholders in investments in the securities of
the Company, as reflected in the footnotes to the Security Ownership of Certain Beneficial Owners and Management table on page&nbsp;21, no related person transactions occurred during the fiscal years ended December 31, 2020 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a written policy for the review and approval or ratification of transactions between the Company and Related Parties (as
defined below). Under the policy, our Nominating Committee will review the material facts of proposed transactions involving Delcath in which a Related Party will have a direct or indirect material interest. The Nominating Committee will either
approve or disapprove our entry into the transaction or, if advance approval is not feasible, will consider whether to ratify the transaction. The Nominating Committee may establish guidelines for ongoing transactions with a Related Party, and will
review such transactions at least annually. If the aggregate amount of the transaction is expected to be less than $200,000, such approval or ratification may be made by the Chair of the Committee. In determining whether to approve or ratify a
transaction with a Related Party, the Nominating Committee (or Chair) will consider, among other factors, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third-party and the extent of the
Related Party&#146;s interest in the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain transactions are deemed <FONT STYLE="white-space:nowrap">pre-approved</FONT>
under the policy, including compensation of executive officers and directors (except that employment of an immediate family member of an executive officer requires specific approval), and transactions with a company at which the Related Party&#146;s
only relationship is as a <FONT STYLE="white-space:nowrap">non-officer</FONT> employee, director, or less than 10% owner if the aggregate amount involved does not exceed 2% of such company&#146;s total annual revenues (or, in the case of charitable
contributions by us, 1% of the charity&#146;s total annual receipts). <FONT STYLE="white-space:nowrap">Pre-approval</FONT> is not required if the amount involved in the transaction is not expected to exceed $120,000 in any calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the policy, a &#147;Related Party&#148; is generally anyone who since the beginning of the last full fiscal year is or was an
executive officer, director or director nominee, owner of more than 5% of our common stock, or immediate family member of any of such persons. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_16"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation and Stock Option Committee reviews and recommends to the Board of Directors appropriate director compensation programs for
service as directors, committee chairs, and committee members. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In lieu of per-meeting fees, non-employee directors of the Company are
paid an annual retainer of $43,000 and certain additional annual retainers for chairing or serving as a member of the committees of the Board as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Annual&nbsp;Retainer</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board Service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chair of Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Member of Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chair of Compensation and Stock Option Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Member of Compensation and Stock Option Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chair of Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Member of Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we reimburse <FONT STYLE="white-space:nowrap">all&nbsp;non-employee</FONT> directors for their <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">reasonable&nbsp;out-of-pocket&nbsp;travel</FONT></FONT> expenses incurred in attending meetings of our Board of Directors or any committees of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board of
Directors in 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned</B><br><B>or Paid in</B><br><B>Cash</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gil Aharon, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">258,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elizabeth Czerepak</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">280,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William D. Rueckert<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Salamon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roger G. Stoll, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">453,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">576,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Sylvester</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">339,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marco Taglietti, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column do not reflect dollar amounts actually received by
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors. Instead, these amounts reflect the aggregate grant date fair value of each stock option granted computed in accordance with the provisions of FASB ASC Topic 718. Assumptions used in the
calculation of these amounts are included in Note 3 to our consolidated financial statements included in our Annual Report. Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors will only realize compensation to the extent the trading
price of our common stock is greater than the exercise price of such stock options. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Rueckert resigned in 2020.&nbsp;A total of $114,225 in accrued director fees, consisting of $12,225
earned in 2020, $72,000 earned in 2019 and $30,000 earned in 2018, was paid to Mr.&nbsp;Rueckert in February 2021.&nbsp;The total accrued director fees were paid to Mr.&nbsp;Rueckert <FONT STYLE="white-space:nowrap">one-half</FONT> in cash ($57,113)
and <FONT STYLE="white-space:nowrap">one-half</FONT> in restricted shares of the Company&#146;s common stock (2,636 restricted shares of the Company&#146;s common stock, valued at $57,112 based on the closing price of a share of the Company&#146;s
common stock of $21.66 on February&nbsp;12, 2021).</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Taglietti resigned in 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_17"></A>INFORMATION ABOUT OUR EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is a list of the names, ages, positions, and a brief account of the business experience of the individuals who currently serve as our
executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="61%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, M.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">59</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Operating Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">56</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interim Principal Accounting Officer</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information concerning Gerard Michel, one of our Directors and our Chief Executive Officer, is provided under &#147;&#151;
Directors Continuing in Office.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>John Purpura</I></B>, our Chief Operating Officer, joined the Company as Executive Vice President, Regulatory
Affairs and Quality Assurance, in November 2009 and was promoted to Executive Vice President, Global Head of Operations, on July&nbsp;19, 2016. He served as Interim Chief Executive Officer of the Company from June&nbsp;1, 2020 to October&nbsp;1,
2020, at which time he was promoted to his current position. Prior to joining the Company, he was with Bracco Diagnostics (formerly <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">E-Z-EM,</FONT></FONT> Inc.) as Vice President and
then Executive Director of International Regulatory Affairs from 2007 to 2008 and Head of Regulatory Affairs for North America and Latin America from 2008 to 2009. Prior to joining
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">E-Z-EM,</FONT></FONT> Inc., Mr.&nbsp;Purpura had an <FONT STYLE="white-space:nowrap">11-year</FONT> career with Sanofi-Aventis, ultimately serving as Associate Vice President for
Regulatory CMC from 2005 to 2007. From 1985 to 1995, he had various quality and regulatory management roles with Bolar Pharmaceuticals, Luitpold Pharmaceuticals and Eon Labs Manufacturing. He earned his M.S. in Management&nbsp;&amp; Policy and B.S.
degrees in Chemistry and Biology at the State University of New York at Stony Brook. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Christine Padula</I></B>, our Interim Principal Accounting
Officer, joined the Company as the Vice President of Finance on September&nbsp;9, 2019 and was promoted to her current position in 2020. She was previously with medCPU, Inc. as the Vice President of Finance and Controller from 2015 to 2019.
Ms.&nbsp;Padula had a <FONT STYLE="white-space:nowrap">19-year</FONT> career with Siemens, of which 17 years were with Siemens Financial Services, Inc. where she ultimately served as the Vice President and Controller of the U.S. division and prior
thereto, from 1987 to 1995, had various senior and staff accountant roles. Ms.&nbsp;Padula earned her B.S. degree in Business Administration with a concentration in Accounting at Montclair State University in New Jersey. Ms.&nbsp;Padula holds an
inactive CPA license from the State of New Jersey. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_18"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee is responsible for formulating and establishing our overall compensation philosophy with respect to our executive
officers. The Company believes that a strong executive management team comprised of talented individuals in key positions is critical to the development and growth of our business and to increasing stockholder value. Accordingly, a key objective of
our executive compensation program is to attract and retain talented and experienced individuals, while motivating them to perform and make decisions consistent with the Company&#146;s business objectives, goals and culture. We emphasize <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> by linking executive compensation to Company performance. For each executive, the amount of pay that is actually realized is primarily driven by the
Company&#146;s performance and each executive&#146;s contribution to that performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee considers the input it
receives from our stockholders when designing and evaluating our executive compensation practices.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Compensation Components</I>. The three primary
components of our executive compensation are base salary, annual incentive cash awards and long-term equity incentive awards: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Base Salary.</I>&nbsp;We pay our executive officers a base salary, which our Compensation Committee reviews
and determines annually. Base salaries are used to compensate our executive officers for performing </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
the core responsibilities of their positions and to provide them with a level of security with respect to a portion of their total compensation. Base salaries are set in part based on the
executive&#146;s unique skills, experience and expected contribution to the Company, as well as individual performance, including the impact of such performance on our business results, and the period of the executive&#146;s performance. Decisions
regarding base salary increases take into account the executive&#146;s current base salary, third-party benchmark and survey data, and the salary compensation paid to executive officers within and outside the Company, as well as the Company&#146;s
overall performance, its ability to afford such increases, its success in achieving its operational and strategic goals and objectives, and the executive officer&#146;s contribution to Company performance. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Annual Incentive Cash Awards.</I>&nbsp;Annual incentive compensation is intended to establish a direct
correlation between annual cash awards and the performance of the Company. The Company&#146;s Annual Incentive Plan, or AIP, is an annual incentive cash bonus plan designed to align the interests of participants with the interests of the Company and
its stockholders. The AIP is designed to strengthen the link between a participant&#146;s pay and his or her overall performance and the Company&#146;s performance, focus participants on critical individual and corporate objectives, offer a
competitive cash incentive, and encourage and reward performance and competencies critical to the Company&#146;s success. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Long-Term Incentive Compensation.</I>&nbsp;In addition to using base salaries and annual incentive cash
bonuses, which our Compensation Committee views as short-term compensation, a portion of our executive compensation is in the form of long-term equity compensation. The Compensation Committee continually evaluates the use of equity-based awards and
intends to continue to use such awards in the future as part of the Company&#146;s compensation program. Historically, we have used an annual equity-based incentive plan to align participants&#146; interests with those of the Company and its
stockholders by rewarding participants for their contributions to the long-term success of the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Base Salary.</I>&nbsp;The
following table summarizes the amount of base salary and year-over-year increase for each of our named executive officers for 2019 and 2020:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Hire Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018&nbsp;Base</B><br><B>Salary</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B><br><B>Increase</B><br><B>in 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019&nbsp;Base</B><br><B>Salary</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B><br><B>Increase</B><br><B>in 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Base</B><br><B>Salary</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/1/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, M.S.<SUP STYLE="font-size:85%; vertical-align:top"> (2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/16/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">385,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/9/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer K. Simpson,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>former President/Chief Executive Officer</I><I><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></I><SUP
STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3/23/2012</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">466,594</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">466,594</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">466,594</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Michel joined the Company in October 2020. His salary in 2020 is shown as its full annual rate, but he
only received a <FONT STYLE="white-space:nowrap">pro-rated</FONT> amount for his time of service between October&nbsp;21, 2020 and December&nbsp;31, 2020. See &#147;<I>Summary Compensation Table</I>&#148; for the amount of salary he received in
2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Purpura served as Interim Chief Executive Officer effective as of May&nbsp;26, 2020 and, since
October&nbsp;1, 2020, has served as Chief Operating Officer. Mr.&nbsp;Purpura&#146;s base salary increased in connection with such appointments. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms.&nbsp;Padula was appointed Interim Principal Accounting Officer in June 2020. Effective upon her
appointment, she received an increase in her base salary by $3,500 per month in recognition of her increased responsibilities. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Simpson left the Company on June&nbsp;1, 2020. Her salary in 2020 is shown as its full annual rate,
but she only received a <FONT STYLE="white-space:nowrap">pro-rated</FONT> amount for time of service until June 2020. See &#147;<I>Summary Compensation Table</I>&#148; for the amount of salary she received in 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Incentive Plan</I>. Under the AIP, annual incentive target award opportunities are expressed as a
percentage of a participant&#146;s actual base salary for the performance year, beginning January 1. The following table sets forth, for each named executive officer, the applicable target bonus percentage of base salary to which each named
executive officer was entitled during 2020 and the amount actually paid to him or her. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Bonus</B><br><B>Expressed as</B><br><B>% of Base</B><br><B>Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Dollars</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B><br><B>Payout&nbsp;as</B><br><B>%&nbsp;of&nbsp;Base</B><br><B>Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Dollars</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, M.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer K. Simpson,<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>former President/Chief Executive Officer</I><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">233,297</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Michel did not participate in the Company&#146;s AIP for 2020. His bonus was set pursuant to the terms
of his employment agreement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Simpson resigned effective June&nbsp;1, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2020, AIP goals were based entirely on Company performance to focus all the executives on the same critical challenges facing the Company. Company
performance in 2020 was measured based upon achievement of objectives in the following areas: (1)&nbsp;Clinical Trials and (2)&nbsp;Capital. The Compensation Committee has determined an overall achievement of 37.0%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Long Term Incentive Compensation</I>. Grants have historically been comprised of a mix of restricted stock and stock option awards (and in recent years,
primarily stock option awards) granted in the first quarter of each year with the number of shares subject to the awards designed to deliver a competitive value targeted at the <FONT STYLE="white-space:nowrap">mid-market</FONT> of the executive
compensation comparison group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee periodically provides long-term equity incentive awards for our named executive
officers based upon a holistic assessment of Company and individual performance for the prior year and its view of the appropriate incentives to best help achieve the Company&#146;s business objectives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_8"></A>COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and officers, and persons who are beneficial
owners of more than 10% of our Common Stock to file with the SEC reports of holdings and changes in beneficial ownership of Delcath&#146;s equity securities. Based on a review of copies of reports furnished to Delcath or written representations that
no reports were required, we believe that all reports were timely filed in 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_9"></A>SUMMARY COMPENSATION TABLE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the total compensation awarded to, earned by or paid to our named executive officers during the fiscal years
ending December&nbsp;31, 2020 and December&nbsp;31, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options</B><br><B>Awards</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,629,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,500</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,761,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">347,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,981,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,419,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">Chief Operating Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">288,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">682,541</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,500</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">426,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">Interim Principal Accounting Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer K. Simpson,<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">253,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">253,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>former President/CEO</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">466,594</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">508,495</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">90,706</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,065,795</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column do not reflect dollar amounts actually received by our named executive officers.
Instead, these amounts reflect the aggregate grant date fair value of each stock option granted computed in accordance with the provisions of Financial Accounting Standards Board (&#147;FASB&#148;) Accounting Standards Codification (&#147;ASC&#148;)
Topic 718. Assumptions used in the calculation of these amounts are included in Note 3 to our consolidated financial statements included in our Annual Report. Our named executive officers will only realize compensation to the extent the trading
price of our common stock is greater than the exercise price of such stock options. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents a nonqualified and <FONT STYLE="white-space:nowrap">non-plan</FONT> stock option &#147;inducement
award&#148; (the &#147;Option&#148;) to purchase 498,000 shares of the Company&#146;s common stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement. The Option vests ratably over a <FONT
STYLE="white-space:nowrap">36-month</FONT> period beginning October&nbsp;1, 2020 (i.e., 1/36th will vest at the end of each month during said <FONT STYLE="white-space:nowrap">36-month</FONT> period), subject to Mr.&nbsp;Michel&#146;s continued
service with the Company on each respective vesting date. The exercise price of the Option is equal to (i) $11.67, the closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020 as to the first 396,000 option shares
to vest, (ii) 1.5 times the closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020 as to the next 51,000 option shares to vest and (iii) 2.0 times the closing trading price per share of the Company&#146;s Common
Stock on October&nbsp;1, 2020 as to the remaining 51,000 option shares to vest. All unvested options are subject to continued employment and certain vesting, forfeiture, and termination provisions. For details concerning Mr.&nbsp;Michel&#146;s
employment agreement, see &#147;<I>Potential Payments upon Termination or Change of Control.</I>&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amount disclosed represents living reimbursement fees as provided for in Mr.&nbsp;Michel&#146;s employment
agreement. For details concerning Mr.&nbsp;Michel&#146;s employment agreement, see &#147;<I>Potential Payments upon Termination or Change of Control.</I>&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amount disclosed represents supplementary salary in connection with Mr.&nbsp;Purpura&#146;s appointment as
Interim Chief Executive Officer from June 2020 to October 2020. Mr.&nbsp;Purpura has served as our Chief Operating Officer since October 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amount disclosed represents supplementary salary in connection with Ms.&nbsp;Padula&#146;s appointment as
Interim Principal Accounting officer in June 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Simpson resigned from the Company effective June&nbsp;1, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts accrued for 2019 include an annual incentive award, a bonus related to Private Placements and a
retention bonus. The 2018 and 2019 retention bonus accruals of $331,259 and $288,790 for Dr.&nbsp;Simpson have not been paid. Retention bonuses to Dr.&nbsp;Simpson and our former chief financial officer, Ms.&nbsp;Barbra Keck, have become the subject
of a dispute. Dr.&nbsp;Simpson and Ms.&nbsp;Keck, as claimants, filed a statement of claim with the American Arbitration Association seeking payment of the disputed retention bonuses. The Claimants seek payment of certain purported unpaid
compensation amounts claimed to be due to them, in an approximate amount of $1.14&nbsp;million in the aggregate, as well as unspecified statutory damages under the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
New York Labor Law, attorneys&#146; fees and costs, and statutory interest. The arbitrator had scheduled hearings to take place during the week of May&nbsp;17, 2021. However, the Claimants and
the Company recently agreed to participate in <FONT STYLE="white-space:nowrap">non-binding</FONT> mediation of their dispute before a neutral mediator, which resulted in the arbitration proceedings being placed in abeyance pending the outcome of the
mediation process. At this time, the mediation process between the Claimants and the Company is ongoing. As of December&nbsp;31, 2020, the Company has accrued for the full purported unpaid compensation amounts. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_19"></A>GRANTS OF PLAN-BASED AWARDS&#151;2020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth grants of plan-based awards made during the fiscal year ended December&nbsp;31, 2020 to the named executive
officers. All equity grants were made pursuant to the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (the &#147;2020 Plan&#148;). At present, under the 2020 Plan, 675,000 shares of common stock of the Company are available for grants
through September&nbsp;30, 2030 to the Company&#146;s employees, directors and consultants. This will increase to 2,475,000 shares if the Amendment described in Proposal 2 is approved by the stockholders. The stock options which were granted to the
named executive officers in 2020 vest over a period of three years commencing from the date of grant in <FONT STYLE="white-space:nowrap">thirty-six</FONT> equal monthly increments. The stock options carry a ten year term and expire on
October&nbsp;1, 2030. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other&nbsp;Option&nbsp;Awards;<BR>Number of Securities<BR>Underlying Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Exercise&nbsp;Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date&nbsp;Fair&nbsp;Value&nbsp;of<BR>Option Award</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,981,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown in this column do not reflect dollar amounts actually received by our named executive officers.
Instead, these amounts reflect the aggregate grant date fair value of each stock option granted computed in accordance with the provisions of Financial Accounting Standards Board (&#147;FASB&#148;) Accounting Standards Codification (&#147;ASC&#148;)
Topic 718. Assumptions used in the calculation of these amounts are included in Note 3 to our consolidated financial statements included in our Annual Report. Our named executive officers will only realize compensation to the extent the trading
price of our common stock is greater than the exercise price of such stock options. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_20"></A>OUTSTANDING EQUITY AWARDS AT FISCAL <FONT STYLE="white-space:nowrap">YEAR-END&#151;2020</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table also sets forth information concerning outstanding equity awards as of December&nbsp;31, 2020 that had been granted under
the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (the &#147;2020 Plan&#148;), unless otherwise noted, but that had not yet vested and had not yet been earned. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options&nbsp;(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities<BR>Underlying<BR>Unexercised</B><br><B>Options&nbsp;(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>Per&nbsp;Share<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">354,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, M.S.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/1/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents a nonqualified and <FONT STYLE="white-space:nowrap">non-plan</FONT> stock option &#147;inducement
award&#148; (the &#147;Option&#148;) to purchase 498,000 shares of the Company&#146;s common stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
terms of a stock option award agreement. The Option vests ratably over a <FONT STYLE="white-space:nowrap">36-month</FONT> period beginning October&nbsp;31, 2020 (i.e., 1/36th will vest at the end
of each month during said <FONT STYLE="white-space:nowrap">36-month</FONT> period), subject to Mr.&nbsp;Michel&#146;s continued service with the Company on each respective vesting date. The exercise price of the Option is equal to (i) $11.67, the
closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020 as to the first 396,000 option shares to vest, (ii) 1.5 times the closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020
as to the next 51,000 option shares to vest and (iii) 2.0 times the closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020 as to the remaining 51,000 option shares to vest. All unvested options are subject to
continued employment and certain vesting, forfeiture, and termination provisions. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represent one option award of 175,000 shares dated October&nbsp;1, 2020 under the 2020 Plan, which vests
equally over 36 months, starting on October&nbsp;1, 2020, and one option award of 357 shares dated February&nbsp;1, 2019 under the Company&#146;s prior plan, which has now been subsumed by the 2020 Plan, which options are now fully vested. All
unvested options are subject to continued employment and certain vesting, forfeiture, and termination provisions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents one option award of 20,000 shares dated October&nbsp;1, 2020 under the 2020 Plan, which vests
equally over 36 months, starting on October&nbsp;1, 2020. All unvested options are subject to continued employment and certain vesting, forfeiture, and termination provisions. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_21"></A>EMPLOYMENT ARRANGEMENTS </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gerard Michel Employment Agreement. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to an employment agreement dated as of August&nbsp;31, 2020 between the Company and Mr.&nbsp;Michel (the &#147;Employment
Agreement&#148;), the term of Mr.&nbsp;Michel&#146;s employment began on October&nbsp;1, 2020. Under the Employment Agreement, Mr.&nbsp;Michel will receive an annual base salary of $450,000, subject to annual review by the Board&#146;s Compensation
and Stock Option Committee and will be eligible to participate in the Company&#146;s annual incentive plan with a target annual cash bonus equal to 50% of his then-current base salary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Employment Agreement, on October&nbsp;1, 2020, the Company granted to Mr.&nbsp;Michel a nonqualified and <FONT
STYLE="white-space:nowrap">non-plan</FONT> stock option &#147;inducement award&#148; (the &#147;Option&#148;) to purchase 498,000 shares of the Company&#146;s common stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option
award agreement. The Option vests ratably over a <FONT STYLE="white-space:nowrap">36-month</FONT> period beginning October&nbsp;1, 2020 (i.e., 1/36th will vest at the end of each month during said <FONT STYLE="white-space:nowrap">36-month</FONT>
period), subject to Mr.&nbsp;Michel&#146;s continued service with the Company on each respective vesting date. The exercise price of the Option is equal to (i) $11.67, the closing trading price per share of the Company&#146;s Common Stock on
October&nbsp;1, 2020 as to the first 396,000 option shares to vest, (ii) 1.5 times the closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020 as to the next 51,000 option shares to vest and (iii) 2.0 times the
closing trading price per share of the Company&#146;s Common Stock on October&nbsp;1, 2020 as to the remaining 51,000 option shares to vest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the Employment Agreement, the Company will reimburse Mr.&nbsp;Michel up to $6,500 per month to cover his temporary
expenses incurred in connection with traveling to and living in the New York City tristate area to work onsite at the Company&#146;s principal corporate office for the initial eighteen (18)&nbsp;months of his employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Michel may resign his <FONT STYLE="white-space:nowrap">at-will</FONT> employment with the Company for &#147;Good Reason&#148; (as
defined within the Employment Agreement) and the Company may terminate Mr.&nbsp;Michel&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment other than for &#147;Cause&#148; (as defined within the Employment Agreement). If
Mr.&nbsp;Michel resigns his <FONT STYLE="white-space:nowrap">at-will</FONT> employment for Good Reason or the Company terminates Mr.&nbsp;Michel&#146;s employment other than for Cause, then Mr.&nbsp;Michel shall be entitled to his accrued and unpaid
compensation and, subject to him entering into and not revoking a general release of claims in favor of the Company and fully complying with the terms of an Employee Confidentiality, Invention Assignment and Restrictive Covenants Agreement (the
&#147;Restrictive Covenants Agreement&#148;), Mr.&nbsp;Michel shall also be entitled to: </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A severance payment equal in the aggregate to twelve (12)&nbsp;months of his annual base salary at the time of
termination, payable in twelve (12)&nbsp;equal monthly installments (and subject to applicable withholdings and deductions) beginning on the last Company payroll date of the first full month following termination of employment (&#147;Severance
Benefits&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If Mr.&nbsp;Michel timely and properly elects health plan (medical, dental and/or vision) continuation coverage
under COBRA, the Company will reimburse Mr.&nbsp;Michel in an amount equal to the difference between the monthly COBRA premium paid by Mr.&nbsp;Michel for him and his dependents and the monthly premium amount paid by similarly situated active
executives under the Company&#146;s group health plans (&#147;COBRA Benefits&#148;). Such reimbursement will be paid to Mr.&nbsp;Michel on or by the last day of the month immediately following the month in which Mr.&nbsp;Michel timely remits the
COBRA premium payment. Mr.&nbsp;Michel will be eligible to receive COBRA premium reimbursement until the earliest of: (x)&nbsp;the twelve-month anniversary of the date his employment with the Company terminates; (y)&nbsp;the date Mr.&nbsp;Michel is
no longer eligible to receive COBRA continuation coverage; and (z)&nbsp;the date on which Mr.&nbsp;Michel becomes eligible to receive substantially similar coverage from another employer. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In addition, the Employment Agreement provides that if Mr.&nbsp;Michel&#146;s
<FONT STYLE="white-space:nowrap">at-will</FONT> employment is terminated by Mr.&nbsp;Michel for Good Reason or by the Company without Cause, in each case within three (3)&nbsp;months before or twelve (12)&nbsp;months following a change in control of
the Company, Mr.&nbsp;Michel shall be entitled to receive his accrued and unpaid compensation and, subject to Mr.&nbsp;Michel entering into and not revoking a general release of claims in favor of the Company and fully complying with the Restrictive
Covenants Agreement, Mr.&nbsp;Michel shall be entitled to receive (i)&nbsp;the Severance Benefits, (ii)&nbsp;the COBRA Benefits, (iii)&nbsp;immediate acceleration of any unvested portion of the Option and any other outstanding stock options granted
to him at the time of his termination and (iv)&nbsp;a <FONT STYLE="white-space:nowrap">pro-rated</FONT> annual cash incentive bonus for the fiscal year in which Mr.&nbsp;Michel&#146;s employment terminates, as determined by the Board or the
Compensation and Stock Option Committee based on its assessment of the actual performance of the Company and Mr.&nbsp;Michel following the completion of the fiscal year in which the termination of employment occurs; such <FONT
STYLE="white-space:nowrap">pro-rated</FONT> cash incentive bonus to be paid to Mr.&nbsp;Michel in a lump sum no later than 60 days after the filing of the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
fiscal year in which the termination of employment occurs. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>John Purpura Executive Security Agreement. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Purpura does not have an employment agreement with the Company. Mr. Purpura and the Company have entered into an Executive Security
Agreement dated as of March 20, 2018 the purpose of which is to provide to Mr. Purpura severance payments in the event of a qualifying termination of his employment (a termination of his employment by the Company without cause or if the Company
gives him a good reason to voluntarily terminate his employment). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that Mr. Purpura&#146;s employment is terminated (other
than &#147;for cause&#148; (as defined in the Executive Security Agreement) or due to his death or disability) or by Mr. Purpura&#146;s resignation for &#147;good reason&#148; (as defined in the Executive Security Agreement), the Company is
obligated to pay Mr. Purpura the following amounts or benefits: (a) any accrued but unpaid annual base salary and any other form or type of compensation, benefit or perquisite that was approved by the Company&#146;s Board that is vested or accrued
on the date of the termination, to be paid in cash in a lump sum within ten calendar days following the date of the termination; (b) payment for any accrued paid time off in accordance with Company policy, to be paid in cash in a lump sum within ten
calendar days following the date of the termination; (c) and, if any employee participant of the Company receives an AIP payment for the fiscal year in which Mr. Purpura&#146;s termination occurs, he will be entitled to receive a prorated AIP
payment (based on the portion of the fiscal year he was employed by the Company) pursuant to the AIP for that fiscal year, subject and according to the terms and conditions of the AIP, with payment to be made at the time the Company pays that fiscal
year&#146;s AIP payments to its other executives but in no event later than March 15 of the subsequent fiscal year; (d) a severance payment equal to eighteen </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
months (the &#147;Severance Period&#148;) of base salary, based upon his annual base salary in effect on the date of the termination, to be paid in cash, less all applicable withholdings and
deductions, in approximately equal installments according to the Company&#146;s regular payroll schedule over the 18 month period following the termination; provided, however, that no payments will be made prior to the 60th calendar day following
the date of the termination. On the 60th calendar day following the date of the termination, the Company will pay Mr. Purpura in a lump sum the amount of the severance payments that he would have received during such 60-day period under the
Company&#146;s regular payroll schedule, and the balance of such severance will be paid to him in approximately equal installments over the remainder of the Severance Period; (e) if Mr. Purpura elects continuation coverage under COBRA for himself
and his covered dependents under the Company&#146;s group health and/or dental plans following the termination, then the Company will pay the COBRA premiums necessary to continue his group health and/or dental coverage in effect for himself and his
eligible dependents until the earliest of (i) the close of the Severance Period following the date of the termination, (ii) the date Mr. Purpura ceases to participate, for whatever reason, in the Company&#146;s group health and/or dental plans, or
(iii) the date on which Mr. Purpura is covered or is eligible to be covered under another group health and/or dental plan or is otherwise no longer eligible for coverage under COBRA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the event that there is a &#147;change of control&#148; of the Company and Mr. Purpura&#146;s employment has been terminated
by the Company other than for &#147;cause&#148; or if Mr. Purpura resigns for &#147;good reason&#148; during the 12 months immediately following the change of control, then on the 60th calendar day following the date of the qualifying termination,
Mr. Purpura will receive a lump sum severance payment equal to 18 months of base salary, based upon his annual base salary in effect on the date of the termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Christine Padula has no employment agreement or severance arrangements with the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_22"></A>POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the potential incremental value transfer to each current named executive officer under various termination or
change-in-control scenarios as of December 31, 2020, the last business day of 2020. Unvested, unexercised stock options and unvested restricted stock awards are valued based on the closing market price of our common stock on that date. The actual
amounts to be paid out in respect of the named executive officers can only be determined at the time of such named executive officer&#146;s actual separation from our company. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Retirement</B><br><B>or&nbsp;Voluntary</B><br><B>Termination</B><br><B>Without<BR>&#147;Good</B><br><B>Reason&#148;</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination</B><br><B>for &#147;Cause&#148;</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Involuntary</B><br><B>Termination</B><br><B>(Termination</B><br><B>Without</B><br><B>Cause, or</B><br><B>Termination</B><br><B>for
Good</B><br><B>Reason)</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Upon a</B><br><B>Change&nbsp;in</B><br><B>Control</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Death or</B><br><B>Disability</B><br><B>Termination</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerard Michel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,722,386</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Purpura, M.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">719,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">719,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christine Padula</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amount includes immediately vesting options, representing the difference between the closing price of our
common stock on December 31, 2020 and the exercise price multiplied by the number of option shares that would accelerate. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_10"></A>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee reviewed and discussed the Company&#146;s audited financial statements for the fiscal year ended December&nbsp;31, 2020, with management
and Marcum LLP, the Company&#146;s independent registered public accounting firm for the fiscal year ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee
also discussed with Marcum LLP the matters required to be discussed by Auditing Standard 1301 (Communications with Audit Committees), as adopted by the Public Company Accounting Oversight Board (&#147;PCAOB&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has received and reviewed the written disclosures and the letter from Marcum LLP required by applicable requirements of the PCAOB
regarding Marcum LLP&#146;s communications with the Audit Committee concerning independence and has discussed with Marcum LLP its independence from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the Company&#146;s audited financial
statements be included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2020, for filing with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Submitted by the Audit Committee of the Board of Directors, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Elizabeth Czerepak (Chair) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven Salamon </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roger G. Stoll, Ph.D. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;7, 2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_11"></A>STOCKHOLDER PROPOSALS FOR THE 2022 ANNUAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order for a stockholder proposal to be eligible for inclusion in our proxy statement for the 2022 annual meeting of stockholders, the
proposal must be received by the Corporate Secretary not later than 120&nbsp;days before the anniversary of the date this Proxy Statement was first released to our stockholders, or Wednesday, December&nbsp;8, 2021, and must otherwise comply with the
requirements of <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-8(e)</FONT> of the Securities Exchange Act of 1934. In addition, in order for a stockholder to present a proposal or other matter or to nominate a person for election as a director at
the 2022 annual meeting of stockholders, the stockholder must give Delcath written notice of the proposal or other matter to be presented at the meeting no later than 120&nbsp;days before the anniversary of the date this Proxy Statement was first
released to our stockholders and must otherwise comply with our amended and restated certificate of incorporation. If the date set for the 2022 annual meeting is more than 30&nbsp;calendar days before or after May&nbsp;6, 2021, such notice must
instead be received no later than 60&nbsp;calendar days before the date set for such meeting. Proposals or notices of intent to present a proposal should be addressed to the Corporate Secretary, Delcath Systems, Inc., 1633&nbsp;Broadway,
Suite&nbsp;22C, New York, New York 10019, and should be sent by overnight delivery or certified mail, return receipt requested. If a stockholder fails to provide timely notice of a proposal to be presented at the 2022 annual meeting, the proxies
designated by the Board will have discretionary authority to vote on the proposals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_12"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We know of no other matters to be brought before the 2021 Annual Meeting. However, if any other matters do properly come before the 2021
Annual Meeting, it is intended that the proxy holders will vote the shares represented by the proxies in the accompanying form as recommended by the Board or, if no recommendation is given, in accordance with the best judgment of the person voting
the proxies. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual and quarterly reports and other reports and information with the Commission. We distribute to our stockholders annual reports
containing financial statements audited by our independent registered public accounting firm and, upon request, quarterly reports for the first three quarters of each fiscal year containing unaudited financial information. In addition, the reports
and other information are filed through Electronic Data Gathering, Analysis and Retrieval (known as &#147;EDGAR&#148;) system and are publicly available on the Commission&#146;s site on the Internet, located at <I><U>www.sec.gov</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide, without charge, to each person to whom a proxy statement is delivered, upon written or oral request of such person and by
first class mail or other equally prompt means within one business day of receipt of such request, a copy of any and all of the information that has been incorporated by reference in the proxy statement (not including exhibits to the information
that is incorporated by reference unless such exhibits are specifically incorporated by reference into the information that the proxy statement incorporates). Please direct such request in writing or by telephone at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Delcath Systems, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1633
Broadway, Suite 22C </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, New York 10019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: (212) <FONT STYLE="white-space:nowrap">489-2100</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may also access such documents free of charge at
<U><FONT STYLE="white-space:nowrap">http://www.delcath.com/investors/sec-filings/</FONT></U> as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Commission. Our website and the information
contained on that site, or connected to that site, are not incorporated into and are not a part of this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your cooperation
in giving these matters your immediate attention and in returning your proxy promptly will be appreciated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BY ORDER OF THE BOARD OF DIRECTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g153004g66y02.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gerard Michel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Appendix&nbsp;A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc153004_14"></A>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 OMNIBUS EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>(As adopted by Board of Directors on September</U><U></U><U>&nbsp;30, 2020 and approved by stockholders on
November</U><U></U><U>&nbsp;23,&nbsp;2020)</U> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>(As amended by the Board of Directors on March</U><U></U><U>&nbsp;30, 2021,
subject to stockholder approval)</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>Purpose.</U></B><B> </B>The purpose of the Delcath Systems, Inc. 2020 Omnibus Equity
Incentive Plan (the &#147;<U>Plan</U>&#148;) is to align the interests of selected Employees, <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors and Consultants with those of Delcath Systems, Inc.&#146;s (the &#147;<U>Company</U>&#148;)
stockholders by providing such individuals with long-term incentive compensation opportunities tied to the performance of the Company&#146;s Common Stock. The Plan is intended to advance the interests of the Company and its stockholders by
attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the successful conduct of the Company&#146;s business is largely dependent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><U>The Plan was originally adopted by the Board of Directors on September</U><U></U><U>&nbsp;30, 2020 and approved by the stockholders of
the Company on November</U><U></U><U>&nbsp;23, 2020. On March</U><U></U><U>&nbsp;30, 2021, the Board approved an amendment of the Plan in the form set forth herein (the </U><U>&#147;</U><U>Amended Plan</U><U>&#148;</U><U>), subject to, and to be
effective upon, the approval of the stockholders of the Company in accordance with the requirements of the laws of the State of Delaware at the Company</U><U>&#146;</U><U>s 2021 annual stockholders</U><U>&#146;</U><U> meeting to be held on
May</U><U></U><U>&nbsp;6, 2021. If the Amended Plan is not so approved by the stockholders, all provisions of the Plan shall remain effective.</U> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><U>Definitions</U></B><B>.</B> Certain terms used in the Plan have the meanings set forth below (capitalized terms used in the Plan that
are not defined below have the meanings set forth elsewhere in the Plan): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means any Subsidiary and any other
corporation or other entity (including, but not limited to, partnerships and joint ventures) controlling, controlled by, or under common control with, the Company. For this purpose, &#147;control&#148; (including, with correlative meaning, the terms
&#147;controlled by&#148; and &#147;under common control with&#148;), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether
through the ownership of voting or other securities, by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Law</U>&#148; means any applicable
securities, federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement
issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any governmental or regulatory body or self-regulatory organization (including the Nasdaq Stock Market, the New York Stock Exchange and the
Financial Industry Regulatory Authority). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Award</U>&#148; means an award under the Plan, including any Incentive Stock Option, a
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option, Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Award, an Other Stock-Based Award or a Cash Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Award Agreement</U>&#148; means the written agreement entered into between the Participant and the Company setting forth the terms
and conditions applicable to an Award, as provided under <U>Section</U><U></U><U>&nbsp;5(c)</U>. An Award Agreement may, in the discretion of the Committee, be transmitted electronically to any Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Price</U>&#148; means the price per share of Common Stock subject to a Stock Appreciation Right at which the Stock Appreciation
Right may be exercised or settled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Company&#146;s Board of Directors, as constituted from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash Award</U>&#148; means an award denominated in cash that is granted pursuant to <U>Section</U><U></U><U>&nbsp;11</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cause</U>&#148;, with respect to any Employee or Consultant, unless the applicable
Award Agreement provides otherwise, shall have the meaning given to such term in any employment or other written agreement between such Participant and the Company or Affiliate, as applicable, or, in the event that such term is not defined in such
agreement or in the absence of any such agreement, shall mean the occurrence of any of the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The
Participant&#146;s willful failure to perform his or her duties and responsibilities to the Company or an Affiliate, or refusal to perform any lawful and reasonable directive of the Company or an Affiliate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The Participant&#146;s gross negligence or willful misconduct in the performance of his or her duties for the Company or
an Affiliate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The Participant&#146;s commission of any act of fraud, embezzlement, dishonesty, moral turpitude,
misappropriation of funds, breach of fiduciary duty, duty of loyalty and fidelity or other willful misconduct with respect to the Company or an Affiliate, or any act, whether or not related to the performance of the Participant&#146;s Service, that
affects the Company&#146;s or any Affiliate&#146;s reputation in a manner that may reasonably be expected to have a material adverse effect on the business, prospects, assets (including intangible assets), liabilities, financial condition, property
or results of operation of the Company or any Affiliate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) The Participant&#146;s unauthorized use or disclosure of any
proprietary information or trade secrets of the Company or any Affiliate or any other party to whom the Participant owes an obligation of nondisclosure as a result of the Participant&#146;s relationship with the Company or any Affiliate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) The Participant&#146;s breach of any of his or her obligations under any written agreement or covenant with, or any
material policy of, the Company or any Affiliate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) The Participant&#146;s indictment or conviction of or plea of nolo
contendere to a felony or crime of moral turpitude; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) The Participant&#146;s debarment, exclusion or disqualification
by any government regulator or government agency from participating in the business of the Company or any Affiliate; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) The Participant&#146;s exhibition of a standard of behavior within the scope of or related to the Participant&#146;s
employment, or is a violation of the Company&#146;s code of conduct, that is disruptive to the orderly conduct of the Company&#146;s or its Affiliates&#146; business operations (including, without limitation, substance abuse, sexual harassment or
sexual misconduct, or other unlawful harassment or retaliation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cause</U>&#148;, with respect to any <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director, unless the applicable Award Agreement provides otherwise, means a determination by a majority of the disinterested Directors that the <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director has engaged in any of the following: (i)&nbsp;malfeasance while in office; (ii)&nbsp;gross negligence, willful misconduct or neglect with respect to the Company or any Affiliate; (iii)&nbsp;false or fraudulent misrepresentation in
connection with the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s appointment; or (iv)&nbsp;conversion of corporate funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, references to the Company and Affiliate in the foregoing definitions of &#147;Cause&#148; shall include the
successor to either as may be appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change in Control</U>&#148; means the date of the occurrence of any of the following
events, provided that the event constitutes a &#147;change in control event&#148; within the meaning of Section&nbsp;409A of the Code: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
The consummation of any consolidation or merger of the Company with any other entity, other than a transaction which would result in the voting power of the securities of the Company outstanding immediately prior thereto continuing to represent
(either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity or its parent
outstanding immediately after such consolidation or merger; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Any one Person, or more than one Person acting as a group, acquires
ownership of the stock of the Company that, together with the stock held by such Person or group, constitutes more than 50%&nbsp;of the total </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voting power of the stock of the Company; provided, however, that for purposes of this subsection, (A)&nbsp;the acquisition of additional stock by any one Person or group, who is considered to
own more than 50%&nbsp;of the total voting power of the stock of the Company will not be considered a Change in Control, and (B)&nbsp;if the stockholders of the Company immediately before such change in ownership continue to retain immediately after
the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#146;s voting stock immediately prior to the change in ownership, the direct or indirect beneficial ownership of 50% or more of the total
voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change in Control under this subsection (ii). For this purpose, indirect beneficial ownership will include, without
limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other
business entities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) A majority of the Directors is replaced during any <FONT STYLE="white-space:nowrap">12-month</FONT> period by
Directors whose appointment or election is not endorsed by a majority of the Directors prior to the date of the appointment or election; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Any one Person, or more than one Person acting as a group, acquires (or has acquired during the
<FONT STYLE="white-space:nowrap">12-month</FONT> period ending on the date of the most recent acquisition by such person or persons)&nbsp;assets from the Company that have a total gross fair market value equal to or more than 50%&nbsp;of the total
gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iv), the following will not constitute a change in the ownership of a
substantial portion of the Company&#146;s assets: (A)&nbsp;a transfer to an entity that is controlled by the Company&#146;s stockholders immediately after the transfer, or (B)&nbsp;a transfer of assets by the Company to: (1)&nbsp;a stockholder of
the Company (immediately before the asset transfer)&nbsp;in exchange for or with respect to the Company&#146;s stock, (2)&nbsp;an entity, 50%&nbsp;or more of the total value or voting power of which is owned, directly or indirectly, by the Company,
(3)&nbsp;a Person, that owns, directly or indirectly, 50%&nbsp;or more of the total value or voting power of all the outstanding stock of the Company, or (4)&nbsp;an entity, at least 50%&nbsp;of the total value or voting power of which is owned,
directly or indirectly, by a Person described in subsection (3)&nbsp;above. For purposes of this subsection (iv), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without
regard to any liabilities associated with such assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, Persons will be considered to be acting as a
group if they are owners of an entity that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, as the same may be
amended from time to time and any successor statute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Committee</U>&#148; means the committee of the Board appointed by the Board
to administer the Plan, pursuant to <U>Section</U><U></U><U>&nbsp;3</U>, which, unless otherwise determined by the Board, shall be the Compensation and Stock Option Committee. In the absence of any such Committee, any action permitted or required to
be taken hereunder by the Committee shall be deemed to refer to the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the Company&#146;s
common stock, par value $0.01 per share, or such other securities of the Company as may be designated by the Committee in substitution thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consultant</U>&#148; means any Person who provides consulting or other services to the Company or any Affiliate and who is
(i)&nbsp;neither an Employee nor a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director and (ii)&nbsp;may be offered securities registrable pursuant to a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the
Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disability</U>&#148; means (a)&nbsp;in the case of Incentive Stock Options, total and permanent disability as defined in
Section&nbsp;22(e)(3) of the Code, and (b)&nbsp;in the case of other Awards, unless the applicable Award Agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provides otherwise, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment (and considered
&#147;disabled&#148; within the meaning of Section&nbsp;409A of the Code). The determination of whether an individual has a Disability shall be determined under procedures established by the Committee, which shall be final, conclusive and binding.
Except in situations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option, the Committee may rely on any determination that a Participant is disabled for purposes of benefits under any long-term
disability plan maintained by the Company or any Affiliate in which a Participant participates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Equivalent
Right</U>&#148; means the right of a Participant, granted pursuant to <U>Section</U><U></U><U>&nbsp;9</U> in connection with the Restricted Stock Unit Award, to receive a credit for the account of such Participant in an amount equal to cash or stock
dividends or other distributions paid by the Company in respect of one share of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Date</U>&#148; means the
date of adoption of the Plan by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Eligible Person</U>&#148; means any of the following: (i)&nbsp;any Employee,
Consultant, or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director or (ii)&nbsp;any individual to whom the Company or any Affiliate has extended a formal offer of employment, so long as the grant of any Award shall not become effective
until such individual commences such employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Employee</U>&#148; means an individual, including, without limitation, any
Officer and Director, who is a common law employee of the Company or an Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities
Exchange Act of 1934, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exercise Price</U>&#148; means the price at which a share of Common Stock subject to an Option
may be purchased upon the exercise of the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fair Market Value</U>&#148; means, as of any date, the value of the Common
Stock determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the Common Stock is publicly traded and is then listed on a national securities exchange, its closing
price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in<I></I><I>&nbsp;The Wall Street</I><I></I><I>&nbsp;Journal</I> or such other source as the
Committee deems reliable (subject to compliance with Applicable Law, including Section&nbsp;409A of the Code); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If the Common Stock
is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in<I></I><I>&nbsp;The Wall Street Journal</I>&nbsp;or such
other source as the Committee deems reliable; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) If none of the foregoing is applicable, by the Board or the Committee in good
faith (and in accordance with Section&nbsp;409A of the Code, as applicable), which such decision shall be final, conclusive and binding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Grant Date</U>&#148; means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting
an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution or action, then such date as set forth in such resolution or action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incentive Stock Option</U>&#148; means an Option that is intended to meet the requirements of Section&nbsp;422 of the Code and is
designated as an Incentive Stock Option. To the extent that any Option is not designated as an Incentive Stock Option, or even if so designated does not qualify as an Incentive Stock Option at or subsequent to its Grant Date, it shall constitute a <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</U>&#148;
means a Director who is not an Employee, and who satisfies the requirements of a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; within the meaning of Section&nbsp;16 of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option</U>&#148; means an
Option that is not an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; means a person who is an officer of the Company within the
meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Option</U>&#148; means the
right to purchase, at the price and for the term fixed by the Committee in accordance with <U>Section</U><U></U><U>&nbsp;6</U>, and subject to such other limitations and restrictions in the Plan and the applicable Award Agreement, a number of shares
of Common Stock determined by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Other Stock-Based Award</U>&#148; means an Award that is not an Option, Stock
Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Cash Award, and that is granted under <U>Section</U><U></U><U>&nbsp;11</U> and is payable by delivery of Common Stock and/or which is measured by reference to the value of
Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Participant</U>&#148; means an Eligible Person to whom the Committee has granted an Award under the Plan (or, if
applicable, such other Person who holds an outstanding Award). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Performance Award</U>&#148; means an award that may vest or may
become eligible to vest contingent upon the attainment during a Performance Period of certain Performance Goals and which is granted pursuant to the terms of <U>Section</U><U></U><U>&nbsp;10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Performance Goal</U>&#148; means one or more goals as may be established by the Committee that must be met by the end of a given
Performance Period as a contingency for a given Award to vest and/or become exercisable, settled or payable, or to otherwise determine the numbers of shares of Common Stock or stock-denominated units that are earned under an Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Performance Period</U>&#148; means one or more periods of time, as the Committee may select, over which the attainment of one or more
Performance Goals will be measured for the purpose of determining a Participant&#146;s right to vesting, exercisability, settlement or payment of an Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, a partnership, a corporation, a limited liability company, an association, a joint share
company, a trust, a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Stock Award</U>&#148; means a grant of shares of Common Stock under <U>Section</U><U></U><U>&nbsp;8</U> that are issued
subject to vesting and transfer restrictions and such other conditions as are set forth in the Plan and the applicable Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Stock Unit Award</U>&#148; means an Award of Restricted Stock Units under <U>Section</U><U></U><U>&nbsp;9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated
under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended from time to time or any successor statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Service</U>&#148; means, as applicable, a Participant&#146;s service with the Company or an Affiliate, as an Employee, <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director or Consultant. For purposes of the Plan, a Participant&#146;s Service shall not be deemed to have been terminated merely because of a change in the capacity in which the Participant renders
service to the Company or an Affiliate as an Employee, Consultant or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director or merely because of a transfer of the Participant&#146;s Service between the Company and/or Affiliates (except as may
be required for compliance with Section&nbsp;409A of the Code). The Committee, in its sole discretion, may determine whether a Company transaction, such as a sale or <FONT STYLE="white-space:nowrap">spin-off</FONT> of a division or subsidiary that
employs a Participant, shall be deemed to result in a termination of Service for purposes of affected Awards, and such decision shall be final, conclusive and binding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stock Appreciation Right</U>&#148; means a contractual right granted under
<U>Section</U><U></U><U>&nbsp;7</U> entitling the holder of such right to receive, subject to limitation and restrictions in the Plan and applicable Award Agreement, the appreciation in value of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means any entity in which the Company owns at least 50% of the combined voting power of all classes of equity
entitled to vote or at least 50% of the combined value of all classes of equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ten Percent Stockholder</U>&#148; means an
Employee who, at the time an Option is granted, owns either directly or indirectly (taking into account the attribution rules contained in Section&nbsp;424(d) of the Code), stock possessing more than 10% of the total combined voting power of all
classes of stock of the Company or any Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><U>Administration of the Plan</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>General</U>. The Plan shall be administered by the Committee (or the Board if no Committee has been appointed). The Committee shall have
the power and authority to (i)&nbsp;prescribe, amend and rescind rules and procedures governing the administration of the Plan; (ii)&nbsp;determine and designate from time to time each Eligible Person to whom an Award will be granted and the type of
Award to be granted; (iii)&nbsp;determine the number of shares of Common Stock subject to each Award and the Grant Date of each Award; (iv)&nbsp;prescribe the terms of each Award, including, without limitation, the time or times when, and the manner
and conditions upon which, each Award shall vest, become exercisable, be settled and/or expire, the Exercise Price or Base Price of each Award (as may be applicable), and the form of payment made in settlement of each Award; (v)&nbsp;specify the
terms of the Award Agreement relating to each Award; (vi)&nbsp;determine or impose other conditions to the receipt of shares of Common Stock subject to an Award, as it may deem appropriate, including but not limited to, cash payments;
(vii)&nbsp;interpret the terms of the Plan and each Award Agreement and the rules of procedures established by the Committee under the Plan; (viii)&nbsp;determine the rights of all Persons under the Plan; (ix)&nbsp;correct any defect or omission or
reconcile any inconsistency in the Plan or in any Award Agreement; (x)&nbsp;make all determinations relating to the Service of a Participant; (xi)&nbsp;grant waivers of any conditions of the Plan or any Award Agreement, subject to Applicable Law;
and (xii)&nbsp;make all other determinations and take all other actions necessary or advisable for the implementation and administration of the Plan. In the case of any fractional share or unit resulting from the grant, vesting, payment or crediting
of dividends under an Award, the Committee shall have the discretionary authority to round such fractional share or unit to the nearest higher whole share or unit, or convert such fractional share or unit into a right to receive a cash payment
(unless determined otherwise by the Committee, such fractional share or unit shall be rounded to the nearest higher whole share or unit). All actions, decisions and interpretations of the Committee, the Board and any delegate of the Committee or
Board under the Plan or any Award Agreement shall be final, binding, conclusive and <FONT STYLE="white-space:nowrap">non-appealable</FONT> on all Persons, and shall be given the maximum deference permitted by law. The Committee&#146;s and the
Board&#146;s determinations under the Plan (including, without limitation, determinations of the persons to receive Awards, the form, amount and timing of such Awards, the terms and provisions of such Awards and the Award Agreements evidencing such
Awards) need not be uniform and may be made by the Committee or the Board selectively among Persons who receive, or are eligible to receive, Awards under the Plan, whether or not such Persons are similarly situated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Composition of the Committee</U>. Except as otherwise determined by the Board, the Committee shall consist of two or more Directors
appointed to such committee from time to time by the Board. To the extent deemed necessary or appropriate by the Board, the Committee shall consist solely of at least two Directors who are <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Directors and are &#147;independent directors&#148; under any applicable exchange requirements. The Board shall have discretion to determine whether or not it intends to comply with the exemption requirements of Rule
<FONT STYLE="white-space:nowrap">16b-3;</FONT> however, if the Board intends to satisfy such exemption requirements, with respect to any insider subject to Section&nbsp;16 of the Exchange Act, the Committee shall be a compensation committee of the
Board that at all times consists solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors. Nothing herein shall create an inference that an Award is not validly granted under the Plan in the event Awards are granted under
the Plan by a committee of the Board that does not at all times consist solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Delegation of Authority</U>. The Board or the Committee may delegate to a committee of
one or more Directors and/or Officers who are not <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors the authority to grant Awards to Eligible Persons who are not then subject to Section&nbsp;16 of the Exchange Act. In the event of such
delegation of authority, all provisions of the Plan relating to the Committee shall be interpreted in a manner consistent with such delegation by treating any reference to the Committee as a reference to the committee or Officers to whom such
delegation has been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Limited Liability; Indemnification</U>. In addition to such other rights of indemnification as they may
have as Directors or members of the Committee, and to the maximum extent allowed by the Company&#146;s charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> and Applicable Laws, the Committee shall be indemnified by the Company against the
reasonable expenses, including attorney&#146;s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein, to which the Committee may be party by reason of any action taken or failure to act
under or in connection with the Plan or any Award granted under the Plan, and against all amounts paid by the Committee in settlement thereof (<I>provided, however</I>, that the settlement has been approved by the Company, which approval shall not
be unreasonably withheld) or paid by the Committee in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such Committee did not
act in good faith and in a manner which such person reasonably believed to be in the best interests of the Company, or in the case of a criminal proceeding, had no reason to believe that the conduct complained of was unlawful; <I>provided,
however</I>, that within 60 days after the institution of any such action, suit or proceeding, such Committee shall, in writing, offer the Company the opportunity at its own expense to handle and defend such action, suit or proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><U>Shares Subject to the Plan</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Aggregate Limit.</U> Subject to adjustment as set forth in <U>Section</U><U></U><U>&nbsp;4(d)</U>, the total number of shares of Common
Stock reserved and available for grant and issuance pursuant to Awards under the Plan is equal to <STRIKE>675,000</STRIKE><U>2,475,000</U> shares (the &#147;<U>Share Reserve</U>&#148;), the full amount of which may be issued under the Plan through
the exercise of Incentive Stock Options. For purposes of counting shares against the Share Reserve, Awards denominated in shares of Common Stock and other Awards that may be exercised for, settled in or convertible into shares of Common Stock will
be counted against the Plan reserve on the date of grant of the Award based on the maximum number of shares that may be issued pursuant to the Award, as determined by the Committee. Shares of Common Stock delivered under the Plan shall consist of
authorized and unissued shares, treasury shares, forfeited shares and/or shares reacquired by the Company in any manner. As of the Effective Date, no further awards shall be made under the Company&#146;s 2019 Equity Incentive Plan or any other prior
equity incentive plans of the Company (but such plans shall remain in effect as to awards made thereunder that are still outstanding as of the Effective Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Individual Limits</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Participants other than <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</U>. Subject to adjustment under
<U>Section</U><U></U><U>&nbsp;4(d)</U>, (A) the maximum number of shares of Common Stock underlying Options and Stock Appreciation Rights that may be granted under the Plan during any calendar year to any one Participant (other than a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall be 500,000 shares; (B)&nbsp;the maximum number of shares of Common Stock subject to Restricted Stock Awards, awards of Restricted Stock Units and Other Stock Based Awards that may be
granted under the Plan during any calendar year to any one Participant (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall be 500,000 (where the number of shares earned is dependent on the level of attainment of
Performance Goals under a Performance Award, the number of shares counted shall be the number that may be earned at maximum performance); (C) the maximum amount of a Cash Award that may be paid pursuant to <U>Section</U><U></U><U>&nbsp;11</U> in any
calendar year to any Participant (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall be $3,000,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</U>. In any director year (as described below), no <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director may receive Awards under the Plan that, when combined with cash compensation received for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
his or her service as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director during such director year, exceed an aggregate value of $750,000 (with value of each equity award based on
its grant date fair value, determined in accordance with U.S. generally accepted accounting principles). Any cash compensation paid or Awards granted to an individual for his or her service as an Employee, or for his or her services as a Consultant
(other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director), will not count for purposes of the limitation under this Section. For purposes of the foregoing, a &#147;director year&#148; shall mean the approximate <FONT
STYLE="white-space:nowrap">one-year</FONT> period beginning on the date of a regular annual meeting of the Company&#146;s stockholders and ending on the date of the next regular annual meeting of the Company&#146;s stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Returned Shares.</U> Any shares of Common Stock subject to an outstanding Award or any portion thereof granted under the Plan will be
returned to the Share Reserve and will be available for issuance in connection with subsequent Awards under the Plan to the extent such shares (or the Awards covering such shares)&nbsp;(i) are cancelled, forfeited or settled in cash;
(ii)&nbsp;expire by their terms at any time; or (iii)&nbsp;are reacquired by the Company pursuant to a forfeiture provision. Notwithstanding the foregoing, shares subject to an Award shall not again be made available for issuance under the Plan if
such shares are surrendered or tendered to pay the Exercise Price or Base Price of such Award or any tax withholding obligation arising in connection with vesting, exercise or settlement of such Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Adjustments for Changes in Common Stock, Etc</U>. In the event of any change with respect to the outstanding shares of Common Stock by
reason of any recapitalization, reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock, or any merger, reorganization, consolidation, combination, <FONT
STYLE="white-space:nowrap">spin-off,</FONT> or other similar corporate change, or any other any relevant change affecting the capitalization of the Company, the Committee shall, in the manner that it, in its sole discretion, determines is
appropriate, cause an equitable adjustment or substitution to be made to (i)&nbsp;the maximum number of shares (or other securities or rights) reserved for issuance and future grant from the Share Reserve, (ii)&nbsp;the individual award limits set
forth in <U>Section</U><U></U><U>&nbsp;4(b)</U>, (iii) the number and kind of shares (or other securities or rights) subject to then outstanding Awards, (iv)&nbsp;the Exercise Price or Base Price with respect to any Option or Stock Appreciation
Right, (v)&nbsp;the Performance Goals applicable to any Award and (vi)&nbsp;any other terms of an Award that are affected by the event. Any such actions shall be taken by the Company in good faith so as to substantially preserve the value, rights
and benefits of any affected Awards. In the case of adjustments made pursuant to this <U>Section</U><U></U><U>&nbsp;4(d)</U>, unless the Committee specifically determines that such adjustment is in the best interests of the Company or Affiliates,
the Committee shall, in the case of Incentive Stock Options, ensure that any adjustments under this <U>Section</U><U></U><U>&nbsp;4(d)</U> will not constitute a modification, extension or renewal of the Incentive Stock Options within the meaning of
Section&nbsp;424(h)(3) of the Code, and in the case of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options and Stock Appreciation Rights, ensure that any adjustments under this <U>Section</U><U></U><U>&nbsp;4(d)</U> will not constitute a
modification of such <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options within the meaning of Section&nbsp;409A of the Code. Any adjustments made under this <U>Section</U><U></U><U>&nbsp;4(d)</U> shall be made in a manner which does not
adversely affect the exemption provided pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be
conclusive and binding for all purposes. In addition, in connection with any of the events described above, the Committee, in its sole discretion, and subject to compliance with Section&nbsp;409A of the Code may provide that each Award
then-outstanding shall terminate in exchange for an equitable payment as determined by the Committee in good faith, which, in the case of Options and Stock Appreciation Rights, may include a cash payment to the extent of the excess, if any, of the
then-Fair Market Value of a share of Common Stock subject to the Award, over the Exercise Price or Base Price per share of Common Stock subject to the Award, and in the event that there is no such excess, a payment of zero. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Substitute Awards</U>. Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in
substitution for, outstanding awards previously granted by an entity acquired by the Company or an Affiliate or with which the Company or Affiliate combines after the Effective Date (&#147;<U>Substitute Awards</U>&#148;). To the extent permitted by
Applicable Law, shares of Common Stock subject to Substitute Awards shall not be counted against the Share Reserve; provided, that, Substitute Awards issued in connection with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assumption of, or in substitution for, outstanding options intended to qualify as &#147;incentive stock options&#148; within the meaning of Section&nbsp;422 of the Code shall be counted against
the share limit applicable to Incentive Stock Options. Notwithstanding any other provision of the Plan, the terms of Substitute Awards may vary from the terms set forth in the Plan to the extent the Committee deems appropriate to conform, in whole
or in part, to the provisions of the awards in substitution for which they are granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><U>Eligibility and Awards</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Designation of Participants</U>. Any Eligible Person may be selected by the Committee to receive an Award and become a Participant under
the Plan in accordance with the Committee&#146;s authority under <U>Section</U><U></U><U>&nbsp;3</U>. In selecting Eligible Persons to be Participants, and in determining the type and amount of Awards to be granted under the Plan, the Committee
shall consider any and all factors that it deems relevant or appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Determination of Awards</U>. The Committee shall
determine the terms and conditions of all Awards granted to Participants in accordance with its authority under <U>Section</U><U></U><U>&nbsp;3</U> and other terms of the Plan. An Award may consist of one type of right or benefit hereunder or of two
or more such rights or benefits granted in tandem. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Award Agreements</U>. Each Award under the Plan shall be evidenced by an Award
Agreement in a written or electronic form approved by the Committee setting forth (as applicable) the number of shares of Common Stock, units or other rights subject to the Award, the Exercise Price, Base Price, or purchase price of the Award, the
time or times at which an Award will become vested, exercisable, settled or payable, the term of the Award and any Performance Goals applicable to the Award. The Award Agreement may also set forth the effect on an Award of a Change in Control or a
termination of Service under certain circumstances. The Award Agreement shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions of the Plan, and may also set forth other terms and conditions
applicable to the Award as determined by the Committee consistent with the limitations of the Plan. The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such
conditions, as are specified in the Plan as being applicable to such type of Award (or to all Awards) or as are expressly set forth in the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>Option Awards</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Grant of Options</U>. An Award of an Option may be granted to any Eligible Person selected by the Committee and shall be evidenced by an
Award Agreement setting forth the Exercise Price, the term of the Option, the number of shares of Common Stock to which the Option relates, any conditions to the exercise or vesting of all or a portion of the Option and such other terms and
conditions as the Committee, in its sole discretion, shall determine. The Award Agreement pertaining to an Option shall designate such Option as an Incentive Stock Option or a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option. In no event
shall an Incentive Stock Option be granted to an individual who is not an employee of the Company or of a &#147;subsidiary corporation&#148; or a &#147;parent corporation,&#148; whether now or hereafter existing, as such terms are defined in
Section&nbsp;424(f) of the Code. To the extent the aggregate Fair Market Value (determined as of the time the Option is granted) of the shares of Common Stock with respect to which an Incentive Stock Option may first become exercisable by a
Participant in any one calendar year under the Plan exceeds $100,000, the Option or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options. The Company shall have no liability to any Participant, or to any other Person, if an Option (or any portion thereof) that is intended to be an Incentive Stock Option fails to qualify as
an Incentive Stock Option at any time or if an Option (or any portion thereof) is determined to constitute &#147;nonqualified deferred compensation&#148; under Section&nbsp;409A of the Code and the terms of such Option do not satisfy the
requirements of Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Exercise Price</U>. The Exercise Price with respect to shares of Common Stock
subject to an Option shall be determined by the Committee in its sole discretion, provided, however, that the Exercise Price per share shall not be less than 100% (or 110% in the case of an Incentive Stock Option granted to a Ten Percent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stockholder) of the Fair Market Value of a share of Common Stock on the Grant Date of such Option. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an Exercise Price
lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section&nbsp;424(a) of the Code, and a
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option may be granted with an Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner
satisfying the provisions of Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Term of Option</U>. The Committee shall determine and set forth in an
Award Agreement the term during which an Option may be exercised, provided that in no event shall any Option have a maximum term greater than ten years from the Grant Date (except that the maximum term of an Incentive Stock Option granted to a Ten
Percent Stockholder shall be no more than five years from the Grant Date), or such shorter period as set forth in the Award Agreement. Each Option shall terminate, cease to be exercisable and be forfeited not later than the end of the maximum term
specified in the Award Agreement pertaining to the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Vesting and Exercisability of Options</U>. The Committee shall, in its
sole discretion, provide in an Award Agreement the time or times at which, or the conditions upon which, an Option or portion thereof shall become vested and/or exercisable. The Committee may condition the vesting and/or exercisability upon the
passage of time (e.g., subject to the Participant&#146;s continued Service for specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in
its sole discretion, provide, in an Award Agreement or other agreement between a Participant and the Company, for the acceleration of vesting and/or exercisability of any Option upon a Participant&#146;s termination of Service under specified
circumstances or upon the occurrence of other specified events or conditions. To the extent the vesting requirements of an Option are not satisfied, the Option shall be forfeited. In no event may any Option be exercised for a fraction of a share of
Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Termination of Service</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>General</U>. Except as otherwise provided in the applicable Award Agreement or other individual written agreement
between the Participant and the Company, if a Participant&#146;s Service terminates (other than for Cause and other than upon the Participant&#146;s death or Disability), the Participant may exercise his or her Option (to the extent that the Option
was vested and the Participant was entitled to exercise such Option as of the date of the termination of Service) within the period of time ending on the earlier of (A) 90 days following the termination of the Participant&#146;s Service, and
(B)&nbsp;the expiration of the term of the Option as set forth in the Plan or Award Agreement. If, after termination of Service, the Participant does not exercise his or her Option within the applicable time frame, the Option will terminate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Disability of Participant</U>. Except as otherwise provided in the applicable Award Agreement or other individual
written agreement between the Participant and the Company, if a Participant&#146;s Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option (to the extent that the Option was vested and the
Participant was entitled to exercise such Option as of the date of termination of Service), but only within such period of time ending on the earlier of (A)&nbsp;the date 12&nbsp;months following such termination of Service, and (B)&nbsp;the
expiration of the term of the Option as set forth in the Award Agreement. If, after termination of Service, the Participant does not exercise his or her Option within the applicable time frame, the Option will terminate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <U>Death of Participant</U><B>.</B> Except as otherwise provided in the applicable Award Agreement or other individual
written agreement between the Participant and the Company, if (A)&nbsp;a Participant&#146;s Service terminates as a result of the Participant&#146;s death, or (B)&nbsp;the Participant dies within the period (if any) specified in the Award Agreement
for exercisability after the termination of the Participant&#146;s Service for a reason other than death, then the Option may be exercised (to the extent the Option was vested and the Participant was entitled to exercise such Option as of the date
of death) by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
Participant&#146;s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Participant&#146;s death,
but only within the period ending on the earlier of (A)&nbsp;the date 12&nbsp;months following the date of death, and (B)&nbsp;the expiration of the term of such Option as set forth in the Award Agreement. If, after the Participant&#146;s death, the
Option is not exercised within the applicable time frame, the Option will terminate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <U>Termination for Cause</U>.
Except as provided otherwise in a Participant&#146;s Award Agreement or other individual written agreement between the Company and a Participant, if a Participant&#146;s Service is terminated by the Company or any Affiliate for Cause, each Option,
whether vested or unvested, that is held by such Participant shall terminate, cease to be exercisable/payable and be forfeited as of the date of such termination of Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Exercise of Options; Payment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Notice of Exercise</U>. Subject to vesting, exercisability and other restrictions provided for hereunder or otherwise
imposed in accordance herewith, an Option may be exercised, in whole or in part, by a Participant only by delivery of written notice (in the form prescribed by the Committee) to the Company specifying the number of shares of Common Stock to be
purchased. An Option may not be exercised after it is forfeited or otherwise terminated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Payment of Exercise
Price</U>. The aggregate Exercise Price shall be paid in full upon the exercise of the Option. Payment must be made by one of the following methods: (A)&nbsp;cash or a certified or bank cashier&#146;s check; (B)&nbsp;if and upon the terms approved
by the Committee in its sole discretion, by delivery to the Company of previously owned and vested shares of Common Stock, duly endorsed for transfer to the Company, having an aggregate Fair Market Value on the date of exercise equal to the
aggregate Exercise Price due for the number of shares being acquired pursuant to such exercise, (C)&nbsp;if and upon the terms approved by the Committee in its sole discretion, through the withholding by the Company of shares of Common Stock
otherwise to be received, with such withheld shares of Common Stock having an aggregate Fair Market Value on the date of exercise equal to the aggregate Exercise Price due for the number of shares being acquired; (D)&nbsp;a &#147;cashless&#148;
exercise program established with a broker; (E)&nbsp;by any combination of such methods of payment, or (F)&nbsp;any other method approved by the Committee in its sole discretion. Unless otherwise specifically provided in the Option, the Exercise
Price that is paid by delivery to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock that have been held for more than six months (or such longer or shorter period of
time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period the Common Stock is publicly traded, an exercise by a Director or Officer that involves or may involve a direct or
indirect extension of credit or arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section&nbsp;402(a) of the Sarbanes-Oxley Act of 2002 shall be prohibited. The Committee may impose limitations and
prohibitions on the exercise of Options as it deems appropriate, including, without limitation, any limitation or prohibition designed to avoid accounting consequences which may result from the use of shares of Common Stock as payment of the
aggregate Exercise Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <U>Disqualifying Disposition with respect to Incentive Stock Option</U>. If shares of Common Stock acquired
upon the exercise of an Incentive Stock Option are disposed of by a Participant prior to the expiration of (i)&nbsp;two years from the Grant Date of such Option, or (ii)&nbsp;one year from the date of the transfer of shares to the Participant
pursuant to the exercise of such Option, or in any other &#147;disqualifying disposition&#148; within the meaning of Section&nbsp;422 of the Code, such Participant shall notify the Company in writing as soon as practicable thereafter of the date and
terms of such disposition and, if the Company (or any Affiliate) thereupon has a tax withholding obligation, shall pay to the Company (or such Affiliate) an amount equal to any withholding tax the Company (or such Affiliate) is required to pay as a
result of the disqualifying disposition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>Stock Appreciation Rights</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Grant of Stock Appreciation Rights.</U> An Award of a Stock Appreciation Right may be granted to any Eligible Person selected by the
Committee and shall be evidenced by an Award Agreement setting forth the Base Price, the term of the Stock Appreciation Right, the number of shares of Common Stock to which the Stock Appreciation Right relates, any conditions to the exercise of all
or a portion of the Stock Appreciation Right and such other terms and conditions as the Committee, in its sole discretion, shall determine. A Stock Appreciation Right may, in the sole discretion of the Committee, be granted in tandem with an Option,
and in such event, shall (i)&nbsp;have a Base Price per share equal to the per share Exercise Price of the Option, (ii)&nbsp;be vested and exercisable at the same time or times that a related Option is vested and exercisable, and (iii)&nbsp;expire
no later than the time at which the related Option expires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Benefits Upon Exercise</U>. Subject to such terms and conditions as
specified in an Award Agreement, a Stock Appreciation Right shall entitle the Participant to receive a payment, upon exercise or other settlement of the Stock Appreciation Right, of an amount determined by multiplying (i)&nbsp;the excess of the Fair
Market Value of each share of Common Stock covered by the Stock Appreciation Right on the date of exercise or settlement of the Stock Appreciation Right over the Base Price per share of Common Stock covered by the Stock Appreciation Right, by
(ii)&nbsp;the number of shares of Common Stock as to which such Stock Appreciation Right is exercised or settled. Such payment may be in cash, in shares of Common Stock (with or without restriction as to substantial risk of forfeiture and
transferability, as determined by the Company in its sole discretion) valued at their Fair Market Value on the date of exercise or other settlement, or in any combination, as the Committee shall determine in the Award Agreement. Upon exercise of a
tandem Stock Appreciation Right, the number of shares of Common Stock for which any related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised. The number of shares of
Common Stock for which a tandem Stock Appreciation Right shall be exercisable shall be reduced upon any exercise of any related Option by the number of Shares of Common Stock for which such Option has been exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Base Price</U>. The Base Price per share of Common Stock subject to a Stock Appreciation Right shall be determined by the Committee in
its sole discretion, <I>provided</I>, <I>however</I>, that the Base Price per share shall not be less than 100% of the Fair Market Value of a share of Common Stock on the Grant Date of such Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Term of Stock Appreciation Right</U>. The Committee shall determine and set forth in an Award Agreement the term during which a vested
Stock Appreciation Right may be exercised or settled, provided that in no event shall any Stock Appreciation Right have a maximum term greater than 10 years from the Grant Date, or such shorter period as set forth in the Award Agreement. Each Stock
Appreciation Right shall terminate, cease to be exercisable/payable and be forfeited, not later than the end of the maximum term specified in the Agreement pertaining to the Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Vesting and Exercisability of Stock Appreciation Rights</U>. The Committee shall, in its sole discretion, provide in an Award Agreement
the time or times at which, or the conditions upon which, a Stock Appreciation Right or portion thereof shall become vested, exercisable and/or settled. The Committee may condition the vesting and/or exercisability upon the passage of time (e.g.,
subject to the Participant&#146;s continued Service for a specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion,
provide, in an Award Agreement or other written agreement between a Participant and the Company, for the acceleration of vesting and/or exercisability of any Stock Appreciation Right upon a Participant&#146;s termination of Service under specified
circumstances or upon the occurrence of other specified events or conditions. To the extent the vesting requirements of a Stock Appreciation Right are not satisfied, the Stock Appreciation Right shall be forfeited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Notice of Exercise</U>. Subject to vesting, exercisability and other restrictions provided for hereunder or otherwise imposed in
accordance herewith, a Stock Appreciation Right may be exercised, in whole or in part, by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a Participant only by delivery of written notice (in the form prescribed by the Committee) to the Company specifying the number of shares of Common Stock with respect to which the exercise
applies.&nbsp;&nbsp;&nbsp;&nbsp;A Stock Appreciation Right may not be exercised after it is forfeited or otherwise terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g.
<U>Termination of Service</U>. The same rules of <U>Section</U><U></U><U>&nbsp;6(e)</U> that apply to Options regarding termination of Service shall also apply to Stock Appreciation Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>Restricted Stock Awards</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Grant of Restricted Stock</U>. A Restricted Stock Award may be granted to any Eligible Person selected by the Committee and shall be
evidenced by an Award Agreement setting forth the number of shares of Common Stock subject to the Restricted Stock Award, the payment (if any) required for such shares, the vesting restrictions applicable to such shares and such other terms and
conditions as the Committee, in its sole discretion, shall determine. The Committee may require that certificates representing the shares of Common Stock issued pursuant to a Restricted Stock Award bear a legend making appropriate reference to the
restrictions imposed, and that certificates representing such shares will remain in the physical custody of the Company or an escrow holder until all restrictions are removed or have expired. The Committee may also require the Participant to execute
and deliver to the Company (i)&nbsp;an escrow agreement satisfactory to the Committee, if applicable, and (ii)&nbsp;the appropriate blank stock power with respect to the shares of Common Stock covered by such agreement. If a Participant fails to
execute an agreement evidencing a Restricted Stock Award and, if applicable, an escrow agreement and stock power, the Award shall be null and void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Vesting of Restricted Stock Awards</U>. The Committee shall, in its sole discretion, provide in an Award Agreement the time or times at
which, or the conditions upon which, a Restricted Stock Award shall vest. The restrictions imposed on shares of Common Stock granted under a Restricted Stock Award shall lapse in accordance with the vesting requirements specified by the Committee in
the Award Agreement. The Committee may condition the vesting upon the passage of time (e.g., subject to the Participant&#146;s continued Service for a specified period) and/or the occurrence of any other event or condition that is established by the
Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other agreement between a Participant and the Company, for the acceleration of vesting of a Restricted Stock Award upon a
Participant&#146;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. If the vesting requirements applicable to a Restricted Stock Award are not satisfied, the shares subject to the
Award shall automatically be forfeited, the Participant shall assign, transfer, and deliver any certificates evidencing ownership of such shares to the Company, and the Participant shall cease for all purposes to be a stockholder with respect to
such shares. If the Participant paid for such forfeited shares in cash or other tangible consideration, then, unless otherwise provided by the Committee in an Award Agreement, the Company will refund to the Participant the lesser of (i)&nbsp;the
amount originally paid by the Participant for such shares and (ii)&nbsp;the Fair Market Value of such shares on the date of forfeiture. Without limiting <U>Section</U><U></U><U>&nbsp;8(a)</U>, by acceptance of a Restricted Stock Award, the
Participant shall be deemed to appoint, and does so appoint by execution of the Award Agreement, the Company and each of its authorized representatives as the Participant&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> to effect the transfer of forfeited shares subject to the Restricted Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Nontransferability</U>. Shares granted under any Restricted Stock Award may not be transferred, assigned or subject to any encumbrance,
pledge, or charge unless and until <U>(i)</U>&nbsp;the vesting conditions applicable to the Award have been achieved, and (ii)<U></U>&nbsp;the other restrictions on transferability applicable to Common Stock set forth in the Plan, the Award
Agreement or otherwise have been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Rights as a Stockholder</U>. Subject to the foregoing provisions of this
<U>Section</U><U></U><U>&nbsp;8</U> and, unless otherwise stated in the applicable Award Agreement, a Participant generally shall have the rights and privileges of a stockholder with respect to shares of Common Stock granted to the Participant under
a Restricted Stock Award, including the right to vote such shares and the right to receive dividends and distributions with respect such shares. However, unless provided otherwise in an Award Agreement, all cash and stock dividends and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distributions shall be held back by the Company for the Participant&#146;s account until such time as the related portion of the Restricted Stock Award vests (at which time such dividends or
distributions, as applicable, shall be released and paid) and if such related portion of the Restricted Stock Award is forfeited, such dividends or distributions, as applicable, will be forfeited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Section 83(b) Election.</U> If a Participant makes an election pursuant to Section&nbsp;83(b) of the Code with respect to a Restricted
Stock Award, the Participant shall file, within 30 days following the date of grant of the Award, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under Section&nbsp;83 of the Code.
The Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant&#146;s making or refraining from making an election with respect to the Award under Section&nbsp;83(b) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>Restricted Stock Unit Awards</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Grant of Restricted Stock Units</U>. An Award of hypothetical Common Stock units (&#147;<U>Restricted Stock Units</U>&#148;) having a
value equal to the Fair Market Value of an identical number of shares of Common Stock may be granted to any Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the number of shares of Restricted Stock
Units subject to the Award, the vesting and/or earnings conditions applicable to the Restricted Stock Units, the timing for settlement of the Restricted Stock Units and such other terms and conditions as the Committee, in its sole discretion, shall
determine. No shares of Common Stock shall be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside funds for the payment of any such Award. A Participant shall have no voting rights with respect to
any Restricted Stock Units granted hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Vesting of Restricted Stock Units</U>. The Committee shall, in its sole discretion,
provide in an Award Agreement the time or times at which, or the conditions upon which, Restricted Stock Units shall vest and/or be settled. The Committee may condition the vesting upon the passage of time (e.g., subject to the Participant&#146;s
continued Service as of a specified date) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or
other agreement between a Participant and the Company, for the acceleration of vesting of any Restricted Stock Units upon a Participant&#146;s termination of Service under specified circumstances or upon the occurrence of other specified events or
conditions. If the vesting requirements applicable to Restricted Stock Units are not satisfied, such units shall automatically be forfeited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Dividend Equivalent Rights</U>. The Committee may permit Participants holding Restricted Stock Units to receive Dividend Equivalent
Rights on outstanding Restricted Stock Units if dividends are paid to stockholders on shares of Common Stock. If so permitted by the Committee, such Dividend Equivalent Rights may be paid in cash or shares of Common Stock (in the sole discretion of
the Committee), and will be payable to the Participant upon settlement of the Restricted Stock Units to which the Dividend Equivalent Rights relate and, to the extent such Restricted Stock Units are forfeited, the Participant shall have no right to
payment in respect of the Dividend Equivalent Rights. If the Committee permits Dividend Equivalent Rights to be made on Restricted Stock Units, the terms and conditions for such Dividend Equivalent Rights will be set forth in the applicable Award
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Settlement.</U> At the time of settlement of a vested Restricted Stock Unit (which may be upon or following vesting of
the Award, as set forth in the Award Agreement), the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted Stock Unit and cash equal to any Dividend
Equivalents credited with respect to each such vested Restricted Stock Unit and any interest thereon (or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to such Dividend Equivalents and the interest
thereon, if any); <I>provided, however</I>, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Common Stock in lieu of delivering only shares of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Common Stock for vested Restricted Stock Units. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the
Common Stock as of the date on which the Restricted Stock Unit vested (or specified deferred settlement date, if later). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.
<B><U>Performance Awards</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Types of Performance Awards.</U> In the discretion of the Committee, a Performance Award may be
granted to any Eligible Person as an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award, Other Stock-Based Award or Cash Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Terms of Performance Awards.</U> Performance Awards will be based on the attainment of Performance Goals that are established by the
Committee for the relevant Performance Period. Prior to the grant of any Performance Award, the Committee will determine and each Award Agreement shall set forth the terms of each Performance Award, including, without limitation: (i)&nbsp;the
nature, length and starting date of any Performance Period; (ii)&nbsp;the Performance Goals that shall be used to determine the time and extent to which a Performance Award has been earned; (iii)&nbsp;amount of any cash bonus, or the number of
shares of Common Stock deemed subject to a Performance Award, and (iv)&nbsp;the effect of a termination of Participant&#146;s Service on a Performance Award. Participants may participate simultaneously with respect to Performance Awards that are
subject to different Performance Periods and Performance Goals. A Performance Award may but need not require the Participant&#146;s completion of a specified period of Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Determination of Achievement. </U>The Committee shall determine the extent to which a Performance Award has been earned in its sole
discretion, including the extent to which Performance Goals have been attained, and the degree of achievement between minimum and maximum levels. The Committee may reduce or waive any criteria with respect to a Performance Goal, or adjust a
Performance Goal (or method of calculating the attainment of a Performance Goal) to take into account unanticipated events, including changes in law and accounting or tax rules, as the Committee deems necessary or appropriate, or to reflect the
impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships. The Committee may also adjust or eliminate the compensation or economic benefit due upon attainment of Performance Goals in its sole discretion,
subject to any limitations contained in the Award Agreement and compliance with Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B><U>Other Stock-Based Awards and
Cash Awards</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Other Stock-Based Awards.</U> The Committee may grant, either alone or in tandem with other Awards, to any
Eligible Person an Other Stock-Based Award that is payable in, valued in whole or in part by reference to, or otherwise based or related to shares of Common Stock, including, but not limited to, shares of Common Stock awarded as a bonus or other
compensation which are issued without restrictions on transfer and other incidents of ownership and free from forfeiture conditions (other than those that generally apply to shares of Common Stock under the Plan). An Other Stock-Based Award shall be
evidenced by an Award Agreement setting forth the number of shares of Common Stock subject to the Award, any payment required for such Award, any vesting conditions applicable to the Award and such other terms and conditions as the Committee, in its
sole discretion, shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Cash Awards</U>. The Committee may grant, to any Eligible Person, a Cash Award that is payable
contingent upon the attainment during a Performance Period of certain Performance Goals and/or such other terms as the Committee may determine (&#147;<U>Cash Award</U>&#148;). A Cash Award may also require the completion of a specified period of
Service. The degree to which Performance Goals applicable to a Cash Award have been attained will be conclusively determined by the Committee, in its sole discretion. The Committee may specify the form of payment of Cash Awards, which may be cash or
other property, or may provide for a Participant to have the option for his or her Cash Award, or such portion thereof as the Committee may specify, to be paid in whole or in part in cash or other property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B><U>Forfeiture Events</U></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>General</U>. The Committee may specify in an Award Agreement that the Participant&#146;s rights, payments and benefits with respect to
an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events. Such events may include, without limitation, a termination of Service for Cause and/or breach of noncompetition,
confidentiality or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is materially detrimental to the business or reputation of the Company. The Committee shall have the power to determine
whether the Participant has been terminated for Cause and the date upon which such termination for Cause occurs. Any such determination shall be final, conclusive and binding upon the Participant. In addition, if the Company shall reasonably
determine that a Participant has committed or may have committed any act which could constitute the basis for a termination of such Participant&#146;s Service for Cause, the Committee may, subject to compliance with Applicable Law, suspend the
Participant&#146;s rights to exercise any Option or Stock Appreciation Right, receive any payment or vest in any right with respect to any Award pending a determination by the Company of whether an act has been committed which could constitute the
basis for a termination for Cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Right of Recapture</U>. Unless otherwise provided in an Award Agreement, if at any time within 1
year after the date on which a Participant exercises an Option or Stock Appreciation Right or on which an another Award vests or becomes payable, or on which income otherwise is realized by a Participant in connection with an Award, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a Participant&#146;s Service is terminated for Cause, or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Committee determines in its sole discretion either that, (A)&nbsp;while in Service, the Participant had engaged in an
act which would have warranted termination for Cause, or (B)&nbsp;after termination of Service for any reason, the Participant has engaged in conduct that violates any continuing obligation or duty of the Participant in respect of the Company, or
any Affiliate, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then any gain realized by the Participant from the exercise, vesting, payment or other realization of income by the Participant in
connection with an Award, shall be paid by the Participant to the Company upon notice from the Committee. Such gain shall be determined as of the date on which the gain is realized by the Participant, without regard to any subsequent change in the
Fair Market Value of a share of Common Stock. The Company shall have the right to offset such gain against any amounts otherwise owed to the Participant by the Company (whether as wages, vacation pay or pursuant to any benefit plan or other
compensatory arrangement), subject to compliance with Section&nbsp;409A of the Code and other Applicable Law. The foregoing shall apply in addition to any other relief available to the Company or any of its Affiliates at law or otherwise and without
limiting the ability of the Company or any of its Affiliates to pursue the same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Clawback/Recovery</U>. All Awards granted under
the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are
listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement or
compensation clawback policy as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event
constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to voluntarily terminate employment upon a &#147;resignation for good reason,&#148; or for a &#147;constructive termination&#148; or
any similar term under any plan of or agreement with the Company or any Affiliate. Without limiting the generality of the foregoing, any such clawback policy of the Company, whether required by applicable listing standards or law, or otherwise
adopted by the Board in its discretion, may provide that if a Participant, regardless of his or her position with the Company, receives compensation pursuant to an Award under the Plan based on financial statements that are subsequently required to
be restated in a way that would decrease the value of such compensation, the Participant will forfeit and repay to the Company the difference </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
between what the Participant received and what the Participant should have received based on the accounting restatement. By accepting an Award hereunder, the Participant acknowledges and agrees
that any such policy shall apply to such Award, and all compensation payable pursuant to such Award shall be subject to forfeiture and repayment pursuant to the terms of such policy. Although not required to give effect to the provisions of this
<U>Section</U><U></U><U>&nbsp;12(c)</U>, the Committee may, as it deems appropriate, amend the Plan to reflect the terms of any such policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B><U>Change in Control</U></B>. Notwithstanding any provision of the Plan to the contrary, in the event of a Change in Control,
outstanding Awards under the Plan shall be subject to the agreement pursuant to which the Change in Control takes place (or to such treatment as the Committee otherwise determines), which need not treat all outstanding Awards or Participants in an
identical manner. Such agreement (or other treatment), without the Participant&#146;s consent, may provide for one or more of the following with respect to Awards outstanding as of or immediately prior to the effective date of the Change in Control:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. The continuation of any outstanding Awards by the Company (if the Company is the surviving entity); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. The assumption of any outstanding Awards by the acquirer or surviving entity or its parent or subsidiary in a manner that complies with
Sections&nbsp;424(a) and 409A of the Code (as applicable), or the substitution by the successor or acquiring entity or its parent or subsidiary of equivalent awards with substantially the same terms for such outstanding Award in a manner that
complies with Sections&nbsp;424(a) and 409A of the Code (as applicable); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Full or partial acceleration of vesting and/or, if
applicable, exercisability, of any Awards, and, in the case of Options or Stock Appreciation Rights, followed by the cancellation of such Options or Stock Appreciation Rights, if not exercised within a time period prior to the Change in Control, as
specified by the Committee. The full or partial exercisability of such Awards and full or partial vesting of any Awards may be contingent on the closing of such Change in Control. Any exercise of Options or Stock Appreciation Rights during such
period may be contingent on the closing of such Change in Control; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. With respect to Performance Awards, the cessation, upon the date of
the Change in Control, of any incomplete Performance Periods applicable to such Awards, with the Committee determining the extent to which the Performance Goals applicable to such Awards have been attained as of the date of the Change in Control
based on such audited or unaudited financial information then available as the Committee deems appropriate, and partial or full payment to the Participant in respect of such Awards based on such determination by the Committee, or, if not
determinable, with the assumption that the applicable &#147;target&#148; level of performance has been attained, or on such other basis determined by the Committee; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. The settlement of Awards (whether or not then vested or exercisable) in cash, cash equivalents, or securities of the successor entity (or
its parent, if any) with a fair market value (as determined by the Committee) equal to the required amount provided in the agreement pursuant to which the Change in Control occurs, followed by the cancellation of such Awards; provided however, that
such Award may be cancelled without consideration if such Award has no value, as determined by the Committee in its sole discretion. Subject to compliance with Section&nbsp;409A of the Code, such payment may be made in installments and may be
deferred until the date or dates the Award would have become exercisable or vested. Such payment may be subject to vesting based on the Participant&#146;s continuous Service, provided that the vesting schedule shall not be less favorable to the
Participant than the schedule under which the Award would have become vested or exercisable. For purposes of this paragraph, the Fair Market Value of any security shall be determined without regard to any vesting conditions that may apply to such
security. Further, subject to compliance with Section&nbsp;409A of the Code, the Participant may be required to bear his or her pro rata share of any post-closing indemnity obligations with respect to the Award and settlement of the Award may be
subject to the same post-closing purchase price adjustments, escrow terms, offset rights, holdback terms, and similar conditions as the holders of Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Without limitation of the foregoing, in the case of Options and/or Stock Appreciation Rights, such settlement may, at the discretion of the Committee, include payment to one or more Participants
holding such Options or Stock Appreciation Rights equal to the excess, if any, of (i)&nbsp;the Fair Market Value of the shares subject to each such Option or Stock Appreciation Right (whether or not such Option or Stock Appreciation Right is then
vested or exercisable) as of the closing date of such Change in Control over (ii)&nbsp;aggregate Exercise Price or Base Price of such Option or Stock Appreciation Right.&nbsp;&nbsp;&nbsp;&nbsp;With respect to any or every Option or Stock
Appreciation Right that has a per share Exercise Price or Base Price that equals or exceeds the Fair Market Value per share of Common Stock as of the closing of the Change in Control, the Committee, in its discretion, may provide for the
cancellation of such Option or Stock Appreciation Right without any payment to the Participant therefor; and/or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. The cancellation of
unvested Awards (or portion thereof) in exchange for no consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise determined by the Committee and evidenced in an Award Agreement
(or as otherwise determined by the Committee), in the event of a Change in Control and either (i)&nbsp;an outstanding Award is not assumed or substituted in connection with the Change in Control, or (ii)&nbsp;an outstanding Award is assumed or
substituted in connection therewith but the Participant&#146;s Service is terminated by the Company (or its successor or affiliate) without Cause within twelve (12)&nbsp;months after the Change in Control, then: (A)&nbsp;any unvested or
unexercisable portion of any Award carrying a right to exercise shall become fully vested and exercisable, and (B)&nbsp;the restrictions (including exercise restrictions), deferral limitations, payment conditions and forfeiture conditions applicable
to an Award granted will lapse and such Award will be deemed fully vested, and any performance conditions on the Award will be deemed achieved based on actual performance levels as determined by the Committee. For purposes of the preceding sentence,
an Award shall be considered to be assumed or substituted for if, following the Change in Control, the Award remains subject to the same terms and conditions that were applicable to the Award immediately prior to the Change in Control except that,
if the Award related to shares of Common Stock, the award instead confers the right to receive, or otherwise relates to, common stock of the acquiring or surviving entity (with adjustment to such number of shares subject to the Award as determined
by the Committee). For the avoidance of doubt, the Committee may accelerate the vesting of or waive restrictions on awards in whole or in part at any time, for any reason (subject to compliance with Section&nbsp;409A of the Code, to the extent
applicable to the Award). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B><U>General Provisions</U></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Additional Documentation</U>. The Company may, at any time, require a Participant to execute any additional documents or instruments
necessary or desirable, as determined by the Committee, to carry out the purposes or intent of any Award and/or to facilitate compliance with securities, tax and/or other regulatory requirements. Any such additional documents or instructions may,
but need not be, appended to an Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Restrictions on Transfer of Awards</U>. Except as expressly provided in the Plan
or an applicable Award Agreement, or otherwise determined by the Committee, no Participant may sell, transfer, assign, pledge, donate or otherwise dispose of (including any transfer by operation of law or involuntary transfer) Awards or any interest
therein for any reason during the Participant&#146;s lifetime, and any attempt to do so shall be void and shall result in the relevant Award being forfeited. The Committee may grant Awards (except Incentive Stock Options) that are transferable by
the Participant during his or her lifetime, but such Awards shall be transferable only to the extent specifically provided in such Participant&#146;s Award Agreement. In the event of the death of a Participant, an Award may be transferred by will or
the laws of descent or distribution. The transferee of the Participant shall, in all cases, be subject to the provisions of the Award Agreement and the terms and conditions of this Plan. Unless otherwise determined by the Committee, an Option or
Stock Appreciation Right may be exercised during the lifetime of the Participant, only by the Participant or, during the period the Participant is under a legal disability, by the Participant&#146;s guardian or legal representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Rights as a Stockholder.</U> A Participant shall have no rights as a holder of shares of Common Stock with respect to any unissued
securities covered by an Award until the date the Participant becomes the holder of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
record of such securities (except for any Dividend Equivalent Rights permitted by an applicable Award Agreement). Except as otherwise provided for in the Plan or an Award Agreement, after shares
of Common Stock are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such shares, including the right to vote and receive dividends or other distributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Prohibition Against Exchange and Buyout of Awards</U>.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provision of the Plan to the contrary,
except in connection with a corporate transaction involving the Company (including, without limitation, a Change in Control or any transaction or event described in <U>Section</U><U></U><U>&nbsp;4(d)</U>), the Committee shall not, without the
approval of the Company&#146;s stockholders, (i)&nbsp;reduce the Exercise Price of an Option or reduce the Base Price of a Stock Appreciation Right after it is granted, (ii)&nbsp;cancel any outstanding Option or Stock Appreciation Right in exchange
for another Award, or Option or Stock Appreciation Right with an Exercise Price or Base Price, as applicable, that is less than the Exercise Price or Base Price of the original Option or Stock Appreciation Right, (iii)&nbsp;cancel an outstanding
Option or Stock Appreciation Right when the Exercise Price or Base Price, as applicable, exceeds the Fair Market Value of a share of the Common Stock in exchange for cash or other securities, or (iv)&nbsp;take any other action with respect to an
Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal securities market on which the Common Stock is traded. Any amendment or repeal of this <U>Section</U><U></U><U>&nbsp;14(d)</U>
shall require the approval of the stockholders of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Deferrals of Payment</U><B>.</B> To the extent permitted by
Applicable Law, the Committee, in its sole discretion, may determine that the delivery of shares of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award shall or may be deferred and may
establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants (or deferred settlement or payment required by the Committee) will be made in accordance with Section&nbsp;409A of the Code, if
applicable, and any other Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Acceleration of Exercisability and Vesting</U>. The Committee shall have the power and
authority to accelerate the time at which an Award or any part thereof may be exercised or the time at which an Award or any part thereof will vest, notwithstanding the provisions in the Award stating the time at which an award may be exercised or
the time at which it will vest. Any such acceleration shall be subject to compliance with Section&nbsp;409A of the Code, to the extent applicable to the Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <U>Corporate Action Constituting Grant of Awards.</U> Corporate action constituting a grant by the Company of an Award to any Participant
will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the
Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., Exercise Price, Base Price, vesting schedule or number of shares) that are
inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally
binding right to the incorrect term in the Award Agreement or related grant documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. <U>Securities Law Compliance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>General</U>. No shares of Common Stock shall be purchased, sold or otherwise issued pursuant to any Award unless and
until (A)&nbsp;any then applicable requirements of state or federal laws and regulatory agencies have been fully complied with to the satisfaction of the Committee and its counsel and (B)&nbsp;if required to do so by the Committee, the Participant
has executed and delivered to the Company a letter of investment intent in such form and containing such provisions as the Committee may require in its sole discretion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Section 16</U>. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies,
the applicable requirements of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> as promulgated under Section&nbsp;16 of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
Exchange Act so that Participants will be entitled to the benefit of Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> or any other rule promulgated under Section&nbsp;16 of the Exchange Act,
and will not be subject to short-swing liability under Section&nbsp;16 of the Exchange Act. Accordingly, if the operation of any provision of the Plan would conflict with the intent expressed in this subsection, such provision to the extent possible
shall be interpreted and/or deemed amended so as to avoid such conflict. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. <U>Tax Withholding</U>. All Awards (including the issuance or
vesting of shares or payment of cash pursuant to an Award) shall be subject to all applicable tax withholding. Prior to the delivery of any shares of Common Stock or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax
withholdings are due, the Company will have the power and right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or local taxes,
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, or other taxes (including the Participant&#146;s FICA obligation) required to be withheld with respect to such Award. The Committee, or its delegate(s), as permitted by Applicable Law, in its
sole discretion and pursuant to such procedures as it may specify from time to time and subject to limitations of Applicable Law, may require or permit a Participant to satisfy any applicable tax withholding obligations, in whole or in part by
(without limitation)&nbsp;(A) requiring the Participant to make a cash payment, (B)&nbsp;withholding from the Participant&#146;s wages or other cash compensation paid to the Participant by the Company or any Affiliate; (C)&nbsp;withholding from the
shares of Common Stock otherwise issuable pursuant to an Award; (D)&nbsp;permitting the Participant to deliver to the Company already-owned shares of Common Stock, (E)&nbsp;withholding from the proceeds of the sale of otherwise deliverable shares of
Common Stock acquired pursuant to an Award either through a voluntary sale or through a mandatory sale arranged by the Company or (F)&nbsp;such other means as the Committee shall deem appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. <U>Section 409A Compliance</U>. It is intended that this Plan and any Awards will comply with, or avoid application of, the provisions of
Section&nbsp;409A of the Code, and they shall be interpreted and construed on a basis consistent with that intent. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares
of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#147;nonqualified deferred compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified employee&#148; for purposes of Section&nbsp;409A of
the Code, no distribution or payment of any amount that is due because of a &#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date
that is six months following the date of such Participant&#146;s &#147;separation from service&#148; or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a manner that complies with
Section&nbsp;409A of the Code, and any amounts so deferred will be paid in a lump sum (without interest) on the day after such six month period elapses, with the balance paid thereafter on the original schedule. Notwithstanding the foregoing, the
Company and its Affiliates and their respective employees, officers and directors shall have no liability whatsoever to a Participant nor any other Person (i)&nbsp;if an Award that is intended to be exempt from, or compliant with, Section&nbsp;409A
of the Code is not so exempt or compliant, or (ii)&nbsp;in respect of any decision to take action to attempt to comply with Section&nbsp;409A of the Code, any omission to take such action or for the failure of any action taken by the Company to so
comply. Notwithstanding the foregoing, in the sole discretion of the Committee, the Company may, but is under no obligation to, agree to pay all or a portion of the individual tax liability of one or more Participants whose awards do not satisfy the
conditions for exemption under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">k. <U>No Obligation to Notify or Minimize Taxes</U><I>.</I>&nbsp;The
Company shall have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising an Award. Furthermore, the Company shall have no duty or obligation to warn or otherwise advise any Participant of a pending
termination or expiration of any Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of any Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">l. <U>Unfunded Plan</U>. The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by the Company to discharge
its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any rights of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Participant under the Plan shall be those of a general unsecured creditor of the Company, and neither a Participant nor the Participant&#146;s permitted transferees or estate shall have any other
interest in any assets of the Company by virtue of the Plan. The Plan is not intended to be a plan that is subject to the Employee Retirement Income Security Act of 1974, as amended, and shall be interpreted accordingly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">m. <U>Stop Transfer Orders</U>. All certificates for shares of Common Stock delivered under the Plan pursuant to any Award shall be subject to
such stop-transfer orders and other restrictions as the Committee may deem advisable under Applicable Law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">n. <U>Other Compensation and Benefit Plans</U>. The adoption of the Plan shall not affect any other share incentive or other compensation
plans in effect for the Company or any of its Affiliates, nor shall the Plan preclude the Company from establishing any other forms of share incentive or other compensation or benefit program for employees of the Company or any of its Affiliates.
The amount of any compensation deemed to be received by a Participant pursuant to an Award shall not constitute includable compensation for purposes of determining the amount of benefits to which a Participant is entitled under any other
compensation or benefit plan or program of the Company or an Affiliate, including, without limitation, under any pension or severance benefits plan, except to the extent specifically provided by the terms of any such plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">o. <U>Plan Binding on Transferees.</U> The Plan shall be binding upon the Company, its successors, transferees and assigns, and the
Participant, the Participant&#146;s executor, administrator and permitted transferees and beneficiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">p. <U>Severability</U><B>.
</B>Whenever possible, each provision of this Plan will be interpreted in such manner as to be effective and valid under Applicable Law, but if any provision of this Plan is held to be invalid, illegal or unenforceable in any respect under any
Applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or the enforceability of this Plan in any other jurisdiction, but this Plan will be reformed, construed and enforced in
such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">q. <U>Foreign Award
Recipients</U>. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws and practices in other countries in which the Company and its Affiliates operate or have Employees or other Eligible Persons, the Committee,
in its sole discretion, will have the power and authority to: (i)&nbsp;determine which Affiliates will be covered by the Plan; (ii)&nbsp;determine which individuals outside the United States are eligible to participate in the Plan; (iii)&nbsp;modify
the terms and conditions of any Award granted to individuals outside the United States or foreign nationals to comply with applicable foreign laws, policies, customs and practices; (iv)&nbsp;establish subplans and modify exercise procedures and
other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable (and such subplans and/or modifications will be attached to this Plan as appendices); provided, however, that no such subplans and/or
modifications will increase the share limitations contained in <U>Section</U><U></U><U>&nbsp;4(a)</U>; and (v)&nbsp;take any action, before or after<B> </B>an Award is made, that the Committee determines to be necessary or advisable to obtain
approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Committee may not take any actions under the Plan, and no Awards will be granted, that would violate the Exchange Act or any other
applicable United States securities law, the Code, or any other applicable United States governing statute or law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">r. <U>No Continued
Service Rights</U>. Neither the Plan nor any Award granted hereunder shall confer on any Participant any right to continuation of the Participant&#146;s employment or other service relationship with the Company or its Affiliates, nor shall it
interfere in any way with such Participant&#146;s right or the right of the Company or its Affiliates to terminate such relationship, with or without Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">s. <U>Governing Law</U>.<B> </B>All issues concerning this Plan will be governed by, and construed in accordance with, the laws of the State
of Delaware, without giving effect to any choice of law or conflict of law provision or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">t. <U>Captions</U>. The captions in the Plan are for convenience of reference only, and are not intended to narrow, limit or affect the
substance or interpretation of the provisions contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B><U>Amendment and Termination</U></B><B>. </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Amendment</U>. The Board at any time, and form time to time, may amend the Plan in any respect that it deems necessary or advisable,
subject to the limitations of Applicable Law and this <U>Section</U><U></U><U>&nbsp;15</U>. If required by Applicable Law, the Company will seek stockholder approval of any amendment of the Plan that (i)&nbsp;materially increases the number of
shares of Common Stock available for issuance under the Plan (except as provided in <U>Section</U><U></U><U>&nbsp;4(d</U>) relating to adjustments upon changes in Common Stock), (ii) materially expands the class of individuals eligible to receive
Awards under the Plan, (iii)&nbsp;materially increases the benefits accruing to Participants under the Plan, (iv)&nbsp;materially reduces the price at which Common Stock may be issued or purchased under the Plan, (v)&nbsp;materially extends the term
of the Plan, (vi)&nbsp;materially expands the types of Awards available for issuance under the Plan, or (vii)&nbsp;as otherwise required by Applicable Law. The Committee at any time, and from time to time, may amend the terms of any one or more
Awards, subject to the limitations of this <U>Section</U><U></U><U>&nbsp;15.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Termination</U>. The Plan shall terminate
automatically on the 10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> anniversary of the Effective Date. The Board at any earlier time may suspend or terminate the Plan. No Awards may be granted under the Plan while the Plan is suspended or
after it is terminated, but Awards previously granted may extend beyond suspension or termination of the Plan. Termination of the Plan shall not affect the Board&#146;s or the Committee&#146;s ability to exercise the powers granted to it under the
Plan with respect to Awards granted or awarded under the Plan prior to the date of such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>No Impairment</U><B>.</B> No
amendment, suspension or termination of the Plan or any Award pursuant to this <U>Section</U><U></U><U>&nbsp;15</U> may materially impair a Participant&#146;s rights under any outstanding Award, except with the written consent of the affected
Participant or as may otherwise be expressly permitted in the Plan. Notwithstanding the foregoing, subject to the limitations of Applicable Law, if any, the Committee may amend the terms of any one or more Awards without the affected
Participant&#146;s consent (i)&nbsp;to maintain the qualified status of the Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (ii)&nbsp;to clarify the manner of exemption from, or to bring the Award into compliance with,
Section&nbsp;409A of the Code; or (iii)&nbsp;to facilitate compliance with other Applicable Laws. <B><U></U></B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>DELCATH SYSTEMS, INC.
</I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>1633 BROADWAY, 22ND FLOOR, SUITE C </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>NEW YORK, NY 10019
</I></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY INTERNET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>Before The Meeting </I>- Go to <B><U>www.proxyvote.com</U></B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 p.m. Eastern Time on May&nbsp;5, 2021. Have
your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>During The Meeting</I> - Go to <B><U>www.virtualshareholdermeeting.com/DCTH2021</U></B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and
follow the instructions. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY PHONE -
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use any
touch-tone telephone to transmit your voting instructions. Vote by 11:59 p.m. Eastern Time on May&nbsp;5, 2021. Have your proxy card in hand when you call and then follow the instructions. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY MAIL </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Mark, sign and date your proxy card and
return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS FOLLOWS: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">D48810-P52503&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; KEEP THIS
PORTION FOR YOUR RECORDS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">DETACH AND RETURN THIS
PORTION ONLY </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1.50pt;border-radius:5pt; background-color:;;padding-top:2pt;padding-bottom:3pt">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>DELCATH SYSTEMS, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Withhold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For&nbsp;All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">To withhold authority to vote for any individual</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Except</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>nominee(s), mark &#147;For All Except&#148; and write the</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.30em; font-size:8pt; font-family:Times New Roman"><B>The Board of Directors recommends you vote FOR</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">number(s) of the nominee(s) on the line below.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.30em; font-size:8pt; font-family:Times New Roman"><B>the following:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.80em; text-indent:-2.50em; font-size:8pt; font-family:Times New Roman">1.&#8195;&#8194;&#8201;To elect the two Class&nbsp;III director nominees</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Nominees:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">01)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Roger G. Stoll, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">02)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Steven Salamon</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="5"><B>The Board of Directors recommends you vote FOR proposals 2, 3 and 4.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>&nbsp;Against&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">To approve an amendment of the Company&#146;s 2020 Omnibus Equity Incentive Plan to increase by 1,800,000 shares the number of shares available under the 2020 Omnibus Equity Incentive Plan;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">To ratify the selection, by the Audit Committee of our Board of Directors, of Marcum LLP as the independent registered public accounting firm of the Company for the fiscal year ending December&nbsp;31, 2021; and</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">To approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="5"><B>NOTE: </B>Such other business as may properly come before the meeting or any adjournment thereof.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="48%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a
corporation or partnership, please sign in full corporate or partnership name by authorized officer.</TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>

<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:16pt">
<TD VALIGN="top"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT STYLE="font-size:16pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature [PLEASE SIGN WITHIN BOX]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature (Joint Owners)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> </div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Notice and Proxy Statement and Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="right">D48811-P52503&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 2.50pt;border-radius:6pt; background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:12pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>May&nbsp;6, 2021 9:30 AM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is solicited by the Board of Directors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">The
stockholder hereby appoints Gerard Michel, John Purpura and Christine Padula, or any of them, as proxies, each with the power to appoint his or her substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side of
this ballot, all of the shares of Common Stock of DELCATH SYSTEMS, INC. that the stockholder is entitled to vote at the Annual Meeting of Stockholders to be held at 9:30 AM, EDT on May&nbsp;6, 2021, via webcast at
www.virtualshareholdermeeting.com/DCTH2021, and any adjournment or postponement thereof. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>This proxy, when properly executed, will be
voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#146; recommendations. </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; padding-bottom:12pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Continued and to be signed on reverse side </B></P>
<P STYLE="font-size:42pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>DELCATH SYSTEMS, INC.
</I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>1633 BROADWAY, 22ND FLOOR, SUITE C </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>NEW YORK, NY 10019
</I></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY INTERNET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>Before The Meeting </I>- Go to <B><U>www.proxyvote.com</U></B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 p.m. Eastern Time on May&nbsp;5, 2021. Have
your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>During The Meeting</I> - Go to <B><U>www.virtualshareholdermeeting.com/DCTH2021</U></B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and
follow the instructions. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY PHONE -
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use any
touch-tone telephone to transmit your voting instructions. Vote by 11:59 p.m. Eastern Time on May&nbsp;5, 2021. Have your proxy card in hand when you call and then follow the instructions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY MAIL </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Mark, sign and date your proxy card and return
it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">51 Mercedes Way, Edgewood, NY 11717.
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS FOLLOWS: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">D48812-P52503
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KEEP THIS PORTION FOR YOUR RECORDS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">DETACH AND RETURN THIS
PORTION ONLY </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1.50pt;border-radius:6pt; background-color:;;padding-top:2pt;padding-bottom:3pt">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt"><B>DELCATH SYSTEMS, INC.</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>For</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt"><B>For&nbsp;All</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">To&nbsp;withhold authority to vote for any individual</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Except</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>nominee(s), mark &#147;For All Except&#148; and write the</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000"><FONT STYLE="font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000"><FONT STYLE="font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.30em; font-size:8pt; font-family:Times New Roman"><B>The Board of Directors recommends you vote FOR</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">number(s) of the nominee(s) on the line below.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.30em; font-size:8pt; font-family:Times New Roman"><B>the following:</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:4pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.80em; text-indent:-2.50em; font-size:8pt; font-family:Times New Roman">1.&#8195;&#8194;&#8201;To elect the two Class&nbsp;III director nominees</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>Nominees:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">01)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Roger G. Stoll, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">02)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steven Salamon</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-size:8pt"><B>The Board of Directors recommends you vote FOR proposals 2, 3 and 4.</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt"><B>For</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt"><B>&nbsp;Against&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">To approve an amendment of the Company&#146;s 2020 Omnibus Equity Incentive Plan to increase by 1,800,000 shares the number of shares available under the 2020 Omnibus Equity Incentive Plan;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">To ratify the selection, by the Audit Committee of our Board of Directors, of Marcum LLP as the independent registered public accounting firm of the Company for the fiscal year ending December&nbsp;31, 2021; and</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">To approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>NOTE: </B>Such other business as may properly come before the meeting or any
adjournment thereof.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="48%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a
corporation or partnership, please sign in full corporate or partnership name by authorized officer.</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>

<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:16pt">
<TD VALIGN="top"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT STYLE="font-size:16pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature [PLEASE SIGN WITHIN BOX]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature (Joint Owners)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> </div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Notice and Proxy Statement and Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="right">D48813-P52503&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 2.50pt;border-radius:6pt; background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:12pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>May&nbsp;6, 2021 9:30 AM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is solicited by the Board of Directors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Series E Convertible Preferred Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">The stockholder hereby appoints Gerard Michel, John Purpura and Christine Padula, or any of them, as proxies, each with the power to appoint
his or her substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Series E Convertible Preferred Stock of DELCATH SYSTEMS, INC. that the stockholder is entitled to vote
at the Annual Meeting of Stockholders to be held at 9:30 AM, EDT on May&nbsp;6, 2021, via webcast at www.virtualshareholdermeeting.com/DCTH2021, and any adjournment or postponement thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in
accordance with the Board of Directors&#146; recommendations. </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; padding-bottom:12pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Continued and to be signed on reverse side </B></P>
<P STYLE="font-size:42pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>DELCATH SYSTEMS, INC. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>1633 BROADWAY, 22ND FLOOR, SUITE C </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16pt; font-size:8pt; font-family:Times New Roman"><I>NEW YORK, NY 10019
</I></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY INTERNET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>Before The Meeting </I>- Go to <B><U>www.proxyvote.com</U></B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 p.m. Eastern Time on May&nbsp;5, 2021. Have
your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>During The Meeting</I> - Go to <B><U>www.virtualshareholdermeeting.com/DCTH2021</U></B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and
follow the instructions. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY PHONE -
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use any
touch-tone telephone to transmit your voting instructions. Vote by 11:59 p.m. Eastern Time on May&nbsp;5, 2021. Have your proxy card in hand when you call and then follow the instructions. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY MAIL </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Mark, sign and date your proxy card and
return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY&nbsp;11717.
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK
INK AS FOLLOWS: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">D48814-P52503
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KEEP THIS PORTION FOR YOUR RECORDS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">DETACH AND RETURN THIS PORTION ONLY
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1.50pt;border-radius:6pt; background-color:;;padding-top:2pt;padding-bottom:3pt">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>DELCATH SYSTEMS, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Withhold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For&nbsp;All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>To withhold authority to vote for any individual</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Except</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>nominee(s), mark &#147;For All Except&#148; and write the</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.30em; font-size:8pt; font-family:Times New Roman"><B>The Board of Directors recommends you vote FOR</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">number(s) of the nominee(s) on the line below.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.30em; font-size:8pt; font-family:Times New Roman"><B>the following:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.80em; text-indent:-2.50em; font-size:8pt; font-family:Times New Roman">1.&#8195;&#8194;&#8201;To elect the two Class&nbsp;III director nominees</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Nominees:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">01)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Roger G. Stoll, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">02)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Steven Salamon</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="5"><B>The Board of Directors recommends you vote FOR proposals 2, 3 and 4.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">To approve an amendment of the Company&#146;s 2020 Omnibus Equity Incentive Plan to increase by 1,800,000 shares the number of shares available under the 2020 Omnibus Equity Incentive Plan;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">To ratify the selection, by the Audit Committee of our Board of Directors, of Marcum LLP as the independent registered public accounting firm of the Company for the fiscal year ending December&nbsp;31, 2021; and</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">To approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10" COLSPAN="5"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="5"><B>NOTE: </B>Such other business as may properly come before the meeting or any adjournment thereof.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="48%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a
corporation or partnership, please sign in full corporate or partnership name by authorized officer.</TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:16pt">
<TD VALIGN="top"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:16pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature [PLEASE SIGN WITHIN BOX]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature (Joint Owners)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> </div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Notice and Proxy Statement and Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="right">D48815-P52503&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 2.50pt;border-radius:6pt; background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:12pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>May&nbsp;6, 2021 9:30 AM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is solicited by the Board of Directors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">The stockholder hereby appoints Gerard Michel, John Purpura and Christine Padula, or any of them, as proxies, each with the power to appoint
his or her substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Series <FONT STYLE="white-space:nowrap">E-1</FONT> Convertible Preferred Stock of DELCATH SYSTEMS,
INC. that the stockholder is entitled to vote at the Annual Meeting of Stockholders to be held at 9:30 AM, EDT on May&nbsp;6, 2021, via webcast at www.virtualshareholdermeeting.com/DCTH2021, and any adjournment or postponement thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in
accordance with the Board of Directors&#146; recommendations. </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; padding-bottom:12pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Continued and to be signed on reverse side </B></P>
<P STYLE="font-size:42pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g153004g12w27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g153004g12w27.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( "L D ,!$0 "$0$#$0'_Q  ;   " P$! 0              " 8'"04*
M!/_$ "L0  $$ P$  @$$ 00#      8#! 4' 0((  D3$A$4%187&"$B(R11
M<?_$ !<! 0$! 0                 ! @/_Q  L$0 " 0(%! $#!0$!
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M;XOSPU%YQP065,OI]+6S"E$2%9I9<6-]$AIMQ5RYHM%?RW3-0\F;@>& \ >
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M'*^OA8M-)]LOZDSW^05+HT_YJ*'':6W$_/%4OWS-B)A L%VAVYT226-)?FB
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M$'C>V^A5Q-\JR7W40D0^H["8KLW"*N^R0TJ)OLN7=]E/#:9I7X9#P!X \ >
M/ '@#P!X \ > / '@#P!X \ > 0_GM@T>]J?(.4NTOW) SF.9*X9RB^ZBKAF
M##]&L#R(&&F-]\I-8MF8V>?$6$4$T]EI(GD%G.ZWZ-]4(KOF/"?Y97;#PWY?
;\(?#U('@#P!X \ > / '@#P!X \ > / ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g153004g41v01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g153004g41v01.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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-^3==QLJ5  MYP7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g153004g41v02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g153004g41v02.jpg
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M$  !! (! @0$!P         $ @,%!@<( 0 4"1(36!89I]<7&#AXE[?6_\0
M%P$! 0$!                  (! __$ "41  ( !0(& P             !
M A$2,7%1H2%!D;'!T5*!\/_:  P# 0 "$0,1 #\ K>U%U#U.F=4-89>7U@UX
ME9:5UYPK)2DI)85QL=(R4B=C:M%&GGFE5ITDPTPEUT@HHAUQ\A]QQUUQ;BU*
MY%-N;XN[YO4(;\F6GWM1UK_@O%_^6Z&3>KZL5+M[@',-3WCTNI>L.@.K5LU!
MN$M%M;7W0G6K"4D73XQVYLAR+HLM(#QLG%\M513QG"HZ)E%)6GAU*5.<<-<B
MTU3$W$ZE93?']G),;N#C'&T-MKM'#P^/:/%1,5L7FV-BXN-J<"#'1L<#DNS"
M@@  BQ[0P808S30XHH[3; [#;;++:&T)3P+5EA%Y.G#31&G6J[#[3;S#VM&#
MFGF74)<:=:<Q;6$.-.MKX4AQMQ"N4+0OCE*D\\I5QSQSSQT.,5WE]P(<FZCB
M0=UG Z1J!B>V59PI9L-(U73K2 F)$!-6L@>&X-R)L7C:T2!D.TM !L@74(Q@
MU]E9 O#K+G"NALW\FLM^$,BPW*W*4HD8F^T^RTRR1BEQ)05H!QQ%%23(K3"Q
MY>/B,6Y(RI68J)=0]V(H"K4J0:=CR%O@##.!ND"?N?7RD05;I_K'VS_<QGC^
MTK5T.\-EA=@@L*^*AOG5<-XEK$#G;L(.N8RH<#"@_AAAHKLXF'JT5'QPG<FX
M\(,([<,=EGURR'R7O)ZC[SKJEK4,IA?+=^SIGS;_ !"/<#]*<(_;;H*(=-W[
M-\V_Q"/<#]*<(_;;H*(=-W[)U,W;*YKM>:,NVF?NG?SMER??I^:.^'*D+WLM
@,6N6D9(OM0H$8,;N3"7GO0$'8&9\_IL,M-)0A(JQ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g153004g41v03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g153004g41v03.jpg
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KJ(CT#]B(_<1X*VAT'U'X"S7<%LM*W*F?E*-?UGES_<C[@L=?H'J'P5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g153004g66y02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g153004g66y02.jpg
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M(C%1_\0 %P$! 0$!                  (! __$ "D1  $# P,$ @(# 0
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M%/"E(K=6]VC<O:<CZMY*J..7US'6<!M_AZOH_([M2J( >N'2R:SDMI=-.%R
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M'-7ZUUETQ#PI1X1*"]K-J7@*<\LU)S QGTHMQ.YPO5UAPBKI"L&F4HY:Y-,
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MZ\Y[Y#AR4QO>Q1,5_M%M1T.AS7[#EDV5(5]]4!\3K.O!&KN63J3$W:B+1H,
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$G"__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g153004g70x52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g153004g70x52.jpg
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M4U5Q@9&3E-'3)$)BP1<S5'*"H<(6-**QU-4E)D1TI*7#_]H # ,!  (1 Q$
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M.+"/_P!.JB7@/Q?O?Q8.(XV4^;#$OM64S\.^$^YM$;1ETJS_ -7982?+G/\
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MMF_:C/E.39(AKL1WXR2/SDQ^-%%(F06!%[^)]XEV'P]6%9N%RQ'!3KM[X0(
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MUQ9N%EKM^[<=BSVK=BPS$Y),TSR$Y_XM=3TX%JU*M91Q6O7AA51[A%&J ?\
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M,=^D9L7[W3_YA*_S?6V^HZ/PW/[$?]+3#TB;ZU;[1^_H^D9L7[W3_P"82O\
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M42EE!DD=4#,JYRP!4LR4*<8DLB")6=8TS&&:21LE8XXU5GDD(!(2-68A6.,
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M8OW:?RT?,?IO\+-?_I*#_9='K;=/SC>_BI_OZ.A!^1B_=I_+1\Q^F_PLU_\
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M5^/4_I5:=;9ZU^6;;4MW[ER)&W."]9CBKTDJY$$-6I9@:662PQF>RI:.-(1
M 9)6#.U8M3[G-4CCNM6J5JTCK1EJ0/)-::Q@RRSV()1'&D*]-82 [M*96(1%
M+G.+>=XMZU/ WV!.BV2)O=UCZB9;S: =>9G5V)EPK7I]]=U?*2]&S<A8$IJ!
MG"((O#4H_#)FR1V#)0AO$1N_J_TM6VYHVB>O7:98%LK72YTP+*UA;1+'0:0&
M2,2+E!)TP2J#4CMOIOH[+>5Q(L\RQ&5H&F>MS)@,YK,T/6"$(Y0X8IS(!8Z;
M_*0^U=T\R>0.M7=X;)UWI77&D>.,G'UO69T)79XW9%ZF]]N3,MFW$0<G-1L>
M+!0%9<,B(]X=J;-;AE'N9C8TV,F)-'IT-BVRT-OJ6;]J_NB-+;626-:M>/;A
M&G0$B1NQDEE"R,"8UZ@7+,&C8LEFWNUZN;EB"G!3V]ECKLD;FQ,][FW5*,ZJ
M$2,E5(#D)D\597:I"V#DBKA55N5UAY-[*F-NUW8%8K\!%QPE*@]8VNJ1?(V.
MTN)&W>C 59(=CE]HU1K,Q<[!DH.0BK59"GJ JH1,7$18\Q)'M7KZ;9HMIJQT
M9:TTDCN9Y+<,S[6]]GKV&FY1)3F/""+#*\,2BSUW9W,:DFX>J(]SDW&P]I)X
MT1%$*5I(EOK3"RPB+#M9B'.5\AEED)@,2*JB;G/^7]_L[_'_ ..^._\ [X_W
M]:!K<-1X\*92W(F;'2M^;&VR=RQIM>3G<-'NDZ(K6UG%FIQ>(C=&BH",B@*[
MC5<\1$&1U656U,R=/:(-I6RP&[J$I]W9]_2#A%8VVK379IY/[#8@C/I41CC'
M.AN,K.TOID8=7FZN5G(6Q58UVP(':&EYR0WK%IMSAC_M<,SCT>4,_LW*2*BI
MZ*Y4K%PP\()ALCK#)D.ZUC4]HZ-&D=Y$R"(GC]O24<5A*(W3NS9!:L]L82@.
ME39"E9[_  [8PWG.>_PZ?;8O/<MO0>;WJB_:L1C_ #TTOMPHW6^K4LM^R%S_
M ):U_B6!B*XJ\9HM*<)3&\?=,@83CX83@/7-;'PG&/LQC#?;'2N]-SWC=G^M
MN=]OM6I3_GK#:UX[9MR_5HU%_97C&FKZSJ6VN0^S^8BKCR'V[4-<4#D<7KG4
M=4U5+0-,-@PXC3.G)&>DY2SIKLA-S#*+;,3:H.ND$X@PB'9TV:$L*I2,8KTO
M;FI;94V/H;92FM6=K%J[-<22PLC/>O+&J1&58XST8T$D@!D8"-8S%P8R1M>*
MU?L[KU;]J&O!?->K'69(2@6I49V:3IL[CJN_",G@#U"X?DHC7WA)?+QL?C92
MK%L:PNVZWA6/;5(D;<3'Q<6?;!-8[BO^M8*TRL?"!Q\*+-6. J47,S;</'Q\
M5F7--7' !!J9%:CM_K5ZNZV(JL71@:*E82$,[K"UNC6M20HTC-(8XI9GCCYL
M[\%7D[-EB]V>>:QM\,D\G5E$EJ%I2JJTHKVYZZ2LJ*J!Y(XE=PBJG-CQ 7 T
MFC#5YY&<DN1-.D-K[$UOJSCF=K;7D-4=630E.E[C>[GK.N;<L-[MMM9C2K01
M%QD+>ZI5ZE6XB3B(%)T3:Y"P#6(@N,;@W1-?:]JVN=:=6U<W1;5J2:Y&9T@K
M06Y:45:&$L(@[R5YIIY75Y.+PK$8@K&1N!-?W"_$UFQ7K;>U>!(JSB)I9Y:\
M=J2:64*9"JI-%%%&K*G)96<2$KP?% 1;D'!0L([+2T^[#Q,=%NSL^\,3.S3D
M>&R(N6FB A(\-^6DE,Y,D7A  AG3'GEL"#-*0RC7Y'$DDD@1(P[LXCC!$<89
MBW",,S,$3/%0S,0H&6)[ZF47@B(69RBJO-R"[\0!R<@*"S8RQ"@$DX ';66Z
MPUEJ*WF_59J@;0HF^*PE3"WR(L<LM*%*;'M58<P5$K+SCR^9N4B&6Q4L95E+
MK,,4A>?*YA.;#\)6(KNWW-GL8("R,J^]J]@<9 OSCD/+/N,JD>6M=W:-X;$-
MR/MDJ"?A)'W7/QY*,?H0@^[2];$H51YG:AKESJ1PD7;0!W7(DHA67,1TDIMK
MWU3[#EE"GT#X)0VIHE+*W!U8&E VG@C763(>C<L^%MSGJV4:2NY E5?[\>3T
MK,&2%+<205S@^U&Q#("KR>&/=:L<L1"RJ"5)_NMVYQ/CN!G&#C([,!Q8Y8"G
M7O+^@I?I$1%[ACXM;CK/L=3+L!E;7AU6<..#FP)#\0PT3YLJ>6E]C+B%9P5C
M&<*3C<S=\,W"+<LFV/)@'E96%9QCR!291*2N.PP<?W?=J%Z&Y0_@56TJGMB,
MN8S^@H2G?S\Q\].XXN<3I&A2J-L;?]C!EXID@Z#@""QB40KF6EK?L5A.2ZX$
MDP9C+K@@Z'WD *4H\M]LUEIH;6O$/B-+D?J[;.3Q2$)-,JLIE&<+!"F Q1C@
M,2H+]D4%22TGM^VM"PLVL*RY9$)'L=N[N<XR!G S[/XQ.1@(A9Y=?+GE3!Q$
M2ETJA0)#(33GD7AE5/@"LG3TNZG.,>BJPE+<%"<=0ESR&PPQ"/4;RG$M7C'A
MKP]+)+A;LP+$9[^DS#A#&#[^@@#. <965AYZ:2-ZSW%%7O"AP.W;I(<NQ^'4
M/92?K(#J8S&,8QC&,8QC&,8QC&.V,8Q\,8QC'PQC&/[8ZK#6T:_>C1HZ-&DC
MVGJV7V/F (@=R;<TW*5]4GZ4IJR0H_:59E4@I?'GX#9%#V-3YE(V8]M48296
MUGQ2GSO=Y@Z3RDNO:=M*O4$E&E>27AE+BV/8*<L&.2K9JSIGD>867B^%Y*2J
MX:V:SV.F4MVJC1\L-6:'V@W'(DCL06(GQQ]DF/DN6XD<CGSTKI*I:+K<U U@
MZRSTA;;=-; O=SNLSF>N5[O-@:!%E+199) X(.3%QT5#PP,?#1</ PL'#1,+
M!Q$;%QXHK?M_<)]QECDF6*-88(ZU>"O'TX*U>(L4AB3+-Q#.[LTCR222.\DC
MN[$GRG3BI1ND;2.TLKSSS3/SFGF<*&DD;"KGBB(JHJ(B(B(BJH&F@<HZ5$\N
M-J:-T<Q0MG8@]3[E<VAN'8<U0;]1*&/18"DVJNR&LX.Y6>!@ZWMP7>#]N"I=
MC@*+*6B":H2KA+6 R,E8FN#'S>T3OLM/<-P-FGU+M'T2C52S6LV38DL0RK;D
M@ADDEI-MX@:Q%+92&0V.C'&KI)*5B]RA3=+-*F(+/"K;-FU.T$\$ A2&6-JZ
M321I':%PRK#)'"TB=#JM(RLL8:1_K5M3^FRVGC(!>[U!VF\[>W%;*E6-BP.U
MZYIN3D->BZVB+S4Y!N:J4H@N$US$[0D@JO/L#3\-7IS94K7&I40-TF))8#%'
M:EH=V:M7DAKTJ,,TU62E+>1;)M/7F4QS)QDM/41IHR8Y)8ZB2E"P#@L28^3;
MUFF22:U:EBCL)9CJL8!72:)@\392NMEEC<!T1[#(& )4@ !?K/7(BXUJPU&P
M"Y-@;3!RU<FP\.NL9+B)P B,DA</L+;?9R0$4\UZK+B'6_/YVUI7C"L1L,KP
M2Q31GC)#(DL;8!P\;!T.#D'# '!&#[]/9(TECDBD&4E1HW&2,HZE6&1@C()&
M1W'NTGNC]29TAKZ'UPQL;8>RH>M"QT169'93M*)G8*LPL-&0<)5QS:12:,/)
M1T4'&(6W)V *8M1Y119$S8I-2F,,.=PN^L++VC5JU'E+/*E06!')+([R23%;
M%BP49V?ND3)"H"B.).^4*=7T.!:XL3V$C"I&U@PETC1%1(P8880RJ%_&</*Q
M)+R-VQJ.R>-T)>MBQ^X*OL39VE=K"U5BB2=YU3(4_!-LI 4I(3<35[E6-D4G
M8U L@4!,3$Y(UJ0D:@Y8*T_/SZ8*9CQYN49+7J[K)7JM1FJU+],S&PE>XL^(
M;#(L;S035;%6S$TB)&LJI.(Y1''U$8QH0E8V])K"VXY[%2R(Q"TU9HLRPAF=
M8YH[$-B"14=G:-FBZD9=^#J'8%9:;72JG6HNOFVJSW<R.;?P3:[D]#OV6;?)
M+(,<*E%U^&KL&AQ*B,L,#Q$%%1X@C0XH@3#+*$],9Y1-*\JPPUU;&(8!((HP
M%"@)U9)9#Y9)>1V9B26).G<49BC6,RR3%<YEE*&1R23ENFD:>_ "HJ@    :
MUZN:MK-7V/LK:4<Y*+L^U0J+'V9)9C;T8T+KP"8CJ^W$B)&;<"[M3LBZ=ZA!
M.""'<.(PQC&4*4EN2S5:E-@G2IM8:+BN')LLCR%VR>7>-0N , 8[Z3CK1QV+
M%E2W4LB%9,D%0(%=4X# ([.Q;).3W&-)J/Q7UB+H2N<<6GK1\WM8G:;8@'53
M#&;$](4?:</M^*P=*>[\,D#E6R$%1*M)!:R7$.E H6PX[@EMV=XMMN4NZD0^
ME31SQ-[!Z06Q3>B_%.601#(>!Y'BX#=P,:;C;:PHQ[?^$Z$3PR+[8ZA:"REI
M.3<<$&5!R&!R0E>V<Z<)* YDXR1C4FG1JI $L'$C%O(&DP,ECN,8-CB'&GVV
M#A<N>N(\MEY#1#;:U-.)3E&8Q&X.K<5;BRMQ<91N)!XL,C*G&&&1D9[Z?,.2
MLN67DI')3AER,94X.&'F#@]_=IO5"XYL4:^R6W9G9VS-T;3Q03=;UFQ[9-H@
MC%7IQLN!9#ZY$Q6JM=:Z@4#3UAA8 ^>GI6"G;47B%C6?>^11<"+D[.Z&Q62E
M'4J4*?I*VIHJ2V&,TZHT2RN]RU:DS%%)*L4:21PKU'/#)R&,% 0SM:>Q8MV>
M@:\<EDP@1Q%Q(T:K6@KIAY$1G=D>0\%'+ QI0=)TNX:\U31Z?L*_RFT[[$0K
M7]:; ETX9?M%J.>>DI^0""3\(J"3*&%#5J%PM[,+71XN*424L-1+K:_8@M7+
M$]:LE.N\AZ%9.XAA4!(U9O[\G!097P.I*7? Y8"]2*6"M#%/.UF94'6G;L9)
M6)9V _NIR)$:=^$85<G&2J73/3G6G;$H\-LW7]YUM8W#VJ]L&G6:CSKL60@.
M3;AK9"FP,HY'%N,D(%/0$>^H,A8[Z&",-NJ9=PG*%+U;$E2S7M1!3+6GBL1A
MQR0R0R+(@9<C*\E'(9&1D9&DIX4L035Y.73GBDA?B<-PE0HW$X.&XL<'!P?=
MK(5&L1E)J=8ID)A_$-4:]"UB(P4[A\K$9 1HT4!@EY*&DO/X%$:]9U+;>''/
M,O"$8SY<8SS/8FFGDQU)Y9)GP,#G(Y=L#O@<F.!DX&O8HUABCA3/"*-(UR<G
MBBA5R?>< 9.M6UQJJL:M7L%RLKE'%[+V59-JV14H8V9G^I[2Q%BR*(_TQQ_9
M8MH>'!9"#7Z[C"&U840[YN^%K5R:YZ,)>&*E2*G%P7C^!A+LO+N<N3(Q9NV<
M^0TG7K1UNOT^7]HL269.1S^$E"AN/884!5 '?'Q.OW46JZQI37\-K:G+E'*]
M!EV(X1R:,;/DW2K19IBVRSI1;0PC;JG9B=/<;\H[?D94VWGSY1E:O+MR:_9D
MM3\>K(L2MP!50(8DA0 $L1A(U'F>^3HJUHZD"5XN730R$<SR8F21Y6).!YN[
M8[# [:36[<:8JQ;&EMM4;:.V-&[ M$%"UJ\S6JCJ&^%?HFM9/_IG^JJKM+7^
MS::_-5]J4D HRV1=>BK>B*(;AB)XB(!C@0W=?=7BJI2L4Z>X5H9)):\=Q;(:
ML\O'J]&:G9J3B.4HK/"\KPEP7$8=G9F\VWK).]J&S9I3RHD<SUC 1.L?+I]6
M.S!8B+QAF595C67B0A<JJ@*Q8Z,NR4P*G.72]PRQ"*<2Y;JY.,0MS/54)V$G
M5MFRXL=[/D>UYA<Q%Q'&CQ6I>"EYN-92"@Y*V&45CI3M.(*\G(3@02QF2!>O
M')'E49LYAZG. EB4D2-SRX]W4D/4B$76F3!B/5C<)*W2='P7"XQ+PXR@*.2,
MZCCGMO?3?2VM(V-0*_L^FS=)LK&78R9&]/#S>$^U1YC2L.@R82U8SALP$E+;
M[.<XRVYY5,/I<'==:6[HW)MOM16X#B2)LX/XKJ>SQL/>KJ2I]XSD8(!",\*6
M(GA?\5QC/O4^:L/FI[C]A[$ZAQ29N[A7L L1KL_"R3N?+@I@A^G7:-85GT2F
M\)<0H.4':7CU,,D,RD8XYEE[+X#^,%V?QVGQ725SVEC'?B5%JH[#NI['G&2.
MV5,<@&1Q<>SJ^;>U3$#NC>603%,H]_F,,,]\'DI['(/=U$=XB]27'I7+ZXL8
MTIAO'G'CI:,-CU.XQ\?*82W'D(;4KXXQD%Q2,9[=UYQW5KS^![(?$=Z!H\]F
M>.1'Q_N*74G_ (QGY:D5WR/C[<#AO@K*5_:>)_Y']>FV[5Y0;6Y$DLZ[IE?(
M@X2;?2,FKP#C\I.6'/F\V&9:30R+E8",)]9X0<4(%"$N.23I3+*'&IW;O#^W
M;&IO6YUEEB&?2)@(X8/=F./+8<YP&9G?/:,*206-G<+%XB")"B,<=-"6=_D[
M=LCWX  ']XG&=2%<7./0^CJH\3,>SEWZRML.V$QG*768P9KNL6OQ[^,?78%6
MI3IQ+?9)QV?-C+@PH64:5X@WMMWL@1<EIP%A I[&1CV:9Q[F8#"*?Q$[=F9\
MS6WTA4C)?!FDQS([A1[D!^ \R?>?D!ITO6O:D='1HT=&C4,L?XB6T9;:W,ZV
MR<OH/7'&C@K?-BTO8&MIR&M=JY7[7C]6:Z<O%GN=&9'V'4*O5X6=[*QKS!]0
MM;%B&BYM)LC')%6<+O3>&*:4]BA1-RM;KXAK59ZUN-X8=FI-<M>CPP6":T\T
MSQ__ %7&:$Q%XRJOGB=27?K+V=WE9Z-?;]EGL0SUW267<[2UJ_6DFA GBCC1
M^_0Y0RB0*^67!8:S7_&IA+2["5"N\5-G3NY[)LG3=!@-6PNR-0R3,H+OW3=M
MW5K6PM[!9LV*6+C^FJ@8S=X:1D SJ6^2,X4LY"VT.K2> WA$D\N\5(Z,52_9
MDN/5NKP.VWH:%N(US%US^%G4UY%5EG ...,Z33Q>DA2)-LL/<DL58$K)8JMR
M%VI+;KN)Q)T1^#B(F0L&A)&<^_[]<>-?K+9]?Q=*]HG8;5)J7&@KDYNB9D[A
MKB+E=>U5H791 <%5JI)3P4]MF8.SJ^8SEZJ#L QHLE#DRSP2WBQP\+7@*W3E
M]'EW&J;$^[#::")!:=+,Q-4&2:9(VCIHOI<?:8EF*N$# *6RK^+ZUE.K'2L"
M&+;CN-MVEKJ\$06R0D432![3MZ,_>(!5#(6(R0,6#XTBY6O:Z*C.$O(=RW[3
MDKZBCU.:?A*,'9JU1-(!;XDKG7K7L4:H14W7PJH26-/%@LJ9CCHQ_,(_:6#X
M)R6S;P'PEM*^_P"V""FM;TB:,26&BEL[@VW)!+#5,[QR-,%,:MW97'4$)60)
M@OB[G'7*[/?ZMEIQ#$Y6!9(X*8NM-'+.(E>,1$ARH(5E/ RAD+ZFUXW3J\;1
MO:.,EA-U#1>.O$?=D&@._4]O:%EE^5]PJE0K]9:K9)R O3CI&U.#I)'=<3_Q
M<*.E'XP2Q5]#JY\ #^QUO6T2WK&Z;U0DY5YC3B39H9II93*J\@62$-@X_P!:
M%0,T<F$AXQ_[S/ZND-6&AM5R/$\/I$C;I+'%''P+8PK28R,X,;%RH=-;WL_Q
ME([7MWMFJT\=YZ3V+5M2[KN$P*!L*NS-9J&RM Z+%W?L[5%TN4/'/TE,Q4P7
M2X&534[;9YT<\(8@^MQ8%@@2S6U3P,UJO#<]9QI5FNT($9JTL<LU7<MP.WU+
MD$$C"QTYFXR)UH(HRK$+*[12!5['BQ8)I:WH$C6(JUR5PLZ/'%8HTA<L5IID
M4P\XE)1NE+*X8#E&H="="K_C'7,(JD$W'1[EBE=A:OX7%0.H-;%UEZ?=VIRW
ML]W@H :+V?,;(76)2(D1JP$:!5Y6K5B0K/MZ1K%;RC$2 T4YE\#0,+(@W#II
M5N;\LEZTLHB%/98:\DA>I'5ZJ.IE8-,DTR2\<Q0 <2Z">+)E,)EI]1IZ^T%*
MM=HRYL[I),D86R]@QLC",,L;QQM'R DE)Y!2V^/3KFK:^1:E\:]D/6FN4V^W
M_;-+/V#K"$3K^LT3?$CQT>]TV(Z:R/LJ>FMCQA0<7 4V/**]A:<D"G6 \-ON
MD/T=6IK)A]:U1#+/7K4K"U;<GI,MC;DW0<XECS4CCJN"\D[ <O9 )R 2^-J\
M<'5]7V#+'#//:A,]9.A'!=:A[$A?%AWL*0B1*3@<C@8)?IRNYCW+COO?AAJ"
M!U9&6^.Y07>^UVRV.5ND36ETB)H5)7;Y8F.%/=9:EI(<+U)+T%OI3(CQ;\%$
M-&6*9AQU:YLVQP;GMV^WI;CP-M%>M+%$E=Y?2'LV! @8J"44MA,X]DN)'*Q1
MN=3>Y[M+0N[152LLJ[E-.DDCS+'T4@AZKE0V.3 >UC/M!2BYD=-1H:3\=^1^
M9"N6ODMQGML%LFQ:.HVYJA\V3L454-L!;$WR]H.OM5>O9M-UN-)#_JOSK0BT
ME2L[*Q$-+3$;#*?D*W!RVUW_ *.U]82P[5NL,E6+<+%&?TL.)J;5MN&Y2F:7
MHUX+#=' _ JD:/(B/)A99$UVGXU;T..7<=NE2Q)2@N1>C%#%:6Q=-%.G'U)9
M81U?=(6=E5F5.\:.]S>//O9$%X<E@YBZXTY+:RVFBV46D0FJN1U0M 2XZ=L?
M(VI:.D2)JOB2=$L<E#% S4A9*L8V?72#@UQ1<@(&O!T2B V_PW5D\41;':O)
M;IF&Q8DN;7/"W..+:YMP01R%+,2R!HUBF4K*%;F%+>R^IF[OEA-@?=H*C5K/
M5AA2MN$4HXO)?BI,70-#(R$.TD1!3D.!8#NNFIM>,;MC0M7(C>9'%Z>C-EP4
M'>=RV7%-Q":C&:XMP^V(C4=*V@'KG;>QYZUJV!;+#(%J^9P>RR=@'C(]F9<D
M&!98)CJ8/@>EN,P?8]WC>I))7HQ=?J76.[O2>[/4:U2JQ0BM#$@_MQB2(NQ0
M*3&QU&#Q7:I1%=VVUQ8C2:W+TN%4#;4LI5ALBO:GDE,\LC-_91(SA5#\@'4:
MW.=\=#3L%L63U [HO;!NT(J;L6NWZJ$_$YR[N]O<,[JK7.FQY A [*[1M6-@
MG-D5YY;3; 5++&--:5_BK;0C^CV])52[ZPIK4>.*R)F#]MO-*.W:O%1DB*F\
M@JRC.6G4JI\@5G\95$G:KZ%::PC20&-2G_?/2WJUZ@8]C)95#8C/]V$@L//'
MK_PW50,A=FVF XF\B9^GTZPBU6DW!B(:BJGM"R*Y 5GCN55X:UV *)JD=:WK
M/9Q[!!0*YV1>.JX$J[./UB9CC8<?S_L!.KU(I=YVN*>>,S6("_.:G%ZMFW-9
MI(8V>9H1#"8I).F@69D$8FC99"?]L8F2S+'M=^2*&010RA.,5F3TZ.@8TED"
MQ+*9)1(B<V+1JW,QNK('A<I^>+?%6I:$7:=+V.;VYOH.R$1NJ6+YKVO@5 G7
MNLR=H;0!L^TK#,A43#E1B 3(R.<C3#4W&8;:8@$NLOX?1";/X=]<3[ET;\4=
M+;FB#7#6LR-.MFV*=1HJ<2-8Q,[*[API@0DR=QC4MN6]>K(J74IR/:NK(5JB
M:!!$:]8V;*R69'6#\$BE5XD]5OQ.W<(=PLY^;3YJ\L]FQ%.IT35.)E&XT\>M
MI1)-BA&OG3E;IR(K^+G6AYF1%OKH40('"1]G S%1M/G0R'(!<B]: AY2 ]]2
M&_>&Z>P[+4>>=YMYL;KN=-Q%(?0T@VR7H3&-36#2$R-$W-YXV EXB%BDO39;
M1O=G=]TL+#$L>UP[?0LH9$_M+S7XS-&'83$(%19!P6)P>'(R -'S;%/>*+R?
M-XZ<N^7U5+XEUO7VA[)N"C47CY:XB_V/?9,SKBX#4>+G-F2L9M2J1D(N6DW<
M3!M*C*2@D: ,!6U:U.JP0_+1^$=H7=-DV28;U+9W&*C8L;E"]:+;0EJ V'CJ
M(].9Y!&HX+8>?#2*V80.PCG\2;BVW[KNL1VR."E);AAH2I/)>+UY1"KV&6S$
ML99CS,*PY$94]7XJ',>-@!5$/4FS<0-[JY"![3O6KWM*5I<)<YDU_7&I:GMZ
MQ2H1VOUW="I B!N< $!61!Y5(LH<M,S8H^'C9><!;)X":8BQ%O>W>K&IU[8O
MRB2!%6U=FI1(RV?1SQ$D$C-*Q3*+[$;.R1LNWB]8LPR[5=].6S-6-2,I,[&"
MK%:=E,'6[F.9 (U#\6)YN$5W&,OWCF5^GV&W0\7P_P!W3P-63MU"Y*2M.NJ:
M9@_1NBJGR+V;%3=<L,NS.5V2I^M;,I^;")%*+Q81!JS#L34N>L<'*M]'TL\4
M$C[WM\;3>A'@D-J<<=PW";;*CQRQ(8Y4GM181@57I,99#&B@MC/XSCB>55VJ
MXZQ>E LTM>$YITH]PL*\<C!XVBKR9=2">H!&G-F(7;"_&PUP5:"H&K:$V-+Q
MC_O6HU^P2-KUU#$R.YP./?TB&:$?2W+ 1<8NJJKSHU<-VJN,>J8=D<6G&'HE
MK,KE$> K0A$DNXU48<)I(UAM2!*+;EZL-E9Q&('FZ@,JT^8G:(>YSPTJ?%]<
MRF.*E8=3SB1VD@0M;6AZ>(##S,JQE,1M9X])9#[U]K3<&/'%W!7!->['O'%D
M*=U3*\&:+RRV;&:UN->,MM"_KOD'):@BIMJQ3]R#AY6MDQ@\8X'KL:LO;#Q/
M2CCDM(Q$=$2K LJ?H^HRM9JU]X:.XGB"QLU1K4$H@L^C[8MUXS%' 724.7#6
MC,*O33")(\B$QX\96HQ7GFVT/6?9H=TL+7E0RP=:\U57$CS!&C*A<0"/K]1C
MR9%1@''6[QL*'6W>1TG&<7N0UGH/'Z=MU1^<>.KZQ*C<;A1=OT734[6V9X\!
MFNP,A)6*\,FU$0B>D)*6CXLAN;C:M(FQH1,5#X"LR^JT?=]LBL[E'!/Z*TH:
M>""Q2L7HY3&K&614BKE9F$:HCN#&\R!F$A+XP@C.X,NVWY8*+RQ&PL>(I9H+
M4-1X^;*(T9I)LQ R,S*IYK&Q4')W[QEJ9J[9DIJR[:%N3%BK>L=U7*Z-UNZ5
MFWC4B\:&XX2G)&]:FLE@@Q7Z'BUBP$.76,,0]UF)46>4&;)U\&O2$?+E8UO
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M)&F-4/VYRZ1^QW+2]KJH.V->PXF,7"Q5]7.+AU2:KI&0[CD3'VA169P*,6L
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)1HZ-&CHT:__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
